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Résumé court  
Détection de métabolites par des peptides d'arrêt ribosomaux  
Les bactéries doivent s'adapter rapidement aux modifications de leur environnement en ajustant leur 
modèle d'expression génétique et leurs activités enzymatiques. Dans la plupart des cas, les variations 
de leur habitat impliquent de petites molécules que les bactéries peuvent détecter et auxquelles elles 
peuvent réagir. Le ribosome, la machinerie de la cellule qui catalyse la formation de la liaison 
peptidique, est capable de détecter les métabolites ou les antibiotiques afin de réguler l'expression 
des gènes, où le peptide naissant au sein du ribosome est capable d’induire l’arrêt de la traduction. 
Dans ce mécanisme, le peptide en cours de traduction (peptide d'arrêt) bloque le ribosome en 
interagissant avec les parois du tunnel ribosomal correspondant à la cavité par laquelle le peptide 
atteint le cytoplasme. L'arrêt peut dépendre uniquement de la séquence du peptide ou bien nécessiter 
la liaison d’une petite molécule. L’arrêt du ribosome en cours de traduction contrôle à son tour 
l'expression sur le même ARNm d'un gène situé en aval. Malgré plusieurs études biochimiques et 
structurales antérieures, le mécanisme exact de détection de ces petits métabolites par le peptide 
d’arrêt est encore inconnu. Mon travail de doctorat a porté sur : (1) comprendre comment de petites 
molécules sont détectées par les peptides d'arrêt ribosomaux, et (2) un cas particulier d'arrêt de la 
traduction dépendant du ligand : la détection des antibiotiques par des peptides d'arrêt courts. 
Pour répondre au premier problème, j'ai étudié biochimiquement et structurellement un nouveau 
peptide d'arrêt (appelé SpeFL) qui détecte l’ornithine (un petit métabolite) et qui est codé en amont 
de l'opéron speF chez Escherichia coli. La structure cryo-EM que j'ai résolue a révélé comment 
l’ornithine est détectée de manière très spécifique par un complexe ribosomal en cours de traduction. 
De plus, j'ai montré que le mécanisme d'induction du gène en aval speF implique un arrêt du ribosome 
au niveau de speFL empêchant ainsi une terminaison prématurée de la transcription Rho-dépendante.  
Dans la deuxième partie de ma thèse, je me suis concentrée sur la façon dont un antibiotique ciblant 
les ribosomes, l'érythromycine, est détecté par un peptide d'arrêt court. L'érythromycine est capable 
de bloquer la traduction de manière séquence-dépendante, où le motif +X(+) est le motif principal de 
blocage. Des données biochimiques publiées antérieurement suggèrent que l'encombrement stérique 
et électrostatique causé par le premier acide aminé chargé positivement (+) empêche l'addition du 
second, arrêtant ainsi le ribosome en cours de traduction. La résolution de la structure cryo-EM d'un 
ribosome arrêté par un peptide MKFR en présence d'érythromycine suggère le contraire, ce qui ouvre 
la voie à d'autres recherches sur le sujet.  
Ribosome, peptide d’arrêt, détection des métabolites, antibiotique, cryo-EM 
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146 rue Léo Saignat, 33076 Bordeaux 
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Short abstract 
Metabolite sensing by ribosome arresting peptides 
Bacteria need to rapidly adapt to the changing environment by adjusting their gene expression 
patterns and enzymatic activities. In most cases, the variations in their habitat involve small molecules 
that bacteria are able to sense and respond to. The ribosome, the machinery of the cell that catalyzes 
peptide bond formation, is able to detect metabolites or antibiotics to regulate gene expression via 
nascent-chain mediated translational arrest. In this mechanism, the peptide that is being translated 
(arrest peptide) stalls the ribosome by interacting with the walls of the ribosomal tunnel, the cavity 
through which it reaches the cytoplasm. The arrest may depend solely on the sequence of the peptide 
or need a small molecule to be triggered. Ribosomal stalling in turn, controls the expression of a gene 
that is located downstream on the same mRNA. Despite previous biochemical and structural studies, 
the exact mechanism of sensing of small metabolites by the nascent chain is still unknown. My PhD 
work focused on: (1) understanding how small molecules are sensed by ribosomal arrest peptides, and 
(2) a special case of ligand-dependent translational arrest: drug sensing by short arrest peptides. 
To address the first issue, I studied biochemically and structurally a novel L-ornithine sensing arrest 
peptide (SpeFL) encoded upstream the speF operon in Escherichia coli. The cryo-EM structure that I 
solved revealed how a small molecule is sensed by a ribosome nascent chain complex in a highly 
specific manner. Besides, I showed that the mechanism of induction of the downstream gene speF 
involves ribosomal arrest at speFL preventing premature Rho-dependent transcriptional termination.  
On the second part of my thesis, I focused on how a ribosome-targeting antibiotic, erythromycin, is 
sensed by a short arrest peptide. Erythromycin is able to block translation in a sequence dependent 
manner, with the +X(+) motif being the main stalling motif. Previously published biochemical data 
suggest that steric and static hindrance caused by the first positively charged amino acid prevents the 
addition of the second one arresting the ribosome. I solved the cryo-EM structure of a ribosome 
arrested by an MKFR peptide in the presence of erythromycin that shows otherwise and opens up 
further investigation on the matter. 
Ribosome, arrest peptide, metabolite sensing, antibiotic, cryo-EM 
INSERM U1212, CNRS UMR 5320 
146 rue Léo Saignat, 33076 Bordeaux 
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Résumé en français 
1. Introduction générale 
Les bactéries sont des organismes omniprésents qui doivent s'adapter rapidement aux milieux 
qu'elles colonisent. Leur survie est liée à leur rapidité et à leur capacité à contrôler de manière 
précise leur programme d'expression génique et leur activité enzymatique en réponse à des 
conditions environnementales changeantes. Dans la plupart des cas, les variations dans leur 
habitat impliquent de petites molécules que les bactéries peuvent détecter et auxquelles elles 
peuvent réagir.  
Généralement, un gène ou un opéron est régulé par une combinaison de mécanismes ciblant 
différents stades de l'expression génique (Bervoets & Charlier, 2019). La plupart de ces 
éléments régulateurs sont situés ou agissent au niveau de la région non traduite 5' UTR 
(untranslated region) en amont des gènes qu'ils contrôlent et nécessitent la détection de 
petites molécules. De nombreux types de molécules peuvent être détectées par les bactéries, 
allant des petits ions aux molécules plus complexes comme les coenzymes et les cofacteurs, 
les sucres, les nucléotides ou les acides aminés. Ils sont capables non seulement de détecter 
l'excès de ces composés mais aussi leurs absences. 
Les mécanismes que les bactéries utilisent pour détecter différentes molécules afin d’ajuster 
l'expression des gènes sont abordés en détail dans le premier chapitre de cette thèse, en se 
concentrant sur la façon dont l'ARN polymérase, les facteurs protéiques, les ARN et le 
ribosome sont capables de réguler la synthèse des protéines en fonction des différentes 
concentrations de métabolites auxquels elles sont confrontées.  
L'ARN polymérase, l'enzyme chargée de transcrire l'information contenue dans l'ADN en ARN, 
est capable de réguler sa propre activité en réponse à des taux de nucléotides ou un groupe 
de molécules appelées alarmones. L’ARN polymérase peut détecter les taux de pyrimidines 
pour réguler l'expression des enzymes de la voie biosynthèse des pyrimidines (Turnbough & 
Switzer, 2008). Les alarmones se lient à l’ARN polymérase pour répondre à une carence en 
acides aminés (Bervoets & Charlier, 2019; Steinchen & Bange, 2016). 
Les protéines sont capables de contrôler l'expression d'autres protéines en réponse à de 
petites molécules et elles peuvent le faire en se liant soit à l'ADN soit à l'ARN Il existe un type 
de protéines qui se lient à l'ADN appelées facteurs de transcription, qui peuvent agir comme 
répresseurs ou activateurs de l'expression génique. En l'absence du ligand inducteur, les 
répresseurs se lient à un opérateur empêchant le recrutement de l’ARN polymérase, alors 
qu'en présence du ligand inducteur, le répresseur se lie au ligand et perd l'affinité pour 
l'opérateur permettant ainsi la transcription. Les activateurs permettent le positionnement 
correct de l’ARN polymérase sur l'ADN pour permettre la transcription. Les protéines de 
liaison à l'ARN peuvent réguler l'expression génique après la transcription en modulant la 
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dégradation de l'ARN ou en contrôlant l'efficacité de l'initiation, de l'élongation ou de la 
terminaison de la traduction (Babitzke et al., 2019; Holmqvist & Vogel, 2018; Van Assche et 
al., 2015). 
Les riboswitches sont des éléments régulateurs de l'ARN qui dépendent d’un ligand. Ils ont 
deux fonctions principales, la reconnaissance de petites molécules et la modification 
structurale. Ils sont donc composés de deux domaines, un domaine aptamère pour la 
détection du ligand et un domaine plateforme d'expression qui contrôle l'expression génique 
par des changements conformationnels (examiné dans Abduljalil, 2018; Breaker, 2012, 2018; 
Sherwood & Henkin, 2016). Les riboswitches régulent les gènes impliqués dans l'absorption 
ou le métabolisme du ligand qu'ils détectent. Les riboswitches peuvent déceler une variété de 
petites molécules, allant des petits ions aux coenzymes et à leurs dérivés. La plupart des 
riboswitches bactériens régulent l'expression des gènes au niveau de la transcription ou de la 
traduction. 
Les ribosomes sont chargés de synthétiser les protéines en traduisant l'information génétique 
codée dans les ARNm (Alberts, Johnson, Lewis, Morgan, Raff, Roberts, & Walter, 2017). Ils se 
composent d'une grande sous-unité 50S et d'une petite sous-unité 30S. La formation d'une 
liaison peptidique a lieu au cœur du ribosome dans le PTC (Peptidyl transferase center) et une 
cavité, appelée tunnel ribosomal, allant du PTC vers l’extérieur du ribosome, permet au 
peptide d’atteindre le cytoplasme. La traduction est composée de 4 étapes : initiation, 
élongation, terminaison et recyclage.  
Outre la synthèse des protéines, un autre rôle important du ribosome est de contrôler 
l'expression des gènes en réponse aux métabolites (Henkin & Yanofsky, 2002; Ito & Chiba, 
2013; Seip & Innis, 2016; D. N. Wilson, Arenz, & Beckmann, 2016). L’un des procédés est de 
détecter le manque d'acides aminés par la disponibilité de leur ARNt correspondant et 
d'atténuer l'expression des gènes biosynthétiques par la régulation de la fin de la 
transcription. Un autre mécanisme de régulation est le contrôle de l'expression des gènes par 
des peptides naissants capables d’induire l’arrêt de la traduction au sein du ribosome. Dans 
ce mécanisme, le peptide en cours de traduction (peptide d'arrêt) bloque le ribosome en 
interagissant avec les parois du tunnel ribosomal. L'arrêt peut dépendre uniquement de la 
séquence du peptide ou bien nécessiter la liaison d’une petite molécule. L’arrêt du ribosome 
en cours de traduction contrôle à son tour l'expression sur le même ARNm d'un gène situé en 
aval. La traduction peut être bloquée à différents stades selon le peptide d'arrêt : transfert 
peptidique, liaison de l'ARNt dans le site A ou terminaison de la traduction (Ito & Chiba, 2013). 
Les peptides d'arrêt peuvent réguler l'expression des gènes par deux mécanismes, le contrôle 
transcriptionnel ou translationnel.  
Malgré plusieurs études biochimiques et structurales antérieures, le mécanisme exact de 
détection de ces petits métabolites par le peptide d’arrêt est encore inconnu. Mon travail de 
doctorat a porté sur : (1) comprendre comment de petites molécules sont détectées par les 
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peptides d'arrêt ribosomaux, et (2) un cas particulier d'arrêt de la traduction dépendant du 
ligand : la détection des antibiotiques par des peptides d'arrêt courts. 
2. La détection de l’ornithine par un ribosome en cours de 
traduction contrôle la synthèse de polyamines chez les bactéries 
Des travaux antérieurs au sein du groupe ont conduit à l'identification d'un cadre de lecture 
ouvert (open reading frame ou ORF en anglais) régulateur qui code pour un peptide de 34 
acides aminés situé en amont de l'opéron speF chez E. coli. Cet opéron code pour SpeF, une 
ornithine décarboxylase inductible, et PotE, un antiporteur ornithine-putrescine (Kashiwagi et 
al., 1991). Nous avons nommé cet ORF speFL, pour le peptide leader de speF.  
L'ornithine est un acide aminé non protéinogène. La putrescine appartient à la famille des 
polyamines, molécules qui affectent la croissance cellulaire, stimulent la synthèse de certaines 
protéines, protègent les cellules du stress oxydatif et contrôlent la formation du biofilm 
(Igarashi & Kashiwagi, 2018). 
Des travaux antérieurs dans le groupe ont montré par une technique appelée toeprinting que 
SpeFL est traduit chez E. coli et qu'il s'agit d'un peptide d'arrêt dépendant du ligand. Les 
ribosomes sont bloqués soit à l'élongation, soit à la terminaison de la traduction, 
respectivement avec le codon 33 ou 34 situé au site P du ribosome. De plus, des tests de 
toeprinting effectués en présence de composés présentant de légères différences par rapport 
à la L-ornithine ont montré que SpeFL arrête le ribosome d'une manière très spécifique en 
fonction de la L-ornithine. Par ailleurs, des expériences préliminaires ont été réalisées au sein 
du laboratoire qui ont montré l'induction de l’expression de speF in vivo en réponse à 
l'ornithine.  
En utilisant la bicyclomycine, un antibiotique qui inhibe Rho, le facteur extrinsèque de 
terminaison de la transcription, j'ai montré que SpeFL induit l'expression génique grâce à un 
mécanisme de contrôle transcriptionnel. J'ai proposé un mécanisme d'induction de 
l'expression de speF contrôlée par l’arrêt ribosomique au niveau de speFL pour empêcher 
l'activité Rho et la terminaison prématurée de la transcription. J'ai aussi purifié le complexe 
SpeFL-70S en présence d'ornithine et résolu sa structure par cryo-EM. Cette structure résolue 
à 2.7 Å, montre pour la première fois, comment la liaison d'une petite molécule autre qu’un 
antibiotique déclenche l'arrêt traductionnel de manière séquence-dépendante et très 
spécifique. J'ai pu montrer par toeprinting que le motif conservé HIRRXXH de SpeFL est 
essentiel pour l’arrêt des ribosomes et reconnaît spécifiquement la molécule d’ornithine. La 
structure montre aussi que le blocage de la traduction est effectué à l'étape de la terminaison 
de la traduction par des mouvements de bases au niveau du PTC. L'implication de SpeF et de 
PotE dans la formation du biofilm et l'infection (H. Lee et al., 2018; Igarashi & Kashiwagi, 2018; 
Keogh et al., 2016) suggèrent un rôle potentiel du SpeFL dans la virulence bactérienne causée 
par l'ornithine. 
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3. Influence de la liaison de l'érythromycine au ribosome sur la 
traduction de peptides courts 
La détection d’un antibiotique par le ribosome diffère de la détection d'autres petites 
molécules. Dans le cas des antibiotiques, ils se lient directement au ribosome avec de fortes 
affinités alors que dans le cas des petites molécules, on ne sait toujours pas si le peptide en 
cours de traduction est nécessaire pour la liaison (Contreras, Barbacid, & Vazquez, 1974; 
Svetlov, Vázquez-Laslop, & Mankin, 2017; Vianna et al., 2019).  
Dans ce chapitre de ma thèse, je me suis concentrée sur la façon dont les macrolides sont 
détectés par le peptide en cours de traduction. Les macrolides sont des antibiotiques à large 
spectre qui ciblent le ribosome pour bloquer la traduction. Un membre représentatif de ce 
groupe est l'érythromycine (Ery). L'érythromycine se lie dans la partie supérieure du tunnel de 
sortie ribosomique. Historiquement, on pensait qu'il bloquait le tunnel de sortie ribosomique 
entièrement, empêchant la traduction de progresser au delà de quelques acides aminés et 
entraînant la chute de l'ARNt peptidylé (Mankin, 2008; Menninger & Otto, 1982; T Tenson et 
al., 1997). Cependant, des études plus récentes ont montré que certaines séquences d'acides 
aminés subissent un arrêt de la traduction dépendant des macrolides pour réguler 
l'expression de gènes de résistance situés en aval (Gryczan et al., 1980; Horinouchi & 
Weisblum, 1980; Horinouchi, Byeon, & Weisblum, 1983; Hue & Bechhofer, 1992). Par ailleurs, 
certains motifs se sont avérés enrichis en présence de macrolides par des techniques de 
ribosome profiling ou d’inverse toeprinting, comme le motif +X(+) (Davis, Gohara, & Yap, 
2014; Kannan et al., 2014; Seip et al., 2018). Le mécanisme commun du blocage ribosomique 
dû à l’antibiotique est un déclenchement de réarrangements au niveau du PTC suite à des 
interactions entre le peptide et l’antibiotique. Cependant, les tripeptides courts M+X(+) 
bloquent le ribosome d'une manière spécifique au contexte lorsqu'ils atteignent tout juste le 
site de liaison à l’antibiotique, ce qui suggère l'existence d'un mécanisme complémentaire. 
Selon ce mécanisme, la liaison à l’antibiotique prédispose allostériquement le PTC à 
l'inhibition lorsque les motifs de blocage sont traduits. Afin de mieux comprendre ce 
problème, j'ai résolu la structure d'un ribosome traduisant le peptide MKF en présence 
d'érythromycine et d'Arg-tRNAArg. Le peptide MKF a été fixé à l'ARNt initiateur à l'aide de la 
technologie flexizyme et la structure a été résolue par cryo-EM. Cette structure du complexe 
fMKF-70S montre avec une résolution quasi atomique (2.4 Å) un peptide MKF avec la chaîne 
latérale de Met1 située dans le site A empêchant la liaison d'un ARNt aminoacylé en présence 
d'érythromycine et Arg-tRNAArg. Dans cette structure, comme l'acide aminé occupant le site A 
est la méthionine initiale, il n'explique pas la sélectivité de l'arrêt pour l'acide aminé entrant 
qui a été observée précédemment pour le motif +X(+) en présence d'antibiotiques macrolides 
(Davis, Gohara, & Yap, 2014; Kannan et al., 2014; Seip et al., 2018). La contradiction générée 
entre la structure cryo-EM que j'ai résolue et l'hypothèse soulevée par les données 
biochimiques et structurelles précédemment rapportées sur la façon dont le motif +X(+) 
bloque le ribosome en présence d'érythromycine conduit à des investigations 
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supplémentaires pour tester si cette conformation se produit effectivement in vivo ou si elle 
est un artefact dû à la méthode pour la formation complexe. 
4. Conclusion 
La structure de SpeFL que j'ai résolue a révélé à résolution quasi atomique comment une 
petite molécule est détectée par un complexe ribosomique en cours de traduction d'une 
manière très spécifique. Mon travail a également montré que l’arrêt du ribosome traduisant 
SpeFL conduit à l'induction de l'expression de l'opéron speF par un mécanisme empêchant la 
terminaison de la transcription prématurée Rho-dépendante. L'implication des enzymes 
codées par cet opéron dans la synthèse des polyamines et le rôle que ces molécules et la L-
ornithine jouent dans la formation du biofilm et l'infection suggèrent un rôle de SpeFL dans la 
promotion de la virulence bactérienne. 
De plus, mon étude structurelle du complexe fMKF-70S arrêté en présence d'érythromycine 
et d'Arg-tRNAArg, montre comment les réarrangements du PTC et du peptide empêchent la 
liaison d'un aminoacyl-tRNA entrant. Il n'explique toutefois pas pourquoi un acide aminé 
chargé positivement est important dans le motif +X(+), comme l'ont montré des études 
antérieures. Il ouvre donc de nouvelles recherches biochimiques en la matière pour étudier la 
spécificité du site A d’un complexe obtenu en utilisant du flexizyme. 
En résumé, la structure de SpeFL que j'ai obtenue m'a permis de mieux comprendre comment 
de petites molécules sont capables de bloquer le ribosome de manière séquence dépendante 
en provoquant des réarrangements au PTC. Dans le cas de la structure fMKF-70S, d'autres 
expériences biochimiques devraient être poursuivies afin de déterminer sa pertinence 
biologique. Quoi qu'il en soit, les deux structures servent de base à d'autres études sur la façon 
dont le ribosome détecte de petites molécules pour réguler l'expression génique. 
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1.1. Bacterial metabolite sensing and gene regulation 
Bacteria are ubiquitous organisms that need to rapidly adapt to the niches they colonize. Their 
survival is linked to their speed and accuracy in adjusting their gene expression patterns and 
enzymatic activity to the changing environment. This dynamic environment includes 
variations not only in environmental factors such as temperature, pH, availability of carbon 
sources or oxygen levels, among others, but also in cell density. In most cases these variations 
involve small molecules that bacteria are able to sense and respond to.  
Since 1961 when François Jacob and Jacques Monod predicted the existence of repressors 
that control gene expression in response to specific metabolites (Jacob & Monod, 1961), a 
plethora of mechanisms that regulate gene expression at its different levels have been 
discovered. The original model that Francis Crick proposed as the central dogma of molecular 
biology is that a deoxyribonucleic acid (DNA) molecule is transcribed into ribonucleic acid 
(RNA) by the RNA polymerase (RNAP) and then translated into protein by the ribosome (Crick, 
1958). However, this model has become increasingly complex with the discovery of various 
players in the control of gene expression, like repressors, activators and attenuators, among 
others (Figure 1) (Bertrand et al., 1975; Englesberg et al., 1965; Jacob & Monod, 1961).  
 
Figure 1. Metabolite sensing regulates gene expression at different levels. DNA is transcribed by the 
RNA polymerase (RNAP) into RNA, which is translated into proteins by the ribosome. Excess or absence 
of metabolites (shown as an orange hexagon) can be sensed by the RNAP, the RNA, the ribosome or 
proteins that bind to DNA or RNA. 
In bacteria, transcription and translation are deeply coupled, ensuring a tight regulation of 
gene expression (McGary & Nudler, 2013). The life span of  messenger RNA (mRNA) in bacteria 
is quite short, a few minutes, when compared to eukaryotic mRNA, the half-life of which is in 
the hour range (Rauhut & Klug, 1999). The coupling of transcription and translation in bacteria 
is necessary due to the short half-life of mRNAs. Besides, generally, one gene or one operon 
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is regulated by a combination of mechanisms at different stages of gene expression (Bervoets 
& Charlier, 2019). This makes the existence of mechanisms purely based on transcription or 
translation regulation alone complicated, meaning that bacteria deploy mechanisms that rely 
on the regulation of different levels of gene expression at the same time. All these layers of 
complexity at the gene regulation level cause bacterial protein synthesis rates to vary more 
than 1000-fold in response to environmental or metabolite changes (Alberts, Johnson, Lewis, 
Morgan, Raff, Roberts, & Walter, 2017).  
Most of the regulatory elements are located or act at the 5’ untranslated region (UTR) of the 
genes they control and rely on the sensing of small molecules. The nature of the molecules 
that bacteria can sense is broad, ranging from small ions to more complex molecules like 
coenzymes and cofactors, passing through sugars, nucleotides and amino acids. They are not 
only able to detect the excess of these compounds but also their absence.   
I will now discuss in detail the mechanisms by which bacteria are able to sense different 
molecules to tune gene expression, focusing on how RNAP, protein factors, RNA elements and 
the ribosome control protein production rates.  
1.1.1. RNA polymerase as a small molecule sensor 
Transcription is the first step towards the synthesis of proteins. Bacterial transcription is 
performed by a single RNAP that contains a catalytic core (E) formed by 5 subunits (2, , ’ 
and ) that binds a sigma factor () that recognizes the promoter to form a holoenzyme. 
Promoters have consensus sequences 10 and 35 base pairs upstream (-10 and -35 boxes) of 
the transcription start site (TSS) (Alberts, Johnson, Lewis, Morgan, Raff, Roberts, Walter, et al., 
2017). A primary housekeeping  factor, 70, specifically recognizes the promoters of all 
housekeeping genes whereas several alternative  factors express a particular set of genes in 
response to stress conditions (Berg et al., 2015; Grainger & Busby, 2008). 
The transcription process can be divided into three stages: initiation, elongation and 
termination. Transcription starts when the  factor from the holoenzyme recognizes the 
promoter, allowing the unwinding of the DNA by the catalytic core, leaving around 15 
nucleotides of single stranded DNA that serve as a template to start transcription. Addition of 
the first 10 nucleotides is inefficient, sometimes leading to abortive initiation. Once the 
polymerase overcomes this obstacle,  factor is released from RNAP, which undergoes a series 
of conformational changes that allow it to transition into the elongation cycle. Elongation is 
highly processive, with the RNAP adding nucleotides to the newly synthetized RNA as well as 
unwinding and rewinding the DNA. Nucleotides are attached to each other through a 
phosphodiester bond that is formed by the nucleophilic attack of the 3’ hydroxyl group of the 
last nucleotide added to the chain to the -phosphate group of an incoming nucleoside 
triphosphate. Transcription finishes when the polymerase reaches a termination signal. The 
termination signal can be intrinsic or Rho-mediated. The intrinsic termination signal consists 
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in a GC-rich inverted repeat that forms a stable hairpin and a track of poly-uridines that 
destabilize the polymerase’s hold on the RNA when transcribed. Extrinsic or Rho-mediated 
termination is based on the existence of a Rho utilization (rut) site, consisting of a stretch of 
nucleotides rich in pyrimidines, especially cytosine, and poor in guanine and secondary 
structures. Upon recognizing the rut sequence, a hexameric protein with an adenosine 
triphosphatase (ATPase) activity known as Rho binds 72 nucleotides of single stranded RNA 
and moves in a 5’ to 3’ fashion along the nascent transcript. When Rho reaches the RNAP, its 
ATPase activity makes it capable of pulling the RNA to disrupt the DNA-RNA hybrid. This causes 
transcription termination and the dissociation of RNAP (Grainger & Busby, 2008; Berg et al., 
2015; Alberts, Johnson, Lewis, Morgan, Raff, Roberts, & Walter, 2017).  
Transcription initiation and termination are highly regulated processes, with premature 
transcription termination thought to regulate the expression of at least 10% of bacterial 
operons (Henkin & Yanofsky, 2002). RNAP itself is capable of regulating its own activity in 
response to nucleotide levels or a class of small molecules called alarmones (Figure 2).  
 
Figure 2. RNAP can regulate its own activity according to the levels of nucleotides available or in 
response to alarmones. 
For example, in the case of the pyrBI operon of Escherichia coli (E. coli) which encodes an 
enzyme responsible for pyrimidine biosynthesis, lack of free UTP is sensed by RNAP. The 
region upstream of this operon contains a small open reading frame (ORF) and UTP-sensitive 
transcription pause sites that overlap with the end of the ORF. RNAP pausing at these poly-U 
tracks due to a lack of UTP allows a leading ribosome that starts translating the ORF to reach 
the RNAP and couple with it. RNAP continues transcribing and the trailing ribosome prevents 
the formation of termination hairpins, thus allowing the transcription of genes that synthetize 
uridine. When UTP levels are high, the RNAP does not pause so the ribosome does not have 
time to couple its activity with the polymerase, allowing the formation of a termination hairpin 
(Figure 3a) (Turnbough & Switzer, 2008).  
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Figure 3. RNAP regulates the expression of genes involved in pyrimidine synthesis by sensing the 
levels of free nucleotides. (a) Expression of pyrBI in E. coli is regulated by the levels of free UTP. A 
small ORF upstream of the gene (uORF) contains pause sites for the RNAP that are rich in A and a 
terminator sequence. When the levels of UTP are low, pausing of the RNAP at the pause sites allows 
the leading ribosome to reach the RNAP and trail behind it preventing the formation of the termination 
hairpin. When UTP levels are high, RNAP does not pause, the ribosome and the RNAP are not coupled 
so when the termination hairpin is transcribed it terminates transcription. (b) Expression of pyrC in E. 
coli or pyrD in S. Typhimurium is regulated by the levels of CTP. If the levels of CTP are low, transcription 
starts at the transcription start site 2 (TSS2) that contains guanines. The ribosome binding site (RBS) of 
the transcript is then available for a ribosome to start translating. When the levels of CTP are high, 
transcription starts at TSS1, that contains cytidines that allow the formation of a hairpin that 
sequesters the RBS and prevent translation. (c) Expression of pyrG in B. subtilis is regulated by the 
levels of CTP. When CTP levels are low, RNAP pauses before the cytidine 4 and can slip backwards 
adding extra guanine nucleotides. They anneal with a pyrimidine track downstream to form an 
antitermination hairpin, allowing the expression of the gene. When the levels of CTP rise, the correct 
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addition of the nucleotides in the 5’ end allows the formation of the termination hairpin and 
transcription termination.  
In the case of pyrC and pyrD, dihydroorotase and dihydroorotate of E. coli and Salmonella 
enterica subsp. serovar Typhimurium (S. Typhimurium), respectively, and part of the 
pyrimidine biosynthetic pathway, RNAP initiates transcription differently depending on the 
ratio of CTP/GTP. High CTP levels lead to a transcript initiated with 2 Cs which hybridizes with 
later transcribed nucleotides to form a hairpin that sequesters the binding site for the 
ribosome. Low CTP levels, in contrast, lead to the initiation of transcription downstream of 
the transcription start site in high CTP conditions. This prevents the incorporation of the first 
two cytidines and the formation of the termination hairpin (Figure 3b) (Turnbough & Switzer, 
2008). 
In Bacillus subtilis (B. subtilis), the gene pyrG is controlled by the RNAP sensing the levels of 
CTP. In conditions where there is an abundance of CTP, RNAP is capable of accurately 
transcribing the 5’ UTR, thus generating a termination hairpin. When the levels of CTP drop, 
RNAP pauses at a cytidine in position 4 and it can slip backwards towards a C track in the DNA 
that has already been transcribed. This causes the addition of up to 10 extra guanine residues 
until a C can be added. Transcription then resumes and pairing of a pyrimidine track in the 3’ 
terminus with the extra Gs added at the 5’ end forms an antitermination hairpin, allowing 
expression of the pyrimidine biosynthesis enzymes (Figure 3c) (Turnbough & Switzer, 2008). 
Other small molecules that can bind to the RNAP to control its activity are derivatives of 
nucleotides called alarmones that are part of the stringent response. Alarmones are 
synthetized by RelA in conditions of amino acid starvation when ribosomes with empty A-sites 
because of the lack of the amino-acylated transfer RNA (tRNA) are sensed (Bervoets & 
Charlier, 2019; Steinchen & Bange, 2016). The alarmones guanosine pentaphosphate or 
tetraphosphate ((p)ppGpp) bind to the catalytic core of the RNAP and recruit Dksa, a protein 
that amplifies their effect. When bound to the RNAP they inhibit its activity by promoting an 
unstable open conformation at certain promoters that have specific sequences, called 
stringent promoters. These stringent promoters control genes involved in the generation of 
the translation machinery, DNA replication or nucleotide biosynthesis. Alarmones not only 
control negatively gene expression but also exert a positive control on the non-stringent 
promoters that control amino acid biosynthesis and uptake, stress proteins and some 
alternative sigma factors (Bervoets & Charlier, 2019; Steinchen & Bange, 2016). 
1.1.2. Small molecule sensing by protein factors 
Proteins are able to control the expression of other proteins in response to small molecules 
and they can do so by binding to either DNA or RNA (Figure 4). 
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Figure 4. Proteins can bind to DNA or RNA to regulate gene expression in response to different 
metabolites. 
DNA binding factors 
Although transcription initiation at promoter sequences can be carried out by RNAP alone, a 
repressor protein may be needed to shut down the promoter when the gene is not needed. 
In other cases, initiation at the promoter has to be facilitated by an activator due to difficulties 
of  RNAP recognizing and binding the promoters (Grainger & Busby, 2008). These protein 
factors, called transcription factors, regulate an ensemble of genes that is called a regulon 
(Maas et al., 1964).  
Repressors generally act by causing steric hindrance upon binding to the promoter, by 
blocking the elongation of RNAP, by altering the structure of the DNA, by counteracting the 
activity of an activator or by inhibiting promoter clearance. Activators bind upstream of the -
35 box to recruit the RNAP or remodel the promoter structure, thus facilitating the binding of 
the polymerase (Bervoets & Charlier, 2019). They bind to a specific DNA regulatory sequence 
called an operator. Activators and repressors act in response to certain stimuli that the cells 
are able to sense. They are able to detect ions, sugars or amino acids, among others.  
The best known repressor and the first to be discovered is the lac repressor in E. coli that 
regulates the expression of the lac operon (Jacob & Monod, 1961). This repressor in its 
unbound state has a high binding affinity for the lac operator. Binding of the natural ligand 
allolactose or some other -galactosides such as the artificial isopropyl-b-D-thiogalactoside 
(IPTG), trigger conformational changes in the repressor that drastically diminish its affinity for 
the operator (Figure 5a). The first activator to be discovered on the other hand, was the AraC 
activator that activates the expression of the ara operon in the presence of L-arabinose in E. 
coli (Englesberg et al., 1965). In the absence of L-arabinose, AraC dimerizes and forms a loop 
in the DNA that prevents the binding of RNAP to the promoter. In the presence of arabinose, 
the ligand binds to AraC which dimerizes and binds the DNA stimulating the transcription 
(Figure 5b) (Schleif, 2003). 
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Figure 5. DNA binding proteins control gene expression in response to small molecules. (a) 
Expression of the lac operon in E. coli is regulated in response to allolactose. An operator sequence 
upstream of lacZα allows the binding of the repressor in its ligand unbound state preventing 
transcription initiation. When the levels of allolactose rise, the repressor binds the ligand and it is 
unable to bind to the operator, allowing transcription. (b) Expression of the ara operon in E. coli is 
regulated by the levels of arabinose. When the levels of arabinose are low, a dimer of the repressor 
AraC binds two sequences, the operator and the site i1 bending the DNA and preventing transcription. 
When the levels of arabinose rise, AraC binds arabinose and forms a dimer that binds to i1 and i2 
allowing the expression of the ara operon. (c) Expression of the mer operon is regulated by mercury 
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levels. When the levels of mercury are low, MerR acts as a repressor by bending the DNA away from 
the RNAP. When there is enough mercury, it binds to MerR which bends the DNA in a way that allows 
the correct positioning of RNAP and thus transcription. (d) Expression of argO in E. coli is regulated by 
both arginine and lysine. When bound to lysine, it prevents transcription whilst arginine binding 
activates transcription. 
Some other transcription factors can act as repressors in the absence of an inducing ligand, 
and as activators when bound to it. For instance, MerR (mercury resistance regulator) in the 
absence of the inducing ligand mercury, acts as a weak repressor in its unbound state, bending 
the DNA away from the RNAP preventing the expression of the mer operon from mobile 
elements in Pseudomonas aeruginosa and Shigella flexneri. When bound to mercury it bends 
the DNA in a way that permits correct RNAP positioning for transcription, thus acting as an 
activator (Figure 5c) (N. L. Brown et al., 2003). In other cases, transcription factors can act as 
activators when bound to a metabolite and as repressors when bound to another. This is the 
case, for example, of the factor ArgP in E. coli. When bound to lysine, it stimulates the binding 
of the RNAP to the promoter to repress its activity. However, whilst bound to arginine it 
activates the expression of the argO gene which encodes an arginine exporter (Figure 5d) 
(Laishram & Gowrishankar, 2007). 
RNA binding factors 
RNA binding proteins (RBPs) can regulate gene expression by modulating transcription 
termination or RNA degradation or by controlling the efficiency of translation initiation, 
elongation or termination. Their activity can be regulated by small metabolites, small RNAs 
(sRNAs) or other proteins (reviewed in Babitzke et al., 2019; Holmqvist & Vogel, 2018; Van 
Assche et al., 2015). In this section I will focus on examples of RBPs that sense metabolites to 
control transcription termination and/or translation initiation. 
PyrR is capable of sensing the levels of the uridine nucleotides to regulate via transcription 
termination of the pyr operon for uridine biosynthesis in B. subtilis. When uridine levels are 
low, PyrR is inactive and transcription continues. When the levels of uridine rise, UMP or UTP- 
bound PyrR binds to an RNA structure called the binding loop, that act as an anti-
antiterminator hairpin and prevents the formation of the antitermination hairpin (Figure 6a) 
(Turnbough & Switzer, 2008).  
HutP regulates at a transcriptional level the expression of the B. subtilis hutPHUIGM operon 
that encodes enzymes for the transport and utilization of histidine. Under high levels of this 
amino acid, HutP is activated by binding of histidine to prevent formation of a termination 
hairpin. When the levels of histidine are low, HutP is not activated thus it cannot prevent the 
formation of the termination hairpin and the genes for the export and utilization of histidine 
are not transcribed (Figure 6b) (Babitzke et al., 2019). 
TRAP (trp RNA-binding attenuation protein) is a protein that specifically recognizes L-
tryptophan to regulate the expression of the trp operon in B. subtilis. It can regulate its 
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expression at the transcriptional or translational level. TRAP is a multimeric protein. When 
each of its monomers binds to L-Trp, it recognizes specific sites upstream of the trp operon to 
cause either premature transcription termination or translational repression (Figure 6c) 
(Babitzke & Yanofsky, 2006; Babitzke et al., 2019). 
 
Figure 6. RNA binding proteins control gene expression in response to small molecules. (a) Expression 
of the pyr operon in B. subtilis is regulated by the levels of UTP and UMP. When the levels of these 
molecules are low, unbound PyrR cannot bind the RNA and the formation of an antitermination hairpin 
prevents premature transcription termination. When the levels rise, bound PyrR binds the RNA and 
rearranges its secondary structure to form an anti-antitermination hairpin and a transcription 
termination hairpin. (b) Expression of the hut operon in B. subtillis is regulated by the levels of histidine. 
When the levels of histidine are low, HutP cannot bind the RNA and the formation of a termination 
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hairpin causes premature transcription termination. When the levels of histidine rise, HutP dimerizes 
bound to histidine and binds the RNA rearranging its secondary structure allowing continuation of 
transcription. (c) Expression of the trp operon in B. subtillis is regulated by the levels of tryptophan. 
When the levels of tryptophan are low, TRAP cannot bind the RNA and the formation of an 
antitermination hairpin prevents transcription termination. With the transcription of the rest of the 
5´UTR there is a conformational change on the mRNA that sequesters the anti-RBS sequence in a 
hairpin. When the levels of tryptophan rise, if RNAP has not finished transcribing the 5’ UTR, binding 
of multimeric TRAP bound to tryptophan causes rearrangements in the secondary structure of the RNA 
that cause the formation of a termination hairpin. If the termination is not efficient or the levels of 
tryptophan rise after transcription of the whole 5´UTR, TRAP binding causes the formation of a hairpin 
that sequesters RBS preventing translation. 
1.1.3. RNA regulatory elements as molecular sensors 
RNA regulatory elements are known to be abundant in bacteria (Winkler, 2005). They can 
regulate the expression of genes that are located immediately next to them (cis) or 
somewhere else in the genome (trans). Members of the family of trans-acting elements are 
sRNAs and, as their mechanism of action does not directly rely on the sensing of a small 
molecule, they will not be reviewed in this work. 
Cis-acting elements, on the other hand, can be ligand-dependent or -independent. Ligand-
independent cis-acting elements include RNA thermometers that change their secondary 
structure depending on the temperature (Narberhaus, Waldminghaus, & Chowdhury, 2006) 
or anti-sense RNAs that are transcribed from the opposite strand of the gene they regulate by 
transcription interference or attenuation or by modifying mRNA stability (Thomason & Storz, 
2010). Ligand-dependent cis-acting regulatory elements are called riboswitches because they 
are able to fold and “switch” conformations in response to a ligand. This ligand can either be 
a small metabolite or a tRNA (Figure 7). RNAs that sense the latter are called T-box RNAs and 
are often treated as a distinct class (Breaker, 2018). 
 
Figure 7. RNA elements can detect small metabolites to regulate genes in cis. 
Riboswitches have two main functions, small molecule recognition and conformational 
switching, therefore they are composed of two domains, an aptamer domain for ligand 
detection and an expression platform domain that controls gene expression by 
conformational changes. The expression platform forms base-pairing interactions through a 
sequence called the switching sequence with the aptamer domain depending on whether the 
aptamer is in a bound or unbound state (Figure 8) (reviewed in Abduljalil, 2018; Breaker, 2012, 
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2018; Sherwood & Henkin, 2016). Aptamers can be selected in vitro by using a technique 
called SELEX (Systematic Evolution of Ligands by Exponential Enrichment) based on the 
iterative selection of RNA molecules that bind a specific ligand from a library (Ellington & 
Szostak, 1990; Tuerk & Gold, 1990). The generation of a synthetic riboswitch however, is more 
complex as the conformational switch has also to be taken into account.  With the classical 
SELEX technique most of the aptamers selected were able to bind the ligand with high affinity 
but not to switch conformations. Therefore variations of the technique have been developed 
that allow for screening of the binding and switching capabilities at the same time 
(Boussebayle et al., 2019; Nutiu & Li, 2005). 
 
Figure 8. Riboswitches are composed of an aptamer domain (in blue) that recognizes the ligand, an 
expression platform (in orange) that regulates expression of the downstream gene and a switching 
sequence that connects both. 
Some riboswitches are conserved among all three kingdoms of life, suggesting that some types 
of riboswitches have an ancient origin whereas others are only conserved in phylogenetically 
close organisms (Serganov & Nudler, 2013). They regulate genes involved in the uptake or 
metabolism of the ligand that they sense. Riboswitches can sense a variety of small molecules, 
ranging from small ions to coenzymes and their derivatives (summarized in Table 1). 
Table 1. Examples of ligands for known riboswitches. 
Ligand 
type 
Ligand name Discovery Structure 
Coenzyme 
or 
derivatives 
Adenosyl cobalamin 
(AdoCbl) 
(Nahvi et al., 2002) (Johnson et al., 2012) 
S-adenosylmethionine 
(AdoMet) 
 (Winkler et al., 2003) (Montange & Batey, 2006) 
Flavin mononucleotide 
(FMN) 
(Mironov et al., 2002) (Serganov, Huang, & Patel, 
2009) 
Thiamine 
pyrophosphate (TPP) 
 (Miranda-Rios, Navarro, 
& Soberon, 2001) 
 (Serganov et al., 2006; Thore, 
Leibundgut, & Ban, 2006) 
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Nucleotides 
or 
derivatives 
Adenine (Mandal & Breaker, 
2004a) 
 (Serganov et al., 2004) 
Deoxyguanosine  (Kim et al., 2007) (Edwards & Batey, 2009) 
Guanine (Mandal et al., 2003) (Serganov et al., 2004) 
Amino 
acids 
Glutamine (Ames & Breaker, 2011) (Ren et al., 2015) 
Glycine (Mandal et al., 2004) (Huang, Serganov, & Patel, 
2010) 
Lysine (Grundy, Lehman, & 
Henkin, 2003; Sudarsan 
et al., 2003) 
(Garst et al., 2008; Serganov, 
Huang, & Patel, 2008) 
Sugars 
Glucosamine-6-
phosphate 
(Winkler et al., 2004) (Klein & Ferré-d’Amaré, 2006) 
Ions 
Fluoride (Baker et al., 2012) (Ren, Rajashankar, & Patel, 
2012) 
Magnesium (Cromie et al., 2006) (Dann et al., 2007) 
Some riboswitches can control mRNA stability, self-cleavage or splicing in the case of 
eukaryotes. However, most bacterial riboswitches regulate gene expression either at the co-
transcriptional or translational level (Breaker, 2012). At the co-transcriptional level they can 
induce the formation or disruption of hairpins for termination or antitermination whereas at 
the translational level they play a role in the sequestering or freeing of a ribosome binding site 
(RBS) (Figure 9) (Mandal & Breaker, 2004b). In most cases, Gram-positive bacteria employ 
riboswitches that control gene expression via a co-transcriptional mechanism while 
riboswitches in Gram-negative bacteria exert translational control (Nudler & Mironov, 2004). 
Generally, riboswitches repress transcription or translation in the presence of the ligand but 
riboswitches that activate expression have also been characterized (Waters & Storz, 2009).  
Regulation of gene expression by riboswitches can be either a kinetically or 
thermodynamically driven process (Badelt et al., 2015; Lemay et al., 2011; Winkler, 2005). 
When the riboswitch regulates gene expression solely depending on the concentration of the 
ligand and the affinity of the riboswitch for it, it is a thermodynamically controlled process. 
Thermodynamically controlled riboswitches are in an energetic equilibrium between the on 
and off state. When the ligand concentration rises, their equilibrium shifts to the on state 
reversibly. Riboswitches under a kinetic regime rely on the rates of transcription and ligand 
binding and often need transcriptional pauses to be able to regulate downstream genes. In 
the case of kinetically driven riboswitches, the observed association rate (kobs) of the ligand 
depends on the dissociation rate constant (koff), the association rate constant (kon) and the 
concentration of the ligand. Therefore, the concentration of the ligand must be high enough 
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when the transcription and the folding of the RNA happen to end on the on state. These 
riboswitches need concentrations of the ligand higher that its equilibrium dissociation 
constant (KD) to trigger riboswitch regulation (Lemay et al., 2011; Winkler, 2005). 
 
 
Figure 9. Mechanisms of gene regulation exerted by riboswitches (Based on Abduljalil, 2018)). Gene 
repression can be transcriptional (a) or translational (b). In transcriptional repressor riboswitches, 
binding of the metabolite induces the formation of a termination hairpin (a). However, in the case of 
the translational repressor riboswitches, ligand binding induces the formation of a hairpin that 
sequesters the RBS (b). Gene activation can also be transcriptional (c) or translational (d). In 
transcription activation, ligand binding prevents the formation of a transcription termination hairpin 
(c), while riboswitches that promote translation free the RBS sequence and/or a start codon AUG (d). 
A special case of riboswitch that is often considered a separate class is the T-boxes or tRNA 
binding riboswitches. They act generally at the level of transcription attenuation. Binding of 
the cognate uncharged tRNA to the aptamer region of these riboswitches triggers the 
expression of amino acid-related genes. The binding is mediated by interactions of the 
anticodon of the tRNA with a triplet in the T-box called the Specifier Sequence or loop, hence 
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both charged and uncharged tRNAs are able to bind. A second interaction is needed to 
generate the antiterminator hairpin. This interaction is made between one of the strands of 
the antiterminator hairpin and the conserved 3’ CCA end of the tRNA (Figure 10). If the tRNA 
is charged this interaction is not possible thus the gene cannot be expressed (Sherwood & 
Henkin, 2016).  
 
Figure 10. Schematic view of a T-box mediated transcriptional attenuation mechanism. When there 
is amino acid starvation the tRNA is not acylated and can bind to both parts of the T box, stabilizing an 
antitermination hairpin, which allows continuation of transcription and the expression of the gene. 
When the levels of the amino acid are high most tRNAs are charged and they can bind to the T box 
through the Specifier Loop but not with the anti-terminator, thus the terminator hairpin is formed.  
1.1.4. Ribosomes as small molecule sensors 
Observed for the first time by electron microscopy in 1955 by Palade, ribosomes synthesize 
proteins by translating genetic information encoded within mRNAs. They are essential for all 
kingdoms of life, they are composed of both ribosomal RNA (rRNA) and proteins, and their 
structure has been elucidated at nearly-atomic resolution (Ban et al., 2000; Ben-Shem et al., 
2011; Harms et al., 2001; Klinge et al., 2011; Rabl et al., 2011; Ramakrishnan et al., 2000; 
Schluenzen et al., 2000; Schuwirth et al., 2005). Apart from their main role in protein synthesis, 
bacterial ribosomes are involved in protein folding, quality control of proteins, maintaining 
protein homeostasis and sensing signals from the cell to regulate gene expression (Figure 11) 
(Buskirk & Green, 2017; Rodnina, 2016). Such signals include small metabolites or drugs and 
one of their potential outcomes is to regulate gene expression mediated by ribosomal stalling 
(revised in Ito & Chiba, 2013; Ramu, Mankin, & Vazquez-Laslop, 2009; Seip & Innis, 2016; 
Wilson, Arenz, & Beckmann, 2016).  
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Figure 11. Ribosomes are able to sense different small ligands to regulate gene expression. 
Ribosomes and bacterial protein synthesis 
E. coli contains approximately 25,000 to 31,000 ribosomes per µm3 (Bakshi et al., 2012). The 
E. coli ribosome is a ~2.5 mega Dalton (MDa) ribonucleoprotein complex composed of two 
subunits: the large 50S (Svedberg) subunit and the small 30S subunit, which together 
assemble to form a 70S complex. The large subunit contains 33 proteins, as well as the 5S and 
23S rRNAs, which are ~120 and ~2,900 nucleotides long, respectively. The small subunit is 
composed of the ~1,500 nucleotide-long 16S rRNA and 21 proteins (Figure 12) (Arenz & 
Wilson, 2016; Ban et al., 2014). Throughout this thesis, rRNA nucleotides will be numbered 
using the E. coli numbering unless otherwise stated. 
 
Figure 12. Overall architecture of the large and small subunits of the ribosome. From Yamamoto et 
al., 2014. The ribosomal RNA is depicted in grey and the different ribosomal proteins in different 
colors. PTC stands for peptidyl transferase center, CP for central protuberance and SRL for sarcin-ricin 
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loop. The stalks of the ribosome are shown as well as the different subdomains of the small subunit. 
The three sites for tRNA binding are also shown. 
The large subunit catalyzes peptide bond formation so that 20 amino acids per second can be 
incorporated into the growing polypeptide chain (Maden, Traut, & Monro, 1968; Monro, 
1967). The small subunit contains the decoding center, the molecular infrastructure where 
the anticodon loop of an incoming aminoacyl-tRNA is accurately paired up with the 
corresponding codon of the mRNA that is being translated (Alberts, Johnson, Lewis, Morgan, 
Raff, Roberts, Walter, et al., 2017; Niremberg & Leder, 1964). In E. coli there are 43 different 
elongator tRNAs encoded by 86 genes that serve as adaptors between the 61 different sense 
codons of the mRNA and the 20 natural amino acids (Blattner et al., 1997; Komine et al., 1990). 
The correspondence between the codons and the amino acids is defined by the genetic code 
(Crick et al., 1961). The genetic code is degenerate, meaning that several codons code for the 
same amino acid (Agris, Vendeix, & Graham, 2007; Crick, 1966), with codons used at different 
frequencies (Ikemura, 1985; Nakamura, Gojobori, & Ikemura, 2000).  
There are three different binding sites for tRNAs in the ribosome, called A-site, P-site and E-
site, short for aminoacyl-tRNA, peptidyl-tRNA and exit, respectively. The A-site and the P-site 
of the large ribosomal subunit form the catalytic core of the ribosome, known as the peptidyl 
transferase center (PTC) (Figure 12).  
The PTC is mainly built from rRNA and has very few proteins in its vicinity (Voorhees et al., 
2009). It catalyzes both peptide bond formation and hydrolysis of the peptidyl-tRNA once the 
protein is fully synthesized. The former involves the transfer of the C-terminal carboxylate 
group of the nascent polypeptide attached to the P-site tRNA to the -amino group of the 
amino acid attached to the A-site tRNA (Leung et al., 2011; Simonović & Steitz, 2009).  
The growing polypeptide chain reaches the extracellular milieu by travelling through a large 
cavity called the ribosomal exit tunnel. First discovered in eukaryotic ribosomes (Milligan & 
Unwin, 1986), the exit tunnel is around 100 Å long with a diameter from 20 Å at the vestibule 
to 10 Å at the PTC level with a constriction of 12 Å half-way formed by proteins uL4 and uL22 
(Figure 13) (Ban et al., 2000; Nissen et al., 2000; Voss et al., 2006). This allows the 
accommodation of an extended peptide of around 35 amino acids inside the tunnel or longer 
as both secondary structures, like -helices or turns (Lu & Deutsch, 2005; Nilsson et al., 2015; 
Su et al., 2017; Woolhead, McCormick, & Johnson, 2004), and tertiary structures can be 
formed (Nilsson et al., 2015; O’Brien et al., 2010; Su et al., 2017). The tunnel is conserved 
across the three domains of life, specially at the PTC level. However, the vestibule in 
eukaryotes is narrower than in prokaryotes (Dao Duc et al., 2019). 
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Figure 13. Different regions of the ribosomal exit tunnel (Adapted from Seip & Innis, 2016). Peptide 
bond formation takes place at the PTC. At the upper/central tunnel there is a constriction site formed 
by proteins uL4 and uL22. Secondary structures start forming at the lower tunnel and tertiary 
structures at the vestibule.  
Bacterial translation 
Protein synthesis has four stages: initiation, elongation, termination and recycling (Figure 14). 
Protein synthesis is an energy dependent process driven forward by translational guanosine 
triphosphatases (GTPases), which hydrolyze guanidine triphosphate (GTP) to yield guanidine 
diphosphate (GDP) and pyrophosphate (reviewed in Alberts, Johnson, Lewis, Morgan, Raff, 
Roberts, Walter, et al., 2017; Rodnina, 2018; Schmeing & Ramakrishnan, 2009; Voorhees & 
Ramakrishnan, 2013).  
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Figure 14. Schematic overview of the translation cycle (Adapted from Moore, 2012). The bacterial 
translation cycle can be divided into four phases: initiation, elongation, termination and recycling. The 
30S subunit is represented in yellow and the 50S subunit in blue.  
1) Initiation 
The first step of protein synthesis, initiation, is the rate-limiting step (Laursen et al., 2005; 
Simonetti et al., 2009). In bacteria, it consists in the formation of a 70S initiation complex 
comprising the 30S and the 50S ribosomal subunits, initiator-tRNA and an mRNA with the start 
codon correctly positioned in the P-site. 
Although the exact order of the steps of initiation is still not clear, the first step is thought to 
be the binding of IF-3 (Initiation Factor 3) to a 30S subunit in the process of being recycled. 
The association of this factor to the E-site of the 30S subunit (Dallas & Noller, 2001) releases 
the mRNA and deacylated-tRNA from the previous round of translation and prevents 
premature subunit joining (Godefroy-Colburn et al., 1975; Karimi et al., 1999; Peske, Rodnina, 
& Wintermeyer, 2005). Subsequently, the mRNA to be translated binds to the small subunit 
via base complementarity between the RBS, termed Shine Dalgarno (SD) sequence in bacteria, 
upstream of the initiation codon of the mRNA and the anti-SD (aSD) sequence at the 3’ end of 
the 16S rRNA (Shine & Dalgarno, 1974). This is true for mRNAs containing a SD but not all 
mRNAs contain it. The initiation for non-SD-led mRNAs is carried out thanks to an unfolded 5’ 
UTR and the start codon in a single stranded mRNA (Rodnina, 2018). The level of translation 
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initiation varies not only with the degree of complementarity between the SD and the aSD 
sequences but as well with the context in which this sequence is placed within the mRNA, as 
interactions with adjacent sequences can form hairpin structures that sequester the RBS 
(Schauder & McCarthy, 1989; Schurr, Nadir, & Margalit, 1993). Leaderless mRNAs lack the 
5’UTR and bind directly to 70S ribosomes to start translation in a non-canonical way 
(Yamamoto et al., 2016). 
RBS-mediated positioning of the mRNA in the 30S subunit places the start codon in the P-site. 
In E. coli the initiation codon for most genes is “AUG” (83%) coding for Met with a smaller 
portion being alternative start codons “GUG” (14%) and “UUG” (3%), as well as “AUU” and 
“CUG” in two genes where fMet is incorporated (Blattner et al., 1997). However, a more 
recent article (Hecht et al., 2017), showed evidence of translation initiation from other four 
codons, “AUC”, “ACG”, “CAU” and “GGA”. 
The formyl-methionyl-initiator tRNA (fMet-tRNAiMet) recognizes the start codon and binds to 
the P-site, acting as an initiator for protein synthesis (Adams & Capecchi, 1966). IF-2 recruits 
the initiator tRNA (Canonaco, Calogero, & Gualerzi, 1986) and cooperation with IF-3 ensures 
that this tRNA is the only one positioned in the P-site (Hartz et al., 1990; Hartz, McPheeters, 
& Gold, 1989). IF-2 and IF-3 identify the initiator tRNA by recognition of the formyl group 
(Laursen et al., 2005) and three unique G:C base pairs in fMet-tRNAiMet when compared to an 
elongator tRNA (Hartz et al., 1990). IF-1 binds into the A-site of the ribosome (Carter et al., 
2001) to prevent premature binding of an aminoacyl-tRNA and to stabilize and accelerate IF-
2 binding and recruitment of the initiator tRNA (Pon & Gualerzi, 1984; Wintermeyer & 
Gualerzi, 1983).  
Binding of the three initiation factors causes conformational changes in the 30S subunit (Julián 
et al., 2011) and their presence, in association with initiator tRNA, allows the recruitment of 
the large subunit (Antoun et al., 2004). Large subunit binding in a rotated state known as 
“ratcheted” (Allen et al., 2005) triggers the GTPase activity of IF-2 that causes conformational 
changes to correctly position the initiator tRNA in the P-site. Dissociation of the IF-s leaves the 
ribosome ready for the elongation cycle (Laursen et al., 2005). 
2) Elongation 
The elongation cycle is repeated sequentially to add all the amino acids of a polypeptide chain 
(reviewed in Arenz & Wilson, 2016; Schmeing & Ramakrishnan, 2009; Voorhees & 
Ramakrishnan, 2013). Ribosomes about to start the elongation cycle contain the initiator tRNA 
in their P-site and have a vacant A-site. This vacant A-site is where an aminoacyl-tRNA binds.  
The tRNAs are aminoacylated at their conserved 3’ CCA end by aminoacyl-tRNA synthetases 
in a process that consumes ATP. These enzymes are capable of distinguishing between similar 
amino acids and some of them have a proof-reading activity (Berg et al., 2015). 
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The elongator aminoacyl-tRNAs are recognized by EF-Tu (Elongation Factor Thermo-unstable) 
in complex with GTP (Lipmann, 1969). EF-Tu interacts with the bL12 stalk (Figure 12) to 
position the tRNA in the A-site of the ribosome (Girshovich, Bochkareva, & Vasiliev, 1986). The 
correct match between the anticodon of the tRNA and the codon of the mRNA is ensured by 
the decoding center formed by bases A1493 and A1492 of helix 44 and G530 of the 16S rRNA. 
This match is produced by complementarity by Watson-Crick interactions of the nucleotides 
at the first two positions of the codon-anticodon and allows wobble pairs at the third position 
(Ogle et al., 2001). 
The recognition of the match triggers a conformational change of bases A1493 and A1492 of 
helix 44 and G530 of the small subunit that form the decoding center and interact with the 
first two positions of the mRNA-tRNA duplex. This results in domain closure of the 30S subunit 
(Ogle et al., 2002) and distortions in the tRNA (Valle et al., 2002) which in turn cause 
rearrangements in EF-Tu to avoid clashing with the sarcin-ricin loop, located in the conserved 
helix 95 of the 23S rRNA (nucleotides 2646-2674) (Figure 12). These rearrangements activate 
the GTPase activity and trigger GTP hydrolysis within EF-Tu (Voorhees et al., 2010). 
Consequently, GTP hydrolysis causes conformational changes in EF-Tu that weaken the 
interactions with the ribosome allowing its release (Voorhees & Ramakrishnan, 2013). Initial 
tRNA selection is made by a faster GTP hydrolysis in the case of a cognate tRNA when 
compared to a near-cognate tRNA (Gromadski & Rodnina, 2004). Besides, once EF-Tu leaves 
the ribosome additional proofreading is done by the remaining interactions at the decoding 
center that are stronger for cognate tRNAs, favoring the accommodation of the cognate tRNA 
and the release of near-cognate tRNAs (Ogle et al., 2002).   
The accommodation of the tRNA in the A-site triggers conformational changes in the PTC, 
resulting in a ribosome in the induced state (Schmeing, Huang, Strobel, et al., 2005). These 
changes include the pairing of C75 from the aminoacyl tRNA with G2553 of 23S rRNA, of A76 
of the A-site tRNA with U2585 of 23S rRNA, stacking of A2062 between the CCA of the P-site 
tRNA and the CCA of the A-site tRNA and the shifting of bases U2583, G2584 and A2451 (Kim 
& Green, 1999; Nissen et al., 2000). These movements leave unprotected the peptidyl-tRNA 
ester bond for peptide bond formation. 
Once the aminoacyl-tRNA is fully accommodated into the A-site, peptide bond formation is 
produced by a nucleophilic attack of the -amino group of the aminoacyl-tRNA onto the ester 
carbonyl carbon of the P-site tRNA, leaving a deacylated tRNA in the P-site and a peptidylated-
tRNA in the A-site. Ribosomes enhance the rate of formation of a peptide bond 107-fold 
(Sievers et al., 2004). 
In the first model explaining this reaction, the protonated third nitrogen atom (N3) of the base 
of 23S rRNA residue A2451 in E. coli (A2486 in the archaeon Haloarcula marismortui) stabilizes 
the carbonyl oxyanion formed during the tetrahedral transition state (Nissen et al., 2000). 
However, subsequent structures showed that N3 is not positioned correctly and that the 
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oxyanion is most likely stabilized by a water molecule (Hansen et al., 2002; Schmeing, Huang, 
Kitchen, et al., 2005). In addition, the acid dissociation constant (pKa) of N3 needed to 
deprotonate the amine would have had to be altered by several pH units for this model to be 
correct and biochemical analyses showed that this was not the case (Parnell, Seila, & Strobel, 
2002). Furthermore, the substrate analog used in the original structure lacked the functionally 
important 2’ hydroxyl (OH) of the P-site A76 base and was thus a poor mimic of the natural 
substrate (Nissen et al., 2000). 
There are currently three main models for the movement of protons around the PTC during 
peptide bond formation: the six- (Dorner et al., 2002) and eight-membered (Schmeing, Huang, 
Kitchen, et al., 2005) proton shuttle models and the proton wire model (Polikanov, Steitz, & 
Innis, 2014). The first two models are concerted models in which proton transfer occurs at the 
same time as the nucleophilic attack whereas the proton wire model occurs in two stages, 
with a first concerted step comprising the nucleophilic attack and amine deprotonation to 
form a tetrahedral intermediate, and a second rapid step to yield the products. 
In the six-membered proton shuttle model, the proton from the α-amino group of the 
aminoacyl-tRNA is transferred to the 2’-OH of P-tRNA residue A76, which in turn gives a proton 
to the neighboring 3’-OH to break down the tetrahedral intermediate. The eight-membered 
proton shuttle model is similar to the six-membered proton shuttle but incorporates a water 
molecule interacting with the 2' hydroxyl of A76 in the P-site tRNA to facilitate proton transfer 
(Schmeing, Huang, Kitchen, et al., 2005). The problems of these two models are that they are 
based only on the 50S subunit structure and not the entire ribosome 70S and they lack full-
length peptidyl- and aminoacyl-tRNA substrates. 
The proton wire model overcomes these issues because it is based on the Thermus 
thermophilus 70S ribosome structures of pre-attack and post-catalysis complexes with full-
length aminoacyl-tRNA and peptidyl-tRNA mimics. Besides, the geometry of this model is 
more favorable and the angles of the hydrogen bonds are closer to their ideal values 
(Polikanov, Steitz, & Innis, 2014). It proposes a network of hydrogen bonds (proton wire) 
formed by the 2’OH of the P-site tRNA residue A76 and the 2’OH of the 23S rRNA residue 
A2451 to allow the concerted transfer of protons from the attacking amine to a water 
molecule buried within the active site (W1) and formation of a tetrahedral intermediate 
between the attacking amine and the carbonyl carbon. In this model, W1 is fully coordinated 
by groups from the ribosome (the N-terminus of ribosomal protein bL27 (alanine), the 2’OH 
of A2451 and the N6 group of A2602 of 23S rRNA) and the A-site tRNA (5’ phosphate group of 
A76). The N-terminus of bL27 closes the cavity where the W1 lies so it is not likely to exchange 
with the bulk solvent during catalysis. The loss of the extra proton on W1 could also be delayed 
by the N-terminus of bL27. This extra proton might instead go back to the 2’-OH of A2451, 
resulting in a further proton transfer from the 2’-OH of the P-site A76 to the 3’-OH A76 via the 
W3 molecule that could break down the intermediate to yield the peptidyl-tRNA in the A-site 
and the deacylated tRNA in the P-site. 
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The next step in the elongation cycle is translocation, where the ribosome moves one codon 
down the mRNA to position the next codon into the A-site. During this process the deacylated-
tRNA moves from the P-site towards the E-site, while the peptidyl-tRNA in the A-site shifts 
into the P-site to take part in another round of elongation (Yamamoto et al., 2014). Due to 
steric clashes, the P-site tRNA cannot move to the E-site until the peptide bond is formed and 
it becomes deacylated (Rheinberger, Sternbach, & Nierhaus, 1981; Schmeing, Moore, & Steitz, 
2003). This process occurs spontaneously in vitro but in vivo it is greatly accelerated by EF-G 
(Munro et al., 2010). 
For this to happen, first the A- and P-site tRNAs move their 3’ ends to the P- and E-site of the 
50S respectively forming a hybrid state that in turn triggers a rotation of the 30S subunit that 
oscillates between ratcheted and canonical states (Blanchard et al., 2004; Cornish et al., 2008; 
Dorner et al., 2006; Frank & Agrawal, 2000; Moazed & Noller, 1989; Valle et al., 2003). The 
uL1 stalk closes towards the E-site stabilizing the P/E hybrid tRNA (Connell et al., 2007; Cornish 
et al., 2008; Valle et al., 2003). EF-G in its GTP bound state can bind to the ribosome aided by 
the bL12 stalk stabilizing the ratcheted conformation for translocation (Spiegel, Ermolenko, & 
Noller, 2007). EF-G rotates around the sarcin-ricin loop of the 23S rRNA (Figure 12) thus 
positioning its tip at the A-site to disrupt the codon-anticodon interactions of the tRNAs (Liu 
et al., 2014). The head of the 30S needs to rotate to allow the passing of the mRNA and the 
tRNAs after GTP hydrolysis. After translocation, EF-G dissociates, and the peptidyl-tRNA is 
located in the P-site and the deacylated-tRNA in the E-site. The tRNA in the E-site can then 
leave and a new cognate acylated-tRNA arrives into the A-site (Voorhees & Ramakrishnan, 
2013). 
3) Termination 
The elongation cycle continues until the ribosome reaches a stop codon (UAA, UGA, UAG) on 
the mRNA. The stop codons are recognized at the decoding center of the small subunit by a 
class I termination factor, namely RF-1 or -2 (Release Factor), that binds to the A-site of the 
ribosome (reviewed by Klaholz, 2011; Zhou et al., 2012). Depending on the nature of this 
codon it will be recognized differently, UAG is recognized by RF-1, UGA by RF-2 and UAA is 
recognized by both RF-1 and -2 (Ito, Uno, & Nakamura, 2000; Scolnick et al., 1968). A tripeptide 
anticodon motif PXT (with X meaning any amino acid) spanning residues 184-186 in RF-1 or 
SPF spanning residues 206-208 in RF-2 discriminates the stop codon. Recognition of the stop 
codon causes rearrangements in bases A1492 and A1493 of 16S rRNA and A1913 of 23S rRNA. 
This, in turn, allows a rearrangement of RF-1/2 for the docking of a conserved GGQ motif that 
reaches into the PTC. The GGQ motif, by means of a water molecule, allows the deacylation 
of the tRNA and the release of the peptide (Korostelev et al., 2008; Laurberg et al., 2008).  
RF-3, a class II release factor liberates RF-1/-2 from the ribosome (Freistroffer et al., 1997; 
Goldstein & Caskey, 1970). It binds in the same place on the ribosome as EF-Tu or -G and 
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causes a rotation of the 30S subunit in a GTP dependent manner that destabilizes the binding 
of RF-1/2 (Freistroffer et al., 1997; Gao et al., 2007; Klaholz, Myasnikov, & Van Heel, 2004). 
4) Recycling 
Once the release factors leave the ribosome, the subunits need to dissociate to take part in 
another round of translation and the mRNA and the tRNA have to detach from the ribosome. 
This process is called recycling. It is performed by the ribosome recycling factor (RRF) in 
combination with EF-G, and driven by GTP hydrolysis (Hirashima & Kaji, 1973; Peske, Rodnina, 
& Wintermeyer, 2005). RRF binds to the P-site, stabilizing the ribosome in a ratcheted state 
and the deacylated tRNA in a hybrid P/E state, whereas EF-G binds to the A-site and dissociates 
the subunits. The tRNA and the mRNA are removed from the small subunit by IF-3 thereby 
linking the end of a translation cycle with the initiation of the next one (Karimi et al., 1999; 
Peske, Rodnina, & Wintermeyer, 2005). 
Ribosomes and gene regulation 
The realization that the ribosome can regulate gene expression in response to a small 
metabolite via transcription attenuation was first discovered in the mid-1970s by Yanofsky for 
the trp operon of E. coli (Bertrand et al., 1975) and by Kasai for the his operon of S. 
Typhimurium (Kasai, 1974). Shortly thereafter, in 1980, the first examples of nascent-chain 
mediated translational arrest were discovered (Gryczan et al., 1980; Horinouchi & Weisblum, 
1980) and later shown to regulate gene expression by stalling the ribosome in cis via 
interactions between the ribosome, the peptide and the inducing ligand (Arenz et al., 2016; 
Arenz, Meydan, et al., 2014; Arenz, Ramu, et al., 2014). In all these systems, the ribosome is 
capable of recognizing a small molecule and regulating gene expression accordingly. These 
findings, alongside the more recent identification of ribosome-mediated mechanisms of gene 
regulation, show that the ribosome plays a major role not only in protein synthesis but also in 
the regulation of gene expression and highlight the role of the ribosome as molecule sensor. 
Ribosome-mediated attenuation 
Ribosomes are able to sense concentrations of amino acids through the availability of their 
corresponding tRNA. This allows them to control the expression of operons involved in the 
synthesis of the amino acid they sense (Henkin & Yanofsky, 2002) and a tRNA synthetase that 
consumes the amino acid sensed (Springer et al., 1985). The different ribosome-mediated 
attenuators known so far are listed in Table 2. 
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Table 2. Ribosome-mediated attenuators of gene expression. 
Operon regulated 
Organism 
(discovery) 
Amino acid levels sensed Reference 
trp operon E. coli Tryptophan (Bertrand et al., 1975) 
his operon S. Typhimurium Histidine (Kasai, 1974) 
thr operon E. coli Threonine (Gardner, 1979) 
leu operon S. Typhimurium Leucine (Gemmill et al., 1979) 
ilvGEDA operon E. coli Valine, Isoleucine, Leucine (Lawther & Hatfield, 1980) 
ilvBN E. coli Valine, Leucine (Hauser & Hatfield, 1983) 
phe operon E. coli Phenylalanine (Zurawski et al., 1978) 
pheST operon E. coli Phenylalanine (Springer et al., 1985) 
The general mechanism of ribosome-mediated attenuation involves transcription termination 
attenuation. It is obtained via a competition between the formation on the mRNA of either a 
termination or an antitermination hairpin. The upstream region of the operon contains a short 
peptide-encoding region that is rich in codons for the amino acid metabolized by the product 
of the operon or gene in question. When the ribosome starts translating this region, if the 
levels of the amino acid are low, it leads to a deficiency of the charged tRNA thus causing 
ribosome stalling on the corresponding codons of the mRNA. This, in turn, causes the 
formation of an antiterminator hairpin that allows the polymerase to continue transcription. 
When the amino acid levels are high, the ribosome has access to the correct acylated-tRNA 
and continues translation normally, causing the formation of the terminator hairpin and thus 
premature Rho-independent transcription termination (Henkin & Yanofsky, 2002). 
The best known example of this mechanism is the regulation of the trp operon that encodes 
the enzymes for the synthesis of L-Trp (Figure 15) (Bertrand et al., 1975). The 162 base pair 
(bp) region between the promoter and the first gene of the operon is key to the regulation. 
The region contains four segments (1, 2, 3 and 4) that are able to form alternative mRNA 
hairpins, and encodes a short ORF of 14 codons that overlaps with segment 1. Transcription 
of the operon starts and the RNAP pauses at a hairpin formed by segments 1:2, allowing, in 
turn, a leading ribosome to initiate and unwind the pause hairpin thus freeing the RNAP. When 
L-Trp levels are low the ribosome stalls at consecutive Trp codons of the short ORF due to 
reduced levels of Trp-tRNATrp, leaving segments 2 and 3 free to base pair and form an 
antiterminator hairpin that permits the RNAP to continue transcribing the whole operon. 
When Trp levels are high, ribosomes continue until the stop codon, masking segments 1 and 
2, which allows the formation of a termination hairpin and the transcription of a poly-U track. 
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Together these elements ensure that RNAP undergoes Rho-independent transcription 
termination (reviewed in Turnbough, 2019).  
 
Figure 15. Ribosomal sensing of L-tryptophan regulates the expression of the trp operon via 
transcription attenuation. (a) Genomic view of the operon indicating the promoter, the four segments 
that are involved in the different hairpin formation (1, 2, 3, 4) and the uORF upstream of the trp 
operon. (b) RNAP starts transcribing the operon and pauses at a hairpin formed by segments 1 (blue) 
and 2 (green). The leading ribosome unwinds the hairpin allowing transcription to continue. When 
tryptophan levels are low (– Tryptophan), the ribosome stalls at the Trp codons allowing the formation 
of the antitermination hairpin between segments 2 (green) and 3 (violet), permitting the RNAP to 
continue and transcribe the trp operon. When the tryptophan levels are high, ribosomes continue until 
the stop codon, masking segments 1 (blue) and 2 (green) and permitting the formation of the 
termination hairpin between segments 3 (violet) and 4 (purple), thus forcing the RNAP to terminate. 
Ligand-dependent arrest peptides 
Ribosomes are not only able to sense low amino acid levels, because of a lack of their cognate 
aminoacyl-tRNA, but also to sense an excess of amino acids. They do so via a mechanism called 
ligand-dependent nascent chain mediated translational arrest. In this mechanism, the peptide 
that is being translated, called an arrest peptide, blocks the ribosome upon induction by a 
small metabolite. So far, the only known amino acid dependent arrest peptides are the TnaC 
peptide in charge of regulation of tryptophanase expression in prokaryotes by excess of 
tryptophan (Konan & Yanofsky, 1997) and the arginine attenuator peptide (AAP) that 
regulates an arginine-specific carbamoyl phosphate synthetase by excess of arginine in 
eukaryotes (Luo & Sachs, 1996) but this mechanism of gene expression regulation is thought 
to be widely spread (Ito & Chiba, 2013; Seip & Innis, 2016). 
Amino acids are not the only molecules both eukaryotic and prokaryotic ribosomes can detect 
using nascent-chain mediated translational arrest. Some polyamines like spermine and 
spermidine (Law et al., 2001), drugs like macrolides (Gryczan et al., 1980; Horinouchi & 
Weisblum, 1980; Horinouchi, Byeon, & Weisblum, 1983; Hue & Bechhofer, 1992; Murphy, 
1985), chloramphenicol (Bruckner & Matzura, 1985; Dorman & Foster, 1985) or lincomycin 
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(Dar et al., 2016), sugars like sucrose (Yamashita et al., 2017) or coenzymes like AdoMet 
(Onouchi et al., 2005) are known ligands that trigger ribosomal arrest for regulation of gene 
expression. Alternatively, this process can be ligand independent as it is the case for SecM 
(Nakatogawa & Ito, 2001), MifM (Chiba, Lamsa, & Pogliano, 2009) and VemP (Ishii et al., 2015) 
that regulate genes involved in protein export and protein integration in the membrane. 
Arrest peptides are found in bacteria, eukaryotes and viruses (Ito & Chiba, 2013). Table 3 lists 
the arrest sequences that are known so far. 
Table 3. List of known arrest peptides. The amino acid in the P-site position is underlined and the 
amino acid in the A-site is shown in brackets. References: 1. (Doronina et al., 2008), 2. (Luo & Sachs, 
1996), 3. (Hill & Morris, 1993), 4. (Rahmani et al., 2009), 5. (Bruckner & Matzura, 1985), 6. (Dorman & 
Foster, 1985), 7. (Onouchi et al., 2005), 8. (Murphy, 1985), 9. (Horinouchi, Byeon, & Weisblum, 1983), 
10. (Gryczan et al., 1980; Horinouchi & Weisblum, 1980), 11. (Hue & Bechhofer, 1992), 12. (Chiba, 
Lamsa, & Pogliano, 2009), 13. (Nakatogawa & Ito, 2001), 14. (Konan & Yanofsky, 1997), 15. (Baniulyte 
& Wade, 2019), 16. (Cao & Geballe, 1996), 17. (Ishii et al., 2015) and 18. (Yanagitani et al., 2011). 
Arrest 
peptide 
Sequence 
Ligand 
dependence 
Role Organism Ref. 
2A 
peptide 
LKLAGDVESN
PG(P) 
None Viral protein 
synthesis 
Foot and mouth 
disease virus 
1 
AAP TSQDYLSDHL
WRALNA* 
Arginine Transcriptional 
regulation of 
arginine biosynthesis 
Neurospora 
crassa 
2 
AdoMet
DC 
uORF 
MAGDIS* Polyamines Regulation of 
polyamine 
biosynthesis 
Eukaryotes 3 
bZIP11 
uORF2 
MLNSTIRRRT
HLVQSFSVVFL
YWLYYVS* 
Sucrose Regulation of the 
bZIP11 transcription 
factor 
Arabidopsis 4 
Cat86 
leader 
VKTD Chloramphenicol Translational 
regulation of 
chloramphenicol 
resistance 
B. subtilis 
(plasmid) 
5 
CmlA 
leader 
KNAD E. coli 6 
CGS1 RRNCSNIGVAQ
IVAAKWSQIVA
AKW(S) 
AdoMet Regulation of 
methionine 
biosynthesis 
Arabidopsis 7 
ermA 
leader 
IAVV(E) Macrolides Translational 
regulation of 
macrolide resistance 
Staphylococcus 
aureus 
8 
ermB 
leader 
VD(K) Streptococcus 
sanguis 
9 
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Arrest 
peptide 
Sequence 
Ligand 
dependence 
Role Organism Ref. 
ermC 
leader 
IFVI Macrolides Translational 
regulation of 
macrolide resistance 
S. aureus 10 
ermD 
leader 
MTHSMRL(R) B. subtilis 11 
MifM RITTWIRKVFR
MNSPVNDEED
AGS 
None Translational 
regulation of YidC 
and membrane 
integration 
B. subtilis 12 
SecM FSTPVWISQAQ
GIRAG(P) 
None Translational 
regulation and 
folding of secA 
E. coli 13 
TnaC WFNIDNKIVDH
RP∗ 
L-tryptophan Transcriptional 
regulation of the tna 
operon 
E. coli 14 
toiL MLENVIIR Tetracycline, 
spectinomycin, 
tylosin and 
erythromycin 
Transcriptional and 
translational 
regulation of topAI 
E. coli 15 
UL4 
uORF2 
SAKKLSSLLTCK
YIPP∗ 
None Viral protein 
synthesis 
Cytomegalovirus 16 
VemP HRIXGWKETNA
MYVALNXS(Q) 
None Translational 
regulation of secDF2 
Vibrio 
alginolyticus 
17 
XBP1u YQPPFLCQWG
RHQPSWKPLM
(N) 
None Regulation of splicing 
of XBP1u mRNA 
Human 18 
The arrest motifs contained within known peptides are generally short and do not share 
obvious sequence similarity when comparing arrest peptides with different functions (Table 
3), making the identification of new arrest sequences difficult. Several in vivo methods such 
as genetic selection approaches (Tanner et al., 2009; Woolstenhulme et al., 2013) or ribosome 
profiling (Davis, Gohara, & Yap, 2014; Kannan et al., 2014) have been employed to identify 
and characterize arrest peptides. However, these methods cannot easily be used for the high-
throughput identification of new arrest peptides. For instance, ribosome profiling provides 
information of the ribosome-protected codons. However, rare stalling events cannot be 
detected by ribosome profiling since cells would have to be grown in specific conditions to 
identify them (Seip & Innis, 2016).   
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Mechanisms of gene regulation by arrest peptides 
Bacterial arrest peptides, like all of the other regulators of gene expression already reviewed, 
can regulate gene expression via two mechanisms: translational control or co-transcriptional 
control (Figure 16). In eukaryotic arrest peptides, ribosomal stalling can prevent preinitiation 
complexes from reaching the RBS of the downstream gene, mRNA cleavage by endonucleases 
or mRNA localization to the membrane. In viral arrest peptides, the arrest causes induction of 
peptidyl-tRNA hydrolysis or block ribosomal scanning (reviewed in Ito & Chiba, 2013). 
 
Figure 16. Schematic overview of the different mechanisms for nascent-chain mediated gene 
expression regulation. (a) In the case of the transcriptional control exerted by TnaC, in the absence of 
inducing quantities of tryptophan, the ribosome does not stall, leaving the rut site free for Rho to bind 
and terminate transcription. When the levels of tryptophan are sufficient to induce ribosomal stalling, 
the ribosome masks the rut site allowing the RNAP to continue transcribing the operon or genes 
regulated. (b) In the case of the translational control exerted by ErmCL, in the absence of erythromycin 
(Ery), formation of a hairpin sequesters the RBS sequence of the downstream gene. When the levels 
of erythromycin increase, ribosomes stall freeing the downstream RBS and allowing the expression of 
the gene. 
The well-known arrest peptide TnaC (F. Gong et al., 2001) and the recently discovered ToiL 
(Baniulyte & Wade, 2019) regulate downstream genes through a transcriptional control 
mechanism. In the case of TnaC, in the absence of inducing quantities of tryptophan, RNAP 
starts transcribing and stalls at a pause hairpin downstream the ORF; the ribosome translates 
the ORF normally and is released when it reaches the stop codon. The presence of a rut site 
allows recognition and binding of Rho, which terminates transcription by displacing the stalled 
RNAP. However, when tryptophan levels rise, ribosomes undergo nascent-chain mediated 
translational arrest, masking the rut site and preventing Rho binding and premature 
transcription termination.  
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Translational control on the other hand relies on an mRNA molecule where the RNAP has 
already synthetized the ribosome binding site (RBS). In this case, the RBS sequence of the gene 
whose expression is regulated by the arrest peptide is sequestered inside an mRNA hairpin 
when the concentration of the inducing ligand is too low. When the levels of said ligand rise, 
the ribosome stalls causing rearrangements of the secondary structure of the mRNA that free 
the RBS and allow translation of the inducible gene. This is the case of regulation by most of 
the known arrest peptides, like ErmCL (Gryczan et al., 1980; Horinouchi & Weisblum, 1980), 
SecM (McNicholas, Salavati, & Oliver, 1997), ErmAL (Ramu, Mankin, & Vázquez-Laslop, 2009), 
MifM (Chiba, Lamsa, & Pogliano, 2009), ErmBL (Shivakumar et al., 1980), ErmDL (Hue & 
Bechhofer, 1992) or cat leader (Duvall & Lovett, 1986). 
Mechanisms of ligand sensing and ribosome blocking by arrest peptides 
Translational arrest is produced by interactions between the peptide that it is being 
synthetized by the ribosome and the walls of the nascent polypeptide exit tunnel. These 
interactions in turn can cause rearrangements in the ribosome that block translation. Residues 
that have been shown to be important for stalling in some arrest peptides are A751, U2058, 
A2062, U2585 and U2609 of 23S rRNA and the residues that form the constriction of uL4 and 
uL22. Translation can be blocked at different points depending on the arrest peptide: peptidyl 
transfer, A-site tRNA binding or termination (Figure 17) (Ito & Chiba, 2013). Arrest peptides 
are known to be resistant to puromycin, an antibiotic that reacts with the nascent chain to 
cause premature termination and to which arrest peptides are resistant (Chiba & Ito, 2012; 
Darken, 1964; F. Gong et al., 2001; Muto, Nakatogawa, & Ito, 2006).  
 
Figure 17. Mechanisms for the inhibition of translation by arrest peptides. Rearrangements at the 
PTC level induced by the arrest peptide can lead to inhibition of (a) peptidyl-tRNA transfer, (b) binding 
of the release factor (shown in dark blue) and subsequent hydrolysis of the peptide or (c) binding and 
accommodation of the A-site tRNA.   
To illustrate the mechanism of how arrest peptides are known to block the ribosome, I will 
discuss in more detail a ligand-independent arrest peptide and two types of metabolite 
sensing arrest peptides. 
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Ligand independent ribosomal stalling at secM  
The SecM protein in E. coli is encoded by a long ORF of 170 codons located upstream of secA. 
SecA is an ATPase that drives post-translational translocation of proteins through the SecYEG 
translocon at the inner membrane (McNicholas, Salavati, & Oliver, 1997; Rajapandi, Dolan, & 
Oliver, 1991). The N-terminus of SecM consists in a signal sequence for membrane 
translocation and export into the periplasm. Ribosomal stalling at SecM causes a 
rearrangement in the secondary structure of the mRNA that frees the RBS for translation of 
secA, thus SecM exerts a translational control over secA. This allows expression of secA in the 
vicinity of the inner membrane. When the levels of SecA are high, this protein can inhibit its 
expression by applying a pulling force on the SecM peptide. With the loosening of ribosomal 
stalling, the mRNA rearranges so that the RBS of secA is blocked again (Nakatogawa & Ito, 
2001). 
The stalling motif (FXXXXWIXXXXGIRAGP) of SecM spans from positions 150 to 166 of the 
peptide. Ribosomal stalling can be triggered by this 15 amino acid-peptide alone (Nakatogawa 
& Ito, 2002). Ribosomal arrest happens with the Pro166 codon in the A-site and the Gly165 in 
the P-site. Prolyl-tRNAPro is located in the A-site and therefore makes the peptide resistant to 
puromycin treatment (Muto, Nakatogawa, & Ito, 2006).  
Cryo-electron microscopy studies have shown that ribosomal stalling is due to SecM contacts 
with the ribosomal tunnel (Bhushan et al., 2011; J. Zhang et al., 2015). Essential interactions 
take place between Arg163 of SecM and A2062 of the 23S rRNA and U2585 of the 23S rRNA 
with the O3 in A76 of the CCA end of the P-site tRNA. The higher resolution structure of a 
SecM-70S complex showed that SecM causes rearrangements at the PTC level that mimic an 
uninduced state when Pro166 is not incorporated into the chain. When Pro166 is incorporated 
into the chain, the geometry of the PTC is different from the unincorporated structure. The 
bases C74 and C75 of the peptidylated A-site tRNA deviate from their classical positions where 
they are recognized by the ribosome and might slow down translocation (J. Zhang et al., 2015). 
L-tryptophan mediated nascent chain translational arrest at TnaC 
One of the best-known and characterized arrest peptides that block the ribosome in a ligand 
dependent manner is TnaC. TnaC is encoded as a small ORF of 24 codons that is located 
upstream of the tna operon of E. coli. This operon encodes TnaA, a tryptophanase that 
produces indole from tryptophan, and TnaB, a tryptophan specific permease. As mentioned 
before, ribosomal stalling on tnaC triggers the expression of the tna operon through 
transcriptional control. In E. coli, indole, the signaling molecule produced by the 
tryptophanase, is involved in cell motility, biofilm formation, cell division and stress response 
among others (reviwed in Lee & Lee, 2010). 
In the absence of soluble Trp, tnaC is translated by the ribosome and released when the latter 
reaches the stop codon. However, in the presence of inducing quantities of Trp, a ribosome 
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translating tnaC stalls on the codon encoding Pro24. Stalling occurs immediately before the 
stop codon and RF -2 is unable to release the ribosome or hydrolyze the peptide with the wild-
type (WT) stop codon (F. Gong et al., 2001; Konan & Yanofsky, 1997). The stalled complex has 
been shown to be resistant to puromycin as well (Cruz-Vera & Yanofsky, 2008). 
Structural studies have helped understanding the arrest mechanism. A first cryo-EM structure 
at 5.8 Å resolution of a TnaC-ribosome complex stalled in the presence of L-tryptophan 
showed extensive contacts between the peptide and the ribosomal tunnel. It suggested that 
the movement of bases A2602 and U2585 of the 23S rRNA prevent the correct positioning of 
the conserved GGQ motif of RF-2s that is the responsible for the deacylation of the tRNA and 
the release of the peptide (Seidelt et al., 2009). However, the resolution was not sufficient for 
identifying density corresponding to L-tryptophan inside the ribosomal tunnel. A later study 
at higher resolution (3.8 Å) corroborated the previously reported interactions and claimed to 
identify two L-Trp molecules interacting both with the peptide and the ribosome (Bischoff, 
Berninghausen, & Beckmann, 2014). Nevertheless, the quality of the electron density map 
was not sufficient to see the interactions between the ligand, the ribosome and the peptide 
and, as I will show later in this work, it is arguable whether the densities observed at this 
resolution could unambiguously be identified as Trp molecules. Therefore, it is still not known 
how the peptide specifically senses L-Trp to block the ribosome. 
Macrolide mediated nascent chain translational arrest 
Macrolide antibiotics block the ribosome in a sequence-dependent manner (Davis, Gohara, & 
Yap, 2014; Kannan et al., 2014; Kannan, Vázquez-Laslop, & Mankin, 2012). Among other 
mechanisms, bacteria can become resistant to these antibiotics by expressing 
methyltransferases (erm, erythromycin resistance methylase) that dimethylate specifically the 
N6 of A2058 of the 23S rRNA to disrupt the binding of the drug (Skinner, Cundliffe, & Schmidt, 
1983). Expression of some of these genes is induced via erythromycin-dependent ribosomal 
stalling on an upstream leader ORF. The first macrolide-dependent arrest peptide to be 
characterized is ErmCL, a 19 amino acid long peptide that is encoded by the leader ORF ermCL, 
upstream of the ermC methyltransferase gene. Ribosomal stalling at ermCL induces the 
expression of ermC allowing translation initiation by freeing the RBS (Gryczan et al., 1980; 
Horinouchi & Weisblum, 1980).  
In the presence of erythromycin, incorporation of the first nine amino acids into the nascent 
chain causes translational arrest. The stalling motif (IVI) spans from residues 6 to 9 and 
regardless the nature of the incoming amino acid it cannot be incorporated into the chain 
(Vázquez-Laslop, Thum, & Mankin, 2008).  
Structural studies by cryo-EM have shown that the Phe7 of the ErmCL peptide contacts 
erythromycin. The inactivation of the PTC is caused by rearrangements of 23S rRNA bases 
U2585, U2506, A2062 and A2602 that globally prevent binding and accommodation of an 
incoming A-site tRNA. U2585 shifts and thus would not be able to contact the incoming A-site 
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tRNA, U2506 moves to interact with the peptide, A2062 lies flat against the tunnel to leave 
space to ErmCL and A2602 that shifts towards the PTC when compared to a ribosome in an 
unaccommodated state (Arenz, Meydan, et al., 2014). 
As seen from the examples above-mentioned, characterization of arrest peptides has become 
easier with the improvements in structural techniques such as cryo-electron microscopy (cryo-
EM) that are discussed in the following section of the Introduction. Structures at relatively 
high resolution have been obtained for some stalled ribosome-nascent chain complexes 
(RNC), such as the ErmCL-ribosome complex stalled in the presence of erythromycin (Arenz, 
Meydan, et al., 2014), the TnaC-ribosome complex stalled in the presence of Trp (Bischoff, 
Berninghausen, & Beckmann, 2014) or the SecM-ribosome complex (Bhushan et al., 2011) in 
bacteria. Moreover, low resolution structures of the ribosomal complexes stalled during 
translation of the arginine attenuator in eukaryotes or the human cytomegalovirus uORF 
(Bhushan et al., 2010) have been obtained. However, higher resolution is needed to 
understand how ligand-dependent arrest peptides are able to detect the small molecule 
ligands and subsequently block translation. 
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1.2. Cryo-EM for the study of ribosomal nascent chain 
complexes 
The main tool I used during my thesis for studying ligand-dependent arrest peptides is single 
particle cryo-electron microscopy (cryo-EM). Cryo-electron microscopy is a transmission 
electron microscopy (TEM) technique in which a beam of electrons is transmitted through a 
frozen specimen to form a projected image on a detector.  
Electrons can be considered as waves with a wavelength shorter than that of visible light, 
meaning that the spatial resolution that can be achieved by using electrons instead of photons 
for visualization is greater. When the electrons are transmitted through the specimen, the 
later can either block the transmission of the electrons completely (generating a dark image), 
or let them pass either changing their trajectory (scattered electrons) or not (unscattered 
electrons). The electrons that interact with the atomic nuclei of the sample have their 
trajectories changed. These scattered electrons can either keep their energy (elastically 
scattered electrons) or lose part of it to the sample, thus damaging it (inelastically scattered 
electrons). The electrons that are transmitted are recorded by the detector giving a projection 
of the molecule that is being imaged.  
The first TEM microscope was developed in 1931 by Knoll and Ruska and by 1933 the 
resolution achieved was greater than that of light microscopes (reviewed by Ruska, 1980). The 
basic components of a transmission electron microscope are an electron gun, electromagnetic 
lenses, apertures and a sample port located in the column, and a detector (Figure 18) 
(Amelinckx et al., 2008). The electron gun emits the electrons that are focused into a thin 
beam by the condenser lens and the condenser aperture. After hitting the specimen, the 
electron beam passes through the objective lenses which focuses the beam and the projector 
lens provides the desired magnification. The objective aperture controls the contrast of the 
image, the smaller the aperture the better the contrast but high-resolution information is lost. 
The detector records the electrons that contain information about the sample. 
TEM was used in the late 1960s to produce the first three dimensional (3D) reconstruction of 
a biological sample (De Rosier & Klug, 1968). However, TEM had three major limitations at the 
time: (1) the high vacuum needed to prevent friction of electrons with the air damages the 
sample, as well as (2) beam-induced damage and (3) the low contrast of the particles in 
solution (Nogales, 2015). These three limitations were addressed by applying a negative stain 
to the sample, a layer of heavy atoms such as uranyl acetate, that protects the sample from 
vacuum and beam induced damages and improves the contrast (De Rosier & Klug, 1968). 
However, this type of staining reduces the maximum resolution that can be obtained. Cryo-
electron microscopy was therefore developed to overcome these limitations. 
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Figure 18. Schematic diagram of a transmission electron microscope. 
1.2.1. Development of single particle cryo-EM 
The use of cryogenic temperatures in EM to obtain high resolution was reported for the first 
time by Taylor and Glaeser in 1974 when they obtained high-resolution electron diffraction 
patterns of catalase crystals without staining (Taylor & Glaeser, 1974). Soon after, Henderson 
and Unwin used low electron doses and glucose solutions to protect the sample from vacuum 
and radiation damage and obtained a 7 Å resolution structure of bacteriorhodopsin (Unwin & 
Henderson, 1975). 
Vitrification of the sample for the generation of amorphous ice was developed (Dubochet et 
al., 1982) after seeing that electron beam damage was reduced at cryogenic temperatures 
(Knapek & Dubochet, 1980). In this method, the sample was cooled in liquid ethane or 
propane to form amorphous instead of crystalline ice. 
The main problem at the time of using single particles instead of crystals for EM was that, to 
avoid damaging the sample, the dose that is used is very low and this causes a low signal to 
noise ratio. Therefore, the features of particles in solution are too faint to be visible on a noisy 
background. To tackle this problem, Joachim Frank developed in 1975 a theoretical framework 
in which low dose images of single particles were aligned using cross-correlation functions 
(Frank, 1975). Particles in solution adopt random orientations on the grid. In 1981, Frank and 
van Heel developed a method that sorts the particles according to their orientations (Frank & 
van Heel, 1982; van Heel & Frank, 1981). By illustrating particles as vectors, they can be 
clustered (2D classified) by statistical analysis and averaging them increases the signal to noise 
ratio, allowing the obtention of higher resolution 2D projections. Joachim Frank also 
developed a method to obtain 3D reconstructions from the 2D images of single particles 
(Radermacher et al., 1986). 
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In 1990, Henderson obtained the first high resolution structure of a molecule using cryo-EM 
by averaging millions of bacteriorhodopsin molecules in a 2D crystal, in which the total dose 
of electrons was spread over a large number of particles (Henderson et al., 1990). 
In summary, low electron doses combined with vitrification of the sample and the in-silico 
sorting of the particles to average the orientations for the generation of a 3D reconstruction 
were the main steps towards the development of single particle cryo-electron microscopy. 
Jacques Dubochet, Joachim Frank and Richard Henderson were awarded the Nobel Prize in 
Chemistry 2017 for their contribution to the development of cryo-electron microscopy for 
generating three-dimensional images of biomolecules. 
The most significant advance that allowed improvements in the resolutions obtained by cryo-
EM was the introduction of direct electron detectors in 2012-2013 (Kühlbrandt, 2014b, 
2014a). These detectors are capable of detecting high-energy electrons (with low intensities). 
The speed of these detectors increased as well, allowing the recording of several images or 
frames that form a movie that can be aligned to compensate for beam induced motion (Brilot 
et al., 2012).  
Recent improvements in cryo-EM also include the advancement of image processing methods. 
The implementation of maximum likelihood approaches, in which the particle is assigned a set 
of probabilities to be in any orientation, has been key for 3D classification of heterogeneous 
samples (Nogales, 2015). The development of software such as RELION (Scheres, 2012) with 
low computational costs and user-friendly interfaces has increased the use of single particle 
cryo-EM. In the most recent version of this program, correction of beam induced motions per 
particle have been implemented (Zivanov, Nakane, & Scheres, 2019). 
These two main improvements, namely the development of direct electron detectors and 
more potent image processing software, have sparked a “resolution revolution” in which 
resolutions only achieved previously by X-ray crystallography are now routinely achieved by 
cryo-EM (Murata & Wolf, 2018).  
1.2.2. Steps for single particle reconstruction by cryo-EM 
The main steps for solving a structure by cryo-EM are sample preparation, grid preparation, 
data collection, data processing and model building (Figure 19). 
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Figure 19. Workflow of single particle reconstruction by cryo-EM. 1. Sample preparation step. 2. Grid 
preparation step. The grid is usually a holey mesh grid with a carbon foil. A thin layer of continuous 
carbon fil can be added. Ideally, the particles adopt random orientations in the vitreous ice. 3. Data 
collection in 200 or 300 keV cryo-TEM microscopes. 4. Data processing starts with the motion 
correction of the micrographs and contrast transfer function (CTF) estimation. Particles are picked and 
2D classified. 3D reconstruction followed by 3D classification and refinement give the final cryo-EM 
density map for 3D modelling of the structure. 
1) Sample preparation 
The quality of the cryo-EM data is directly proportional to the quality of the sample. Particle 
homogeneity is desired but not essential in cryo-EM contrary to other structural biology 
techniques such as X-ray crystallography (Cheng et al., 2015; Nwanochie & Uversky, 2019). 
However, it is better to reduce the heterogeneity of the sample by biochemical methods 
before data collection to simplify the image processing steps. 
2) Grid preparation 
Grids for cryo-EM are formed by a mesh composed of copper or gold. The mesh is formed by 
squares that serve as support for a thin layer of carbon (or gold) on top. Most of the time the 
grids have a layer of holey carbon where holes are regularly spaced (Chang & Barford, 2018). 
Variations on these components, like the use of all gold grids, exist to increase the stability of 
the grid under the electron beam and reduce their drift (Russo & Passmore, 2016). Before the 
application of the sample, the grids are usually made hydrophilic as the carbon coat is 
hydrophobic. This can be achieved by glow discharge, in which a high current is applied to a 
low-pressure chamber where the grid is deposited. The resulting ionized air in the chamber 
deposits negatively charged ions onto the grid, rendering it hydrophilic (Passmore & Russo, 
2016). Sometimes, an extra layer of carbon on top of the grid is added to minimize the 
denaturation of proteins caused by the high surface tension of the water-air interface (Chang 
& Barford, 2018). This thin carbon layer helps as well in concentrating the particles, reducing 
the amount of sample needed to observe good dispersion of particles. Although the carbon 
1.2. CRYO-EM FOR THE STUDY OF RIBOSOMAL NASCENT CHAIN COMPLEXES 
39 
coating reduces the contrast and image signal, the signal from the carbon allows a more 
accurate estimation of the contrast transfer function parameter (CTF) (Chang & Barford, 
2018). 
Only a few microlites of sample are needed to be deposited onto the grid. Before vitrification, 
>99,9% of the liquid is removed by blotting with a filter paper (Glaeser, 2015). The blotting 
and the vitrification are generally performed using dedicated machines such as a Vitrobot. A 
waiting time can be added in between sample deposition and blotting to allow reorientation 
of the particles. After blotting a thin layer of liquid remains that is situated in the holes when 
no coating is performed before sample deposition. If a carbon coat is applied then the liquid 
layer is situated on top of it (Figure 19). Then the grid is plunged into liquid ethane cooled with 
liquid nitrogen (Dubochet et al., 1982). The ideal thickness of the ice is less 100 nm to avoid 
electrons scattering several times after transmission through the sample. It has however to 
be thicker than the sample diameter (Glaeser, 2015).  
3) Data collection 
There are several models of cryo-EM microscopes that differ on the accelerating voltage. The 
higher the accelerating voltage, the smaller the wavelength of the electrons and the higher 
the possible achievable resolution. Generally, lower voltage microscopes are used for grid 
screening and higher voltage for data collection. Different cameras exist in the market with 
different characteristics. Some direct electron detector cameras are capable of recording 
images in linear mode or counting mode. In linear mode, the accumulation of charges 
produced by the electrons that reach the detector is integrated over a fixed frame rate. In the 
case of counting mode, individual electrons are detected and their effect is accumulated over 
time (Li et al., 2013). Several software packages have been developed, such as serial-EM 
(Mastronarde, 2005) or EPU (FEI) to render data collection automatic. 
One of the parameters that has to be chosen before starting a data collection is the 
magnification to use. The magnification has to be large enough so that high-resolution 
information is recorded. However, the larger the magnification the fewer particles are 
captured by image decreasing the size of the dataset (Cheng et al., 2015). The maximum 
resolution that can be achieved depends on the pixel size in the sample which in turn depends 
on the magnification used. The pixel size in a sample is equivalent to the number of Å of the 
sample that fit in one pixel of the detector. The Nyquist theorem specifies that the maximum 
attainable resolution is limited to twice the pixel size (Cheng et al., 2015). 
The number of frames collected and the total electron dose accumulated must also be 
carefully chosen. The total dose of electrons is subdivided into the different frames. Low doses 
of electrons are required to reduce beam-induced damage to the sample. Early frames 
correspond to a low accumulated electron dose and contain high resolution information. 
However, they are the most affected by beam induced movement (Cheng et al., 2015).  
CHAPTER 1: GENERAL INTRODUCTION 
40 
4) Data processing 
The raw images collected by cryo-EM must be processed to obtain a 3D reconstruction. The 
main steps are shown in Figure 19. The first step is the correction for motion induced by the 
electron beam. MotionCor2 (Zheng et al., 2017) is a software capable of correcting beam-
induced movements of the sample by dividing the image into patches and motions within each 
patch are determined. Then, the frames are summed remapping each individual pixel with the 
motion information.  
The following step is the estimation of the contrast transfer function (CTF). Generally, in cryo-
EM contrast is increased by focusing the objective lens beyond the sample by a given distance 
in microns. The CTF is a mathematical description of how aberrations of transmission electron 
microscopy induced by defocusing modify the image. Programs have been developed to 
correct for these aberrations like CTFFIND4 (Rohou & Grigorieff, 2015) or Gctf (K. Zhang, 
2016). These programs estimate the real defocus parameters by fitting a model of the 
microscope's contrast transfer function (CTF) to an image's amplitude spectrum. The CTF 
shows oscillatory rings called Thon rings and their diameter depends on the defocus at which 
the image was recorded. After their CTF has been estimated, micrographs can be selected 
according to their resolution estimation and their Figure of Merit (FOM), a value that indicates 
how good the CTF model is fitted to the Thon rings visible in the power spectra (Fourier 
transform) of the micrographs (Zivanov et al., 2018). 
Particles can be selected from the micrographs in a manual, semi-automated or automated 
manner. If particles are clearly visible in the micrographs a good method is to use template-
based particle autopicking. Once the particles are picked, they have to be aligned and stacked 
by averaging images of the same view of the particle. 2D classification gives an initial 
impression of the distribution of views of the sample (Sigworth, 2016).  
Ab initio 3D reconstruction can be performed when no previous structural information is 
available. If a reference exists, ab initio 3D reconstruction can be skipped and 3D classification 
can be performed directly to distinguish heterogeneity in the sample. The 3D classification in 
RELION is based on the maximum likelihood algorithm, by which the particle is assigned a set 
of probabilities to be in any orientation (Scheres, 2012). Then, 3D refinement is performed in 
which the initial 3D map is iteratively refined with a projection matching procedure. In RELION 
3D auto-refinement two criteria are monitored to estimate when the structure cannot be 
further refined (Scheres, 2012). The first one is the estimated resolution and the other one 
the average changes of orientations and the class assignments. The estimation of the 
resolution is obtained from the calculation of the Fourier Shell Correlation (FSC) of two 
independent half maps (Gold standard FSC calculation). Once these values reach a plateau, 
the program automatically changes iteratively the orientational sampling until the angular 
sampling is finer than its estimated accuracy. Post-processing of the map helps calculating the 
real resolution estimation, since in the 3D refinement a circular map is used and in the post-
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processing step a user provided mask that fits tight around the molecule is used. The post-
processing step combines the two halves of the map into one, calculates the resolution 
estimation and reweights the 3D information by applying a negative B-factor (Scheres, 2016).  
Recent improvements in RELION allow to estimate the trajectories of particle motion and the 
amount of cumulative beam damage, permitting a better correction of the blurriness of the 
images. This method is called Bayesian polishing. The release of RELION-3.0 can also correct 
estimated beam tilt and calculate the CTF values per particle (Zivanov et al., 2018; Zivanov, 
Nakane, & Scheres, 2019). All these improvements have allowed the obtention of cryo-EM 
maps containing higher resolution information when compared to the ones obtained with 
previous versions of the program. 
Ribosomes have been key for the development of cryo-EM. As they are large and dense many 
advances in cryo-EM imaging and data processing have been achieved by using them as 
sample (A. Brown & Shao, 2018). The main advantage of studying ribosomes by cryo-EM is the 
ability of sorting computationally the particles to yield several reconstructions at high-
resolution, which in the case of translating ribosomes and stalled ribosomes is key for 
distinguishing conformational movements. 
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1.3. Aims and objectives 
The increasing evidence of a key role of ribosomes as small molecule sensors has been getting 
clearer with the discovery of novel arrest peptides that are able to regulate gene expression 
both in bacteria and eukaryotes in response to diverse ligands. Previously published work 
shows how drugs are sensed by ribosomes translating relatively long arrest peptides and how 
translation is shutdown in a drug-dependent manner. However, the detailed molecular 
mechanism for the recognition of small molecules other than drugs is still unknown.  
The aim of my thesis is to gain understanding on how the ribosome detects and integrates 
signals from small molecules by focusing in the specific case of ribosomal arrest peptides. 
Therefore, the objectives of my thesis were to (1) understand how the small molecule L-
ornithine is sensed by the novel ribosome-arresting peptide SpeFL, and (2) to study a special 
case of ligand-dependent translational arrest: drug sensing by short arrest peptides. 
In the first part of my thesis, I sought first to identify how L-ornithine triggers ribosomal arrest 
at speFL by solving the structure of a SpeFL-70S complex in the presence of ornithine by cryo-
EM. Besides, I aimed to analyze in vitro the effect of mutations in SpeFL on its stalling ability 
and to identify the mechanism of induction exerted by this arrest peptide to control the 
expression of the downstream operon. The second part of my thesis was based on previous 
work in the laboratory aimed to gaining more insight into the molecular mechanism by which 
short arrest peptides sense macrolides in the ribosomal exit tunnel. I sought to obtain a cryo-
EM reconstruction of a tripeptide complex in the presence of erythromycin at higher 
resolution than the one previously obtained to answer some unknowns of the mechanism that 
were not solvable at the previous resolution.
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Note: 
A preprint describing the results of this chapter has been deposited in bioRiv. The complete 
manuscript is available at the Appendix. 
This project began when Iñaki Cervera-Marzal, a masters student in the Innis laboratory, 
identified in silico a potential ORF upstream of the speF operon of E. coli. Dr. Britta Seip 
performed biochemical assays that showed that the ORF was translated and acted as an arrest 
peptide stalling the ribosomes specifically in the presence of L-ornithine. Guénaël Sacheau 
performed biochemical assays alongside Dr. Britta Seip and performed preliminary activity 
assays in bacteria. Dr. Carolin Seefeldt designed the template for the structural 
characterization of this peptide at the end of her thesis and preformed preliminary 
biochemistry. I took over the structural studies and purified the complex of a ribosome 
arrested at the upstream ORF in the presence of L-ornithine and solved its structure first by 
collecting data at the in-house microscopy. The information provided by the structure set the 
basis for initial biochemical assays performed by Dr. Britta Seip and Guénaël Sacheau. 
Moreover, these initial data allowed us to obtain data collection time on two Titan Krios 
microscopes, resulting in two high resolution structures of the stalled ribosomal complex. 
Following the departure of Dr. Britta Seip and Guénaël Sacheau from the laboratory, I carried 
out most of the biochemical and bacterial assays that are shown in this chapter and that 
ultimately feature in our manuscript.   
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2.1. Introduction 
The in silico identification of novel arrest peptides is challenging because they have divergent 
sequences with narrow phylogenetic distribution as the interactions between the peptide and 
the ribosome are species specific (Ito & Chiba, 2013). Besides, as they are small in size, small 
ORFs are generally not annotated and their secondary or tertiary structures are not conserved 
the same way as for larger proteins (Seip & Innis, 2016). Common features of known arrest 
peptides are their location upstream of the gene they regulate, the small size of the motif that 
causes the stalling and their conservation among at least closely related organisms (Ito & 
Chiba, 2013). Relying on these basic assumptions, previous bioinformatics work in the group 
led to the identification of a putative regulatory ORF of 34 amino acids located upstream of 
the speF operon in E. coli. This operon encodes an inducible ornithine decarboxylase SpeF 
(Gene ID: 945297 in Gene NCBI) and an ornithine-putrescine antiporter PotE (Gene ID: 945422 
in Gene NCBI) (Figure 20) (Kashiwagi et al., 1991). We named this ORF speFL, for leader 
peptide of speF.  
Two enzymes are responsible for the decarboxylation of ornithine in E. coli, SpeF and SpeC, 
the constitutive ornithine decarboxylase. They differ not only in their expression levels but 
also in their activity. The optimal pH for activity of constitutive ornithine decarboxylase (SpeC) 
is 8.5 whereas for the inducible one (SpeF) is 7 (Kashiwagi et al., 1991). 
  
Figure 20. Genomic organization of the speF operon and activity of SpeF. The sequence of SpeFL in E. 
coli is shown. The reaction catalyzed by SpeF is shown.  
Ornithine is a non-proteinogenic amino acid. In E. coli L-ornithine is a precursor not only of 
putrescine but also of L-arginine and it is produced from L-glutamate (Cunin et al., 1986). 
Putrescine belongs to the family of polyamines, molecules that play important roles in 
bacteria. More specifically, they affect cell growth, stimulate the synthesis of certain proteins, 
protect cells from oxidative stress and control biofilm formation, as reviewed by Igarashi & 
Kashiwagi, 2018; Michael, 2018; Miller-Fleming et al., 2015; Shah & Swiatlo, 2008.  
Little is known about the expression of the speF operon. In vivo experiments where the operon 
and its upstream region were expressed from a plasmid in E. coli have shown that the operon 
is expressed at mildly acidic pH (5.2) under anaerobic conditions and high ornithine levels 
(Kashiwagi et al., 1991). Moreover, the activity of PotE increased when the gene was 
expressed under the control of a tet promoter instead of its genomic promoter, indicating that 
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under natural conditions the expression of the speF operon is repressed. Further experiments 
from the same group have shown an involvement of RNase III, an endonuclease that cleaves 
double stranded RNA, in the expression of the operon (Kashiwagi, Watanabe, & Igarashi, 
1994). An enhancement of the expression in the presence of RNase III was observed, 
suggesting that this endonuclease processes the 5’ UTR of the speF operon by cleaving a 
secondary structure to induce its expression through a translational control mechanism.  
As the operon is expressed at mildly acidic pH and the optimal pH for activity of SpeF is more 
acidic than for SpeC, it has been suggested that the enzymes encoded by the speF operon are 
involved in the acid resistance mechanism of E. coli (Kanjee & Houry, 2013; Kanjee et al., 
2011). E. coli uses four different types of amino acid-based proton-consuming acid resistance 
mechanisms, the arginine, glutamate, lysine and ornithine dependent acid resistance systems. 
They are two-component systems, with a decarboxylase that incorporates a proton from the 
cytosol into the amino acid by decarboxylating it and an inner membrane antiporter that takes 
in the substrate of the decarboxylase and takes out the product, thus removing a proton from 
the cytosol (Kanjee & Houry, 2013). SpeF acts as a homodimer to decarboxylate ornithine 
consuming a proton to produce putrescine and carbon dioxide (Figure 21). PotE acts as a 
monomer for the antiport of ornithine/putrescine at acidic pH and the proton motive force-
dependent import of putrescine at neutral pH (Igarashi & Kashiwagi, 2010; Kashiwagi et al., 
2000). 
 
Figure 21. Decarboxylation of ornithine into putrescine by SpeF (shown in purple) consumes a proton 
from the cytoplasm. PotE (shown in orange) imports ornithine and exports putrescine, thus 
removing this proton from the cytoplasm.  
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Previous work in the group showed that in E. coli SpeFL is translated and that it is a ligand 
dependent arrest peptide (Figure 22). These results were obtained using toeprinting assays 
(Hartz et al., 1988; Seefeldt et al., 2015), a technique that allows identification of the ribosome 
location on the mRNA (more details in the Methodology section of this chapter). The 
templates used contained either the wild-type speFL sequence (Figure 22a) or a double 
frameshifted sequence (Figure 22b) followed by the first 75 nucleotides of the intergenic 
region between speFL and speF fused to a known 3´end (NV1) (Vázquez-Laslop, Thum, & 
Mankin, 2008). The first lane of the toeprinting gel in Figure 22a shows a reaction performed 
in the absence of ribosomes. The appearance of toeprint bands in this condition is indicative 
of secondary structures on the mRNA. The next three lanes correspond to reactions 
performed in the absence or presence of either of the substrates of the operon, ornithine or 
putrescine, and they show two intense toeprints that appear only in the presence of ornithine. 
These bands correspond to ribosomes stalled either during elongation or termination, with 
codon 33 or 34 at the P-site of the ribosome, respectively. In the absence of exogenous ligand 
or in the presence of putrescine, a faint band is observed, corresponding to ribosomes paused 
on codon 34 and about to undergo termination. When release factors are omitted, the band 
corresponding to the stop codon intensifies, as the ribosomes remain at the stop codon. 
Remarkably, the toeprints that appear in the presence of ornithine are still present when the 
samples are treated with puromycin, an antibiotic that reacts with the nascent chain to cause 
premature termination and to which arrest peptides are resistant (Chiba & Ito, 2012; Darken, 
1964; F. Gong et al., 2001; Muto, Nakatogawa, & Ito, 2006). This hints to SpeFL being an arrest 
peptide able to block the ribosome in the presence of ornithine. In the presence of putrescine 
or in the absence of ligands no toeprints are visible when the samples are treated, indicating 
the dependence on L-ornithine for the stalling. An ornithine titration was performed showing 
a dose-dependence on ornithine for the stalling (Extended Data Figure 2 in the bioRiv 
preprint). A double frame-shifted SpeFL template that encodes a different peptide was used 
to determine whether the mRNA or the nascent chain is important for the arrest (Figure 22b). 
The corresponding toeprint did not show any ornithine-dependent bands, indicating that 
ribosomal stalling depends on the nascent chain and not on the mRNA. Altogether, these 
results indicate that ribosomes translating speFL stall in a nascent chain and ornithine 
dependent manner.   
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Figure 22. Toeprint showing the dependence of SpeFL on the nascent chain and ornithine for stalling. 
(a) The assay was performed with the wild-type speFL template in the absence (–) or presence (+) of 
10 mM of ornithine, 10 mM of putrescine, release factors (RF-1,2,3) or 90 μM puromycin. (b) The assay 
was performed with the wild-type speFL and the double frame-shifted templates in the absence (–) or 
presence (+) of 10 mM of ornithine. Release factors (RF-1,2,3) and 90 μM puromycin were added. The 
empty open triangle indicates the complex arrested at elongation with the codon A33 in the P-site and 
the filled triangle the complex arrested at termination with codon R34 in the P-site. Toeprinting assays 
and gels performed by Dr. Britta Seip. 
Furthermore, toeprinting assays were performed in the presence of compounds that are 
structurally related to L-ornithine (Figure 23). These include the D-enantiomer of ornithine (D-
ornithine), as well as compounds that differ through the addition (L-lysine) or lack (L-2,4–
diamino butyric acid) of a methylene group, or the deletion of other ligand functional groups 
(putrescine, L-norvaline, L-norleucine, 5-aminovaleric acid). This toeprint shows that L-
ornithine is the only ligand tested that can induce ribosomal stalling on speFL. Therefore, 
SpeFL arrests the ribosome in a highly specific L-ornithine dependent manner. 
 
Figure 23. Toeprinting showing the specificity of SpeFL for L-ornithine. Chemical diagrams of the 
structurally similar compounds used for the toeprint are shown. The toeprint shows the positions of 
the ribosomes (empty arrow – Ala33 and filled arrow – Arg34 in the P-site) translating in the absence 
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(–) or presence of 10 mM of different compounds. Toeprinting assays and gels performed by Dr. Britta 
Seip. 
Aiming to test whether speFL induces speF expression in vivo, a region containing speFL, the 
257-nucleotide speFL-speF intergenic region and the first 3 codons of speF was inserted into 
a reporter plasmid containing lacZ by fusing the first three codons of speF into the N-
terminus of lacZ (Bailey, Chettiath, & Mankin, 2008) (See Methods section in the bioRiv 
preprint for further details). Preliminary experiments performed in the laboratory appeared 
to show that the speF1–3-lacZ translational fusion was induced in vivo in response to ornithine 
(data not shown). In these experiments, L-ornithine was added onto a filter disk deposited 
over a lawn of E. coli cells capable of α-complementation. The readout for induction was the 
appearance of a blue ring around the disk in the presence of X-gal (5-bromo-4-chloro-3-
indolyl-β-D-galactopyranoside), indicating the expression of speF1-3-lacZ. Upon the addition 
of ornithine, there was a faint blue ring that appeared around the filter disk pointing to an 
induction of speF via ornithine dependent ribosomal stalling in vivo.   
Knowing that SpeFL is indeed a novel arrest peptide that appeared to induce speF expression 
in the presence of inducing amounts of ornithine, more insight was needed into the molecular 
mechanism employed by the peptide for both blocking the ribosome and inducing the 
expression of speF. I therefore set out to (1) perform further in vivo studies to analyze the 
mechanism of induction of speF expression, (2) structurally characterize a stalled SpeFL-
ribosome complex to investigate the mechanism of L-ornithine sensing and subsequent 
ribosome inactivation, and (3) analyze in vitro the effect of mutations in SpeFL on its stalling 
ability. 
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2.2. Methodological overview 
2.2.1. In vivo studies of the induction of expression 
Previous work in the lab sought to test the SpeFL-mediated induction of speF by ornithine in 
vivo. These assays were performed with the same disk-based assays used to study ermC 
induction by macrolides or ketolides (Bailey, Chettiath, & Mankin, 2008). This assay is based 
in the Kirby-Bauer or disk diffusion assay that was developed to assess the susceptibility of 
bacteria to antibiotics on the basis of the presence or absence of growth around the antibiotic 
wetted disks (Bauer et al., 1966). The original protocol from the Mankin laboratory was based 
on the use of an ampicillin resistance conferring reporter plasmid (pERMZα) containing ermCL, 
the intergenic region between ermCL and ermC and the first three codons of ermC fused to 
lacZ under the control of the promoter of the lac operon (Plac). E. coli cells capable of -
complementation bearing this plasmid were grown overnight before being mixed with soft 
agar and deposited onto solid media. Disks wetted with the antibiotics to test were deposited 
on top of the soft agar. Induction was observed as a blue halo that appears around the disk 
when X-gal and IPTG were added into the solid media. The distance between the ring and the 
disk is an indicator of the growth inhibition effect of the antibiotic, as the blue starts appearing 
when the amount of antibiotic that has diffused from the disk is low enough so cells can grow 
but still high enough to trigger translational arrest. 
For testing the induction of speF by speFL, ermCL, the intergenic region and the first codons 
of ermC in the pERMZα plasmid were replaced by speFL, the 257-nucleotide speFL-speF 
intergenic region and the first 3 codons of speF. Previous results in the lab showed faint blue 
rings around the cells when using the disk-based assays. I decided to avoid using the disks as 
ornithine is not an antibiotic and the cells do not need lesser concentrations of the ligand to 
be able to grow. Instead, I deposited 5 µL drops of the cell culture at 0.6 OD600 (Optical density) 
onto plates containing X-gal, IPTG and the corresponding antibiotics. The cells were left to 
grow at 37˚C until they were visible (around 6 hours) and then 3 µmol of ornithine were added 
to the middle of the cells at once. By growing the cells for 6 hours before addition of ornithine, 
we hypothesized that they would use ornithine for stalling instead as a precursor for other 
amino acids as it would be the case in exponentially growing cells. This approach allowed the 
increase in intensity of the blue the cells produce as seen in the Figure 26 of the Results 
section of this chapter. Using this variation of the β-galactosidase assay I was able to 
distinguish different levels of induction using mutants of SpeFL thanks to the differences in 
blue intensity that were not visible when using the disk-based assay. 
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2.2.2. Structural characterization of SpeFL-70S complex stalled in 
the presence of L-ornithine 
Structural characterization of bacterial arrest peptides has been achieved previously by cryo-
EM (Bhushan et al., 2011; Bischoff, Berninghausen, & Beckmann, 2014; Seidelt et al., 2009; 
Sohmen et al., 2015; Su et al., 2017). Moreover, the possibility of 3D classification in silico after 
data collection allows the study of a heterogeneous sample by cryo-EM. Other structural 
biology techniques such as X-ray crystallography are based on the use of ordered arrays of 
molecules. Using this technique, if there is heterogeneity in the sample, multiple 
conformations cannot be separated (Cheng et al., 2015; Nwanochie & Uversky, 2019). Bearing 
this in mind, I set up the complex enrichment, data collection and processing strategies 
detailed in this subsection.  
Strategy for the enrichment on the complex of interest  
The strategies used for the purification of stalled ribosome nascent chain complexes have 
varied depending on the length of the nascent chain. Long peptides like SecM (Bhushan et al., 
2011), VemP (Su et al., 2017) or MifM (Sohmen et al., 2015) have their N-terminus pointing 
out of the ribosomal exit tunnel. Peptide residues outside of the ribosome are not needed for 
the arrest and N-terminal tag fusions could therefore be used for purification of the complex 
after in vitro translation. In the case of TnaC, a linker was used between the N-terminal tag 
and the N-terminus of the arrest peptide to allow the nascent peptide to protrude from the 
tunnel (Bischoff, Berninghausen, & Beckmann, 2014; Seidelt et al., 2009). Shorter peptides like 
ErmCL (Arenz, Meydan, et al., 2014) or ErmBL (Arenz et al., 2016; Arenz, Ramu, et al., 2014) 
have been purified using a disome approach as their nascent chain does not reach the outside 
of the tunnel. This approach is based on the use of a bicistronic mRNA in which the peptide is 
encoded twice. In the presence of the arrest-inducing ligand, erythromycin in this case, two 
ribosomes would be arrested on the mRNA, one for each copy of the peptide, resulting in an 
mRNA carrying stalled disomes. Disomes are purified over sucrose gradients and then treated 
with RNase H after the addition of an oligonucleotide complementary to the region in 
between the cistrons. RNase H is an endonuclease that cleaves hybrid DNA-RNA duplexes. 
Therefore, following RNase H treatment, disomes are separated into monosomes which are 
collected after a second purification step over sucrose gradients (Figure 24).  
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Figure 24. Schematic representation of the disome approach for the purification of arrest peptides. 
In yellow an antisense oligonucleotide used for the RNase H treatment is depicted. Each ribosome is 
stalled at one of the copies of the arrest peptide covering the ORF (orange box) and preventing other 
ribosomes to bind. RNase H specifically cleaves DNA-RNA hybrid duplexes to dissociate the disomes 
into monosomes.  
Since SpeFL is a long peptide (34 amino acids), the strategy of using an N-terminal affinity tag 
should have worked in theory. However, since little was known from the biochemical 
experiments performed until then in the laboratory and we wished to preserve the integrity 
of the peptide, we decided to use a modified disome approach (Figure 25). The main 
difference in the approach that I used compared to the previously published one is that in 
SpeFL there are polysomes on each cistron, whereas in the case of ErmBL and ErmCL only one 
ribosome fits per cistron. For this reason, I decided to add puromycin after translation. As 
mentioned in the Introduction section, puromycin is an antibiotic known to cause premature 
peptide release and insensitivity to this antibiotic is characteristic of arrest peptides (Chiba & 
Ito, 2012; Darken, 1964; F. Gong et al., 2001; Muto, Nakatogawa, & Ito, 2006). The idea behind 
using this antibiotic is to try to minimize the presence of actively elongating ribosomes and 
maximize the fraction corresponding to the arrested ones. While for ErmBL and ErmCL due to 
the short size of their ORF this was not a problem, in the case of SpeFL, only one of the three 
ribosomes that fit on the cistron corresponds to the stalled complex of interest. Therefore, for 
SpeFL puromycin was hypothesized to increase the ratio of stalled versus elongating 
ribosomes. 
Whilst for the structural characterization of ErmBL and ErmCL the disome fraction was 
collected after purification in sucrose gradients, for SpeFL I decided to collect not only the 
disomes but also all the polysome fractions. These polysome fractions are likely to contain one 
or two ribosomes arrested among them and with the recent advances in cryo-EM data 
processing, 3D classification allows to select for the stalled particles in-silico.  
In cryo-EM, ideally, the macromolecules adopt random orientations in the vitreous ice 
allowing the final reconstruction. However, disomes adopt preferred orientations on the grid, 
probably due to the reduction of movement liberty due to their attachment to the mRNA. 
Preferred orientations cause the loss of information and resolution parallel to the preferred 
orientation axis (Beckert et al., 2018; Zi Tan et al., 2017). To avoid this issue, RNase H 
treatment was performed as in the original papers from the Wilson laboratory (Arenz et al., 
2.2. METHODOLOGICAL OVERVIEW 
53 
2016; Arenz, Meydan, et al., 2014; Arenz, Ramu, et al., 2014). After RNase H treatment, 
fractions corresponding to the monosome peak were collected from sucrose gradients and 
concentrated to use for cryo-EM. 
 
Figure 25. Schematic representation of the purification of SpeFL-70S in the presence of ornithine. 
Briefly, a plasmid containing bicistronic speFL is used for in vitro transcription and translation in the 
presence of inducing quantities of ornithine using a commercial cell extract. After puromycin 
treatment, the sample is applied onto sucrose gradients for purification of the polysome fraction after 
centrifugation. The sucrose is removed and RNase H treatment is performed to select for monosomes 
after another sucrose gradient centrifugation step. The monosome peak is collected and concentrated 
for use for grid preparation for cryo-EM. 
Single particle reconstruction of a SpeFL-70S complex 
Aiming to observe how ornithine is capable of triggering ribosomal arrest at speF, I collected 
three different datasets. The first dataset, SpeFL-IECB, was obtained in-house with a 200 kV 
Talos Arctica transmission electron microscope (FEI). The sample was deposited onto C-flat 
grids (CF-2/1-4C) at a concentration of 380 nM. 20 frames were recorded with a total 
accumulated dose of 45.5 electrons per Å2 at a magnification of 120,000x and a pixel size of 
1.24 Å.  After data processing, the final reconstruction showed clear density for the peptide 
but the N-terminal region was difficult to model. More importantly, it was not possible to 
unambiguously assign density for L -ornithine (shown in the Results section of this chapter).  
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The second, SpeFL-ESRF, and the third, SpeFL-DLS, data collection were performed using two 
300 kV Titan Krios microscopes (FEI) equipped with a K2 Summit direct electron detector 
(Gatan) at ESRF (France) and at the Diamond Light Source (eBIC, UK). Access to these 
microscopes was obtained via ESRF or iNEXT thanks to the preliminary results obtained with 
the Talos Arctica. For both datasets, the complex was purified again and then deposited onto 
carbon-coated R2/2 Quantifoil grids. The use of Quantifoils instead of C-flats facilitated the 
handling as they are more stable. Carbon coating the grid before depositing the sample 
allowed me to reduce the quantities of ribosomes to be deposited to obtain the same 
distribution of particles (shown in the Results section of this chapter). Another improvement 
in these datasets when compared to the Talos Arctica one is that the average electron dose 
was lower, reducing the beam induced damage to the sample. The increase in magnification, 
130,000x in the SpeFL-ESRF and SpeFL-DLS datasets instead of 120,000x in the SpeFL-IECB 
dataset, allowed the reduction of the pixel size from 1.24 Å to 1.067 Å. This implies that the 
theoretical attainable resolution is higher for these datasets when compared to the IECB one 
due to the Nyquist theorem. According to this theorem, the maximum resolution that can be 
obtained is twice the pixel size (Cheng et al., 2015).  
Data processing was performed in a similar way for the three datasets using RELION-2.1 
(Scheres, 2012), RELION-3.0 (Zivanov, Nakane, & Scheres, 2019) and Cryosparc (Punjani et al., 
2017) following the scheme in Figure 31 of the Results section and Extended Data Figure 6 in 
the bioRiv preprint. Firstly, MotionCor2 was used to align the frames correcting for beam 
induced motions (Zheng et al., 2017). The following step was the estimation of the contrast 
transfer function (CTF). In the SpeFL-IECB dataset CTFFIND4 (Rohou & Grigorieff, 2015) was 
used whereas Gctf (K. Zhang, 2016) was used for the SpeFL-ESRF and SpeFL-DLS datasets. 
These programs allow the estimation of the resolution for each micrograph, which is a good 
indicator of the limiting resolution for a given dataset and can be used as a cut-off for selecting 
the micrographs. The 2D classification was performed either in RELION-2.1 (SpeFL-IECB and 
SpeFL-ESRF datasets) or Cryosparc (SpeFL-DLS). The 3D classification was key to separate the 
complex of interest from ribosomes in different conformational states that persisted after the 
biochemical enrichment procedure. The first unsupervised classification allowed me to 
remove ribosomes in the ratcheted state, a conformation where the large and small subunit 
are rotated and that is indicative of translocation. These particles did not contain the P-site 
tRNA, only the E-site one. The second step was a focused 3D classification on all 3 tRNA sites 
with background subtraction. To do so, a first 3D auto-refinement was performed followed by 
background subtraction using masks obtained from low resolution tRNAs. Density 
corresponding to the tRNAs was then extracted from the particles and classified according to 
the relative occupancies of the three tRNA sites. 3D refinement, movie refinement and 
particle polishing were then performed with the selected particles to account for beam-
induced movement of individual particles and radiation damage during data collection 
(Scheres, 2016). The refined map was post-processed using a mask around the 70S. The launch 
of RELION-3.0 came with improvements for correcting beam-induced movements and 
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microscope alignment. We decided to transfer the particles after polishing (shiny particles) 
from the SpeFL-DLS and SpeFL-ESRF datasets from RELION-2.1 to RELION-3.0. The recent 
improvements in RELION allow to estimate the trajectories of particle motion and the amount 
of cumulative beam damage, permitting a better correction of the blurriness of the images. 
They can also correct estimated beam tilt and calculate the CTF values per particle. Overall, 
they increase not only the nominal resolution but also the quality of the maps (Zivanov et al., 
2018; Zivanov, Nakane, & Scheres, 2019). Automatic sharpening in PHENIX was performed to 
maximize the clarity of the refined map from RELION-3.0. 
2.2.3. Toeprinting technique for the study of the effect of mutations 
on ribosomal stalling 
Toeprinting is an in vitro method that allows the identification of the position of the ribosome 
on an mRNA with codon resolution (Hartz et al., 1988). This technique, known as well as 
primer extension inhibition assay, is based on the use of a 5’ end labelled oligonucleotide that 
anneals to the 3’ end of the mRNA. After in vitro translation, this primer is extended by means 
of a reverse transcriptase until it reaches the ribosome protected part of the mRNA. The 
complementary DNA (cDNA) fragments are recovered and analyzed in a denaturing gel. For 
identifying the codon where the ribosome is at, a sequencing reaction is performed and 
deposited in the gel.  
The in vitro translation reaction is performed using the PURE system, a reconstituted in vitro 
cell free translation system (Shimizu et al., 2001). This system contains purified E. coli 
ribosomes, initiation, elongation, termination and recycling factors, aminoacyl-tRNA 
synthetases and the T7 polymerase in addition to nucleotides, tRNAs and other components 
needed to regenerate the energy. The reaction can be started from either DNA or RNA as the 
T7 polymerase is present in the mixture. 
Toeprinting has been used extensively to study bacterial arrest sequences and identifying the 
codon at which ribosomes stall, identifying inducing ligands or analyzing the effect of 
mutations of the amino acid sequence on the stalling capacity, among others (Chiba & Ito, 
2012; F. Gong et al., 2001; Gupta et al., 2016; Ishii et al., 2015; Koch et al., 2017; Muto, 
Nakatogawa, & Ito, 2006; Seip et al., 2018; Sothiselvam et al., 2014, 2016; Vazquez-Laslop et 
al., 2011). 
For this project, the toeprinting assays were performed using a commercial in vitro translation 
system lacking release factors and ribosomes (PURExpress ΔRF123 ΔRibosome system (New 
England Biolabs)) so that they can be added as needed. A reaction lacking ribosomes shows 
toeprints corresponding to the secondary structure of the mRNA. Lack of release factors 
allows the determination of the positioning of the stop codon on the sequencing gel. 
Puromycin was added to some reactions as puromycin resistance is a characteristic of arrest 
peptides.  
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2.3. Results 
2.3.1. Mechanism of control of gene expression by SpeFL 
Gene induction by an arrest peptide can either occur through a co-transcriptional or 
translational mechanism (see Figure 16 in General Introduction). In order to determine 
whether SpeFL exerts a transcriptional or translational control of the speF expression, I 
performed in vivo assays using the plasmid containing speFL and speF fused to lacZα, in the 
presence of bicyclomycin, an antibiotic that inhibits the ATPase activity of Rho, thus impairing 
Rho-mediated transcription termination (Magyar et al., 1996). Cells treated with bicyclomycin 
constitutively express speF1–3-lacZ indicating that premature Rho-mediated transcription 
termination prevents the expression of the speF operon (Figure 26). This is in accordance with 
previously published data where translation of orf34 in S. Typhimurium regulates the 
expression of speF by preventing premature Rho-dependent transcription termination (Ben-
Zvi et al., 2019).   
 
Figure 26.  -galactosidase assays showing that speF expression is induced in the presence of L-
ornithine via a Rho-dependent transcriptional control mechanism. (a) Schematic representation of 
the translational fusion insert containing speFL, the intergenic region between speFL and speF and the 
first three codons of speF fused to lacZ. (b) TB1 E. coli cells transformed with the above-mentioned 
plasmid were grown in the absence (-) and the presence (+) of 3 mol ornithine or 20 g bicyclomycin. 
Cells were grown on rich medium supplemented with 50 g/ml streptomycin, 100 g/ml ampicillin, 1 
mM IPTG and 0.5 mM X-Gal. 
In E. coli there is a putative Rho utilization site (rut), a sequence rich in cytosines, that directs 
Rho binding to the mRNA (Di Salvo et al., 2019). This sequence partially overlaps with the end 
of speFL and with a hairpin that might cause the RNA polymerase to pause. The hairpin is 
conserved among the γ-proteobacteria where speFL is present, including S. Typhimurium.  
Looking at the nucleotide sequence of speFL, two consecutive arginine residues R12 and R13 
are conserved as rare codons (AGG and CGG respectively with a frequency of 1.6‰ and 4.1‰ 
according to Nakamura, Gojobori, & Ikemura, 2000). More generally a conserved drop in 
codon frequency is observed at these positions, especially at position 12 (Figure 1e in the 
bioRiv preprint).  
2.3. RESULTS 
57 
Initial attempts at understanding the importance of the rare codons in the group made use of 
toeprinting experiments with templates that had the rare codons mutated into the codon with 
the highest frequency for arginine (CGT, 21.1‰ (Nakamura, Gojobori, & Ikemura, 2000)). As 
these in vitro experiments were not conclusive (data not shown), I decided to mutate the 
translational fusion reporter to analyze the effects of these mutations on the induction of speF 
in vivo. I generated the point mutant plasmids by site directed mutagenesis and performed 
the β-galactosidase assays (Figure 27).  
 
Figure 27. -galactosidase assays showing the importance of the rare codons at positions 12 and 13 
for the induction of speF. The same assay as in Figure 26, showing the induction of a speF1–3-lacZ 
translational fusion by wild-type (WT – R12AGGR13CGG) or synonymous speFL variants with the WT 
codon mutated into the codon for arginine CGT (in red), in the absence (–) or presence (+) of different 
amounts of ornithine.  
Replacing the codon at position 13 for a common synonymous codon (CGG to CGT) slightly 
reduced the induction of speF1–3-lacZ, suggesting that the speed of speFL translation is 
important for the expression of speF. The same synonymous mutation at position 12 or at 
both codons resulted in a basal level of expression of speF that can be explained by the 
accessibility of the rut site (Figure 28). RNAP transcribes speFL and potentially arrests at the 
pause hairpin. A leading ribosome starts translating speFL as soon as the RBS has been 
synthetized and reaches the pause hairpin, melting it and allowing transcription to continue. 
Ribosomal pausing at the conserved stretch of rare codons partially prevents polysome 
formation. When the levels of ornithine are low, the leading ribosome is recycled and the rut 
site is thus available for Rho to bind and terminate transcription. At inducing levels of 
ornithine, the leading ribosome undergoes nascent-chain mediated translational arrest 
covering the rut sequence. This prevents Rho binding allowing RNAP to continue transcribing 
the speF operon. 
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Figure 28. Schematic model of Rho-mediated transcription anti-termination for speF induction. The 
speFL ORF is boxed and shown partially in turquoise, with the overlapping rut sequence in yellow. The 
rare codons are shown in red and the leading ribosome is outlined in black whereas the following 
ribosomes are outlined in grey. This figure was made by Dr. Axel Innis.  
The -galactosidase assays that I performed shed light on how ribosomal arrest at speFL 
induced by L-ornithine is able to trigger the expression of speF through a Rho dependent 
mechanism. It complements the previously reported involvement of Rho in the induction of 
speF in S. Typhimurium (Ben-Zvi et al., 2019) and it provides an explanation for the previous 
observation that the speF operon is induced by high levels of ornithine (Kashiwagi et al., 1991). 
It does not, however, explain why acidic pH conditions are needed nor the involvement of 
RNase III in the enhancement of expression of the speF operon (Kashiwagi et al., 1991; 
Kashiwagi, Watanabe, & Igarashi, 1994).  
2.3.2. Structural characterization of a SpeFL-70S complex stalled in 
the presence of L-ornithine 
Purification of a SpeFL-70S complex stalled in the presence of L-ornithine 
To understand how a small molecule like L-ornithine is capable of triggering ribosomal arrest 
at speFL, I purified SpeFL-70S complexes formed in the presence of ornithine. The purification 
strategy consisted in a modified version of the disome approach (Arenz, Meydan, et al., 2014; 
Arenz, Ramu, et al., 2014) as explained in the Methodology section of this chapter (Figure 25).  
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The profiles of the sucrose gradients performed after in vitro transcription and translation of 
bicistronic speFL in the presence of L-ornithine showed an enriched polysome fraction, 
indicating the arrest of the ribosomes at speFL (Figure 29a). After puromycin treatment, the 
polysome fraction decreases and the monosome fraction increases, indicating the 
effectiveness of puromycin to release actively elongating ribosomes. However, the polysome 
fraction albeit reduced it is still significant, indicating that the puromycin treatment was not 
completely efficient.  
 
Figure 29. Purification of SpeFL-70S in the presence of ornithine. (a) Overlaid absorbance profiles at 
254 nm of sucrose gradients containing a translation mixture incubated in the absence (black) or the 
presence of L-ornithine untreated (red) or treated with 100 µM puromycin (blue). The expected 
ribosomal populations are depicted. (b) Overlaid absorbance profiles at 254 nm of sucrose gradients 
containing the polysome fraction from (a) with (blue) or without (black) RNase H treatment. The 
expected ribosomal populations are depicted. 
Being able to sort in-silico the ribosome populations during data processing, we decided to 
collect not only the disomes but also the polysomes, as they potentially contain at least one 
SpeFL-arrested ribosome. After treatment with RNase H, an endonuclease that cleaves DNA-
RNA hybrids, and subsequent sucrose gradient centrifugation, the profiles show an increase 
in the monosomal fraction when compared to the sample where the enzyme was not added 
(Figure 29b). Large polysome fractions are reduced as well, indicating the cleavage into two 
mRNA fragments containing a smaller number of ribosomes, as evidenced by the increase in 
the disome fraction. The monosome fraction was collected and the buffer was changed to 
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avoid the presence of sucrose in the cryo-EM grids as it reduces the contrast. A concentration 
of 10 mM of L-ornithine was maintained throughout the purification procedure and in the 
final buffer to prevent diffusion of the inducing molecule out of the ribosome and disassembly 
of the complex. 
Single particle reconstruction using RELION 
In the SpeFL-IECB dataset, the SpeFL-70S complex sample was diluted to a final concentration 
of 380 nM (0.95 mg/mL) for cryo-EM grid preparation whereas for the SpeFL-ESRF and -DLS 
datasets the concentration used was 120 nM (0.3 mg/mL). Such difference in concentration 
was due to the use of a thin carbon layer that was applied to the grids used for the SpeFL-ESRF 
and -DLS datasets. Ribosomes have a strong affinity for the carbon film, tending to go to the 
carbon around the holes instead of the ice when non-coated grids are used, as was the case 
of the SpeFL-IECB dataset. For the three datasets the particles were nicely dispersed, the ice 
was of a good thickness and different views of the ribosome were observed (Figure 30). 
 
Figure 30. Example of the micrographs obtained in the SpeFL-IECB and SpeFL-DLS datasets. (a) 
Representative micrograph from the SpeFL-IECB dataset showing good dispersion of the particles 
obtained at a magnification of 120,000. (b) Power spectra corresponding to the micrograph in (a) 
obtained with CTFFIND4. The maximum resolution estimated for this micrograph was 3.2 Å. (c) 
Representative micrograph from the SpeFL-DLS dataset showing good dispersion of the particles 
obtained at a magnification of 130,000. (d) Power spectra corresponding to the micrograph in (c) 
obtained with Gctf. The maximum resolution estimated for this micrograph was 2.42 Å.  
The detailed view of the processing for the SpeFL-IECB and SpeFL-ESRF is shown in Figure 31  
and Figure 32. The detailed processing for the SpeFL-DLS is not shown as it is similar to the 
ESRF one and present in Extended Data Figure 6 of the bioRiv preprint. 
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Figure 31. Flowchart of cryo-EM data processing for the SpeFL-IECB dataset. In all the steps RELION-
2.1 was used (shown in purple). SpeFL-IECB could be refined to an overall resolution of 3.8 Å, using a 
Fourier shell correlation (FSC) cutoff of 0.143. 
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Figure 32. Flowchart of cryo-EM data processing for the SpeFL-ESRF dataset. Steps where RELION-2.1 
and RELION-3.0 were used are shown in purple and green, respectively. SpeFL-ESRF could be refined 
to an overall resolution of 3.1 Å after postprocessing in RELION-2.1 and 2.7 Å after postprocessing in 
RELION-3.0, using a Fourier shell correlation (FSC) cutoff of 0.143. 
After motion correction and CTF estimation, an average of 200 particles for SpeFL-IECB and 
150-170 particles for SpeFL-DLS and -ESRF per micrograph were visible. The calibrated pixel 
size for the datasets being 1.24 Å for SpeFL-IECB and 1.067 Å for SpeFL-DLS and -ESRF, the 
maximal theoretical attainable resolution for the micrographs is the double, 2.48 and 2.13 Å, 
respectively, according to the Nyquist theorem (Cheng et al., 2015). Taking a look into the 
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distribution of the resolution estimation of the three datasets (Figure 33), it is clear that the 
estimated resolution for the SpeFL-DLS and -ESRF micrographs is better than for SpeFL-IECB. 
For SpeFL-IECB, I chose a conservative cut-off of 5 Å during micrographs selection. For the 
other two datasets, as we knew the peptide was visible and higher resolution was wanted, I 
decided to put a cut-off of 2.7 Å for the micrographs selected for the following steps of data 
processing. Then, the micrographs were further selected according to their Figure of Merit, an 
indicator of how good the calculated CTF fits the Thon rings of the power spectra (K. Zhang, 
2016).  
 
Figure 33. Histogram showing the resolution estimation for the collected micrographs for SpeFL-IECB 
(green), SpeFL-ESRF (blue) and SpeFL-DLS (orange). 
~1,000 ribosomes from each dataset were manually picked from micrographs obtained at 
different defocus values to be used as templates of different views of the ribosome for 
automatic picking in RELION-2.1. After automatic picking, 2D classification was performed 
either in RELION-2.1 (SpeFL-ESRF and SpeFL-IECB) or Cryosparc (SpeFL-DLS), showing different 
views of the ribosome.  
The first step of unsupervised 3D classification allowed me to remove undetermined particles 
and ribosomes in the ratcheted state that did not contain peptidyl-tRNA in the P-site. Focused 
3D classification on the A-, P- and E-site tRNAs with background subtraction showed different 
classes in the three datasets. In the case of the SpeFL-IECB dataset, 5 different occupancies 
were visible. In the case of SpeFL-ESRF and -DLS three (ESRF) or four (DLS) occupancies were 
visible. As the ESRF and DLS complexes were obtained from a biological replicate of the IECB 
one, the differences in the occupancies could come from the preparation and purification of 
the complex. The differences between ESRF and DLS could be due to a difference in the 3D 
classification. The E-site class specific of the IECB and DLS datasets was discarded for the same 
reason as the ratcheted class. The rest of the classes were separately refined and post-
processed. As the A- and P-site or A-, P- and E site class did not show density for a peptide in 
the tunnel (data not shown), I believe that it corresponds to ribosomes that were actively 
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elongating and where the treatment with puromycin was inefficient. Both P-site and P- and E-
site tRNAs containing classes in the ESRF and DLS datasets had clear density attached to them. 
Superimposition of both classes showed that the peptide was in the same conformation and 
therefore were combined for further processing. A second step of focused 3D classification on 
the P-site tRNA for the DLS and ESRF datasets ensured the removal of particles that only 
contained E-site tRNA. 3D refinement followed by movie refinement, polishing and another 
round of 3D refinement and postprocessing led to three maps with an overall resolution of 
3.8, 3.1 and 3.0 Å from 49,249, 68,195 and 137,494 particles for SpeFL-IECB, SpeFL-ESRF and 
SpeFL-DLS, respectively (Figure 34 and Figure 35). As both SpeFL-ESRF and -DLS datasets had 
the same pixel size, I decided to combine particles from both datasets. As this did not improve 
the quality of the map, I decided to keep both maps separate and use them for validation of 
one another. 
After the release of RELION-3.0 and the improvements for particle polishing and beamtilt 
refinement implemented in this version, I decided to re-process the ESRF and DLS datasets. I 
performed CTF-Refinement and Bayesian polishing on both datasets, which not only improved 
the nominal resolution to 2.7 Å but greatly enhanced the quality of the map (Figure 35 and 
Extended Data Figure 7 in the bioRiv preprint). When taking a look into the local resolution 
estimation (Extended Data Figure 7 in the bioRiv preprint), it is clear that the core of the 
ribosome where SpeFL is located is at higher resolution (2.5 Å) almost reaching the Nyquist 
limit.  
Model building, map sharpening, refinement and validation 
The initial coordinates used for model building came from a high-resolution crystal structure 
(2.1 Å) of the E. coli 70S ribosome (PDB code: 4ybb) (Noeske et al., 2015). After initial fitting 
of the entire ribosome and subsequent fitting of the different subdomains as independent 
rigid bodies, manual rebuilding of mobile ribosomal RNA bases in the exit tunnel, the PTC and 
the decoding center was performed in Coot (Emsley & Cowtan, 2004). Protein bL9 adopts a 
different conformation in X-ray crystals compared to cryo-EM. As the initial model was 
obtained by X-ray crystallography and our density map by cryo-EM, coordinates for bL9 were 
taken from the coordinates of a cryo-EM model where this protein adopts the same 
conformation seen in our structure (PDB code: 5o2r (Florin et al., 2017)). Real space 
refinement was carried out in PHENIX after manually modifying the model in Coot. 
SpeFL was built manually into the density. In the three SpeFL-70S datasets, all of the 34 
residues of SpeFL attached to a tRNAArg bound to the P-site were visible in the cryo-EM density 
map (Figure 34a and c). In the case of SpeFL-IECB, the backbone and the side chains of the 
peptide in the upper part of the tunnel were easily modeled. However, the assignment of the 
density for the side chains in the N-terminal segment of SpeFL was more difficult. The increase 
in resolution obtained in the SpeFL-ESRF and -DLS datasets made all the side chains of SpeFL 
visible so mismodelling in the initial model from residue Met8 to the N-terminus could be fixed 
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(Figure 34b and d). The tRNAArg was built manually by mutating a fMet-tRNAiMet model. The 
variable loop was disordered so it was not modelled. The few residues of the mRNA that were 
visible in the SpeFL-ESRF and -DLS datasets were manually built into the density. 
 
Figure 34. Cryo-EM density map of the SpeFL-70S complex. (a) Transverse section of SpeFL-IECB 
density map, showing the small (30S, pale gray) and large (50S, white) subunits, the P-site tRNA (pale 
blue) and SpeFL (turquoise). (b) Density of SpeFL from SpeFL-IECB displayed as mesh with the fitted 
model of SpeFL, showing the N-terminal part forming the hairpin and the C-terminal part. (c) 
Transverse section of SpeFL-DLS density map, showing the small (30S, pale gray) and large (50S, white) 
subunits, the P-site tRNA (pale blue) and SpeFL (turquoise). (d) Density of SpeFL from SpeFL-DLS 
displayed as mesh with the fitted model of SpeFL, showing the N-terminal part forming the hairpin and 
the C-terminal part. 
When the SpeFL-IECB structure was solved no clear density that could be unambiguously 
assigned to L-ornithine was visible (Figure 35a). Hoping that obtaining higher resolution data 
would help us identify the density corresponding to this small molecule in the ribosome, we 
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applied for data collection time at ESRF and at the Diamond Light Source (eBIC). After particle 
polishing in RELION-2.1, the two datasets obtained at ESRF and DLS showed density that was 
conserved and positioned in a pocket formed by the ribosome and closed by SpeFL. It seemed 
to fit for an L-ornithine molecule but the orientation of the carboxyl and the amino group was 
not clear. Bayesian polishing with RELION-3.0 improved the quality of the map and was key 
for assigning the observed density to L-ornithine and for correctly positioning this molecule in 
our model. The resulting map also showed some hints of extra density surrounding L-ornithine 
that were conserved in both the ESRF and DLS maps and were thus considered not to 
correspond to noise. Sharpening both maps with PHENIX Auto-Sharpen using a model that did 
not contain ornithine allowed us to clearly distinguish the density both for ornithine and these 
solvent molecules. Therefore, assignment of the density corresponding to L-ornithine and the 
surrounding solvent would not have been possible without sharpening of the electron density 
maps obtained from the SpeFL-ESRF and -DLS datasets in RELION-3.0. 
 
Figure 35. Comparison of the quality of the density around the L-ornithine molecule. (a) Density 
corresponding to the SpeFL-IECB dataset after particle polishing and postprocessing in RELION-2.1. (b) 
Density corresponding to the SpeFL-ESRF dataset after particle polishing and postprocessing in 
RELION-2.1. (c) Density corresponding to the SpeFL-ESRF dataset after Bayesian polishing and 
postprocessing in RELION-3.0. (d) Density corresponding to the SpeFL-ESRF dataset after sharpening 
with PHENIX with a model that lacked ornithine and the ions. 
Sharpening of the DLS and ESRF maps also allowed us to model other ions bound to the 
ribosome, such as potassium, magnesium and hydrated magnesium clusters. The coordinates 
for most ions were taken from the latest model of a recent crystal structure of the Thermus 
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thermophilus 70S ribosome (PDB code: 6qnr) in which the positions for potassium and 
magnesium ions were correctly identified using anomalous diffraction (Rozov et al., 2019). 
Additional hydrated magnesium clusters were built into the cryo-EM density. Real space 
refinement in Phenix was performed once again using the improved model coordinates and 
the sharpened map.  
The values for the data collection, model refinement and statistics of both ESRF and DLS 
datasets can be found in the Extended Data Table 3 in the bioRiv preprint. 
Structure interpretation and biochemical validation 
The SpeFL-70S models obtained from SpeFL-ESRF and SpeFL-DLS show compaction of the 
SpeFL peptide, which completely obstructs the ribosomal exit tunnel. SpeFL is composed of 
an N-terminal domain that forms a hairpin and a C-terminal domain that contains secondary 
structure elements that stabilize it. These elements include two type I -turns between 
residues 19-22 and 23-26, and one 310-helix between residues 27-32 (Figure 36). 
SpeFL interacts with the ribosomal tunnel, both with the 23S rRNA and the ribosomal proteins 
uL4 and uL22 by hydrogen bonding and -stacking (Figure 36). Ala33 appears to form a 
hydrogen bond through its carbonyl group with the amino group of the 23S rRNA residue 
G2061 (Figure 36a). However, most of the interactions are not between the ribosome and the 
backbone of SpeFL but rather with its side chains, as can be seen in panels b-f of Figure 36 and 
detailed further down in the text.  
CHAPTER 2: ORNITHINE CAPTURE BY A TRANSLATING RIBOSOME CONTROLS BACTERIAL POLYAMINE SYNTHESIS 
68 
 
Figure 36. Cartoon representation of SpeFL (turquoise) showing the secondary structure elements 
and the contacts between SpeFL and the ribosome. (a) Potential hydrogen bond between Ala33 of 
SpeFL and the base of 23S rRNA residue G2061. (b) Potential hydrogen bond between Asn32 of SpeFL 
and the base of 23S rRNA residue U2506. (c) Hydrophobic core of the SpeFL effector domain formed 
by residues Phe20, Phe26, Phe28, Phe30 and Phe31. Phe28, Phe30 and Phe31 of SpeFL form π-stacking 
interactions with the bases of 23S rRNA residues U2586, G2505 and A2062, respectively. (d) Potential 
hydrogen bonds between Asn24 of SpeFL and Lys90 of ribosomal protein uL22, and electrostatic 
interaction between Arg23 of SpeFL and the phosphate backbone of 23S rRNA residue U747. (e) The 
HIRRXXH ornithine-binding motif of SpeFL, showing potential hydrogen bonds between His10 and 
His16 of SpeFL, Gly91 and Lys90 of ribosomal protein uL22, respectively. π-stacking interaction 
between 23S rRNA residue A1614 and His10 of SpeFL. (f) Electrostatic interactions between residue 
Glu2 and Asn3 of SpeFL, and residues Arg67 of ribosomal protein uL4 and the phosphate backbone of 
23S rRNA residue C796, respectively. 
L-ornithine binds to a cavity formed by the N-terminus of SpeFL and the ribosome. As a result, 
we decided to call the N-terminal domain of SpeFL the sensor domain. The ornithine binding 
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cavity is composed of 23S rRNA residues C462, G463, U464, A751, A788 and A789, and SpeFL 
residues Pro9, Arg12 and Arg13 (Figure 37a). L-ornithine interacts with these residues directly 
or via bridging solvent molecules, resulting in the complete coordination of its functional 
groups (Figure 37b) and explaining toeprinting results showing that structurally similar 
compounds to L-ornithine fail to trigger nascent-chain mediated translational arrest (Figure 
23). L-ornithine interacts directly through its α-carboxyl group with the base of 23S rRNA 
residue A751 and the side chain of SpeFL residue Arg13. The α-amino group of L-ornithine 
directly interacts with the phosphate group of 23S rRNA residue C462 whereas the side chain 
amino group interacts with the phosphate of 23S rRNA residue A789. Additional interactions 
of the aforementioned groups with solvent molecules that fill up the cavity further stabilize 
the ornithine molecule (Figure 37). Most of these interactions are made with the ribosome, 
suggesting that L-ornithine is loosely bound to the ribosome prior to the arrival of the nascent 
peptide. 
 
Figure 37. L-ornithine binds in a pocket form by the ribosome and the SpeFL peptide. (a) Density 
corresponding L-ornithine (orange) and the solvent molecules (red) that fill-up the cavity from the 
SpeFL-ESRF map. The binding pocket is formed by residues from the 23S rRNA (white) and the SpeFL 
peptide (turquoise). (b) Chemical diagram showing the potential interactions of L-ornithine (orange) 
with the solvent molecules (red), the ribosome (gray) and SpeFL (turquoise). Figure made by Dr. Axel 
Innis. 
The residues of SpeFL involved in the formation of the binding cavity for L-ornithine are part 
of a conserved motif (HIRRXXH) spanning residues 10 to 16. The residues of the motif help 
forming the pocket where L-ornithine binds by interacting with the 23S rRNA or ribosomal 
protein uL22. To assess their importance for the stalling, I performed toeprinting experiments 
with variants of SpeFL in which conserved residues His10, Ile11, Arg12, Arg13 and His16 were 
individually mutated to alanine, as well as Arg12Lys and Arg13Lys variants. All of these 
mutations abolished ornithine-dependent translational arrest, underlying their importance 
for the arrest process (Figure 38 and Figure 39). Furthermore, not only this motif is important 
but also the whole N-terminal hairpin structure of SpeFL, as shown by the disruption of the 
arrest in vitro when the first 7 residues of SpeFL are deleted (Figure 40).  
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Figure 38. Toeprinting assay showing the importance of residues His10, Ile11 and His16 of SpeFL for 
translational arrest. The assay was performed in the absence (–) or presence (+) of 10 mM of ornithine, 
release factors (RF-1,2,3) or 90 μM puromycin. The empty open triangle indicates the complex arrested 
at elongation with the codon Ala33 in the P-site and the filled one the complex arrested at termination 
with codon Arg34 in the P-site. 
 
Figure 39. Toeprinting assay showing the importance of Arg12 and Arg13 for translational arrest. The 
assay was performed in the absence (–) or presence (+) of 10 mM of ornithine, release factors (RF-
1,2,3) or 90 μM puromycin. The empty open triangle indicates the complex arrested at elongation with 
the codon Ala33 in the P-site and the filled one the complex arrested at termination with codon Arg34 
in the P-site. 
 
Figure 40. Toeprinting assay showing the importance of the first seven residues of SpeFL for 
translational arrest. The assay was performed in the absence (–) or presence (+) of 10 mM of ornithine, 
release factors (RF-1,2,3) or 90 μM puromycin. The empty open triangle indicates the complex arrested 
at elongation with the codon Ala33 in the P-site and the filled one the complex arrested at termination 
with codon Arg34 in the P-site.  
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While the interactions between the sensor domain of the peptide and the ribosome explain 
how the L-ornithine is specifically recognized, they do not account for the blocking of 
translation. The C-terminus of SpeFL constitutes the effector domain. The phenylalanines 20, 
28, 30 and 31 of the C-terminal domain of SpeFL interact with each other to form a 
hydrophobic core by nucleating around the conserved Phe26 residue. Phe28, Phe30 and 
Phe31 of SpeFL form π-stacking interactions with the bases of 23S rRNA residues U2586, 
G2505 and A2062, respectively. To investigate their importance for stalling, I performed 
toeprinting experiments with templates bearing mutations of these aromatic residues to 
alanine. The disappearance of the band corresponding to the stalled complex in the presence 
of puromycin and ornithine indicates the importance of these residues for translational arrest 
(Figure 41).  
 
Figure 41. Toeprinting assays showing the importance of the Phe26, Phe28, Phe30 and Phe31 for 
translational arrest. The assay was performed in the absence (–) or presence (+) of 10 mM of ornithine, 
release factors (RF-1,2,3) or 90 μM puromycin. The empty open triangle indicates the complex arrested 
at elongation with the codon Ala33 in the P-site and the filled one the complex arrested at termination 
with codon Arg34 in the P-site. 
The C-terminal domain of the peptide forms other interactions with the ribosome that could 
contribute to the arrest. The amino group of Lys90 from uL22 is within hydrogen bonding 
distance of the amide of Asn24 of SpeFL and the side chain amine of Arg23 of SpeFL forms a 
salt bridge with the phosphate of base U747 of 23S rRNA. The amide group of Asn32 appears 
to form a hydrogen bond with the carboxy group of base U2506 (Figure 36). This residue, 
Asn32 might as well be important for the stalling. The SpeFL-arrested structure corresponds 
to ribosomes that contain the UAG stop codon in the A-site, which is recognized by RF-1. 
Comparison of our structure to that of a Thermus thermophilus 70S ribosome in complex with 
RF-1 (PDB code: 5j3c (Pierson et al., 2016)) shows that the binding of RF-1 is prevented by the 
base of 23S rRNA residue U2585 that occupies a position that would sterically clash with the 
GGQ loop of RF-1. Asn32 would cause the movement of U2585 as it occupies the place of this 
base in the 70S-RF1 complex. In vitro toeprinting experiments performed with an Asn32Ala 
mutant show that mutation to this residue does not abolish the stalling, suggesting that the 
nature of the side chain at position 32 is not important for the arrest (Figure 42). Rather, it 
appears that the compaction of the effector domain places the backbone of residue 32 in a 
position that forces U2585 to adopt a conformation that prevents the binding of RF-1. The 
importance of the identity of the stop codon for the prevention of termination is unclear. The 
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amber (UAG) stop codon seen in E. coli speFL is not conserved among -proteobacteria, where 
the opal (UGA) stop codon is also seen to occur in some species. As a result, this indicated that 
the action of both RF-1 and -2 could be prevented by SpeFL.  
 
Figure 42. The backbone of Asn32 forces U2585 to adopt a conformation that prevents the binding 
of RF-1. (a) Structure of a Thermus thermophilus ribosome in complex with RF-1, showing the GGQ 
loop (peach) and 23S rRNA base U2585. (b) Same view as in a) of the SpeFL structure. The peptide 
(turquoise) occupies the space of U2585 (white), forcing it to adopt a conformation that prevents RF-
1 binding. (c) Toeprint showing that mutation of Asn32 to alanine does not affect translational arrest. 
The assay was performed in the absence (–) or presence (+) of 10 mM of ornithine, release factors (RF-
1,2,3) or 90 μM puromycin. The empty open triangle indicates the complex arrested at elongation with 
the codon Ala33 in the P-site and the filled one the complex arrested at termination with codon Arg34 
in the P-site. Panels (a) and (b) of the figure made by Dr. Axel Innis. 
From all the structural and biochemical data, we propose the following model for ornithine-
dependent translational arrest (Figure 43). Translation of SpeFL begins. The ornithine 
molecule could already be associated with the ribosome as most of its contacts are made with 
the ribosome, either directly or thanks to the solvent molecules that fill up the binding pocket. 
The N-terminal domain of SpeFL seems to have to be folded as a hairpin for the interaction 
with the L-ornithine as suggested by the abolishment of the arrest when the first seven amino 
acids are deleted. Since the binding pocket for ornithine is located immediately after the 
constriction formed by proteins uL4 and uL22 in the tunnel, the sensor domain might fold 
before the constriction site to be in a conformation where it can specifically recognize L-
ornithine once it reaches its location. The recognition of L-ornithine by SpeFL is highly specific, 
as similar compounds cannot be sensed. Once the sensor domain is blocked in the tunnel by 
its interactions with the ornithine and the ribosome, continuation of translation and synthesis 
of the effector domain causes it to fold and inhibit the release of SpeFL, thus arresting the 
ribosome. 
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Figure 43. Proposed model for the sensing of ornithine and the arrest of the ribosome. The coding 
sequence and the peptide of SpeFL are shown in turquoise. The ornithine is shown in orange. The 
constriction of the tunnel formed by proteins uL4 and uL22 is symbolized with a dashed line. The red 
cross indicates the disruption of the PTC leading to impaired translation. Figure made by Dr. Axel Innis. 
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2.4. Discussion 
Our findings show for the first time how a small molecule other than a drug is specifically 
recognized by a nascent chain to trigger ribosomal stalling. Ribosomes translating SpeFL 
undergo ornithine-dependent translational arrest in a two-step mechanism: a single L-
ornithine molecule is first sensed by the N-terminal sensor domain of SpeFL and translation is 
then blocked by the C-terminal effector domain. Our cryo-EM structure explains why only L-
ornithine and not similar compounds are able to arrest the ribosome. The β-galactosidase 
assays show that L-ornithine dependent arrest induces the expression of the speF operon. The 
induction is obtained via a mechanism that prevents premature transcription termination.  
Mechanism of L-ornithine sensing 
The sensing of drugs, as discussed more in detail in Chapter 3, is different from the sensing of 
ligands as the drug binds to the ribosome with high affinity even when the arrest peptide is 
being translated (Svetlov, Vázquez-Laslop, & Mankin, 2017). Regarding the sensing of other 
small ligands, it is not clear yet how this could be achieved as the structures obtained are not 
at a resolution sufficient to pinpoint the molecular mechanism for the sensing (Bhushan et al., 
2010; Bischoff, Berninghausen, & Beckmann, 2014; Seidelt et al., 2009). 
L-ornithine binding to its pocket in the ribosome is mediated by direct or solvent-mediated 
hydrogen bonds to the α-amino and α-carboxylate groups of the backbone and the amino 
group of the side chain. There are several enzymes that have L-ornithine as their substrate, 
such as ornithine cyclodeaminase (OCD) in clostridial strains that converts L-ornithine into L-
proline (Goodman et al., 2004) or SidA, the enzyme siderophore A, that catalyzes the 
conversion of L-ornithine into N5-hydroxyornithine, the first reaction for production of 
hydroxamate-containing siderophores in the fungus Aspergillus fumigatus (Franceschini et al., 
2012). There are as well other proteins that sense ornithine like the periplasmic lysine, 
arginine, ornithine binding protein (LAO) that detects these three amino acids  and is part of 
an ABC transporter (Oh, Ames, & Kim, 1994). All these enzymes bind tightly the α-amino and 
α-carboxylate groups by direct interaction by salt bridges with protein residues (Figure 44). 
 
Figure 44. Binding of ornithine in OCD, SidA and LAO. (a) Ornithine interacts with OCD either directly 
or by bridging with a water molecule. The amino group of the side chain is mobile as it is the leaving 
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group of the reaction to obtain L-proline. Ornithine is shown in orange and OCD in light blue. PDB code: 
1x7d (Goodman et al., 2004) (b) Ornithine binds to SidA in combination with Nicotinamide adenine 
dinucleotide phosphate (NADPH) and Flavin adenine dinucleotide (FAD). Interactions with the α-amino 
and α-carboxylate groups stabilize ornithine in its pocket. The side chain extends towards NADPH 
contacting it directly and via a water molecule. PDB code: 4b69 (Franceschini et al., 2012) (c) L-
ornithine is highly coordinated in the LAO structure. In this structure, the α-amino, α-carboxylate and 
amino side chain groups interact directly with residues of LAO by salt bridge interactions or hydrogen 
bonding. The side chain is additionally stabilized by water molecules. PDB code: 1lah (Oh, Ames, & Kim, 
1994). 
For ODC and SidA as the side chain of L-ornithine reacts to generate other molecules, L-proline 
and N5-hydroxyornithine, respectively, either loose hydrogen contacts or no contacts are 
observed. In the case of the LAO transporter however, the side chain is highly coordinated 
either by direct contacts with protein residues or by bridging with solvent molecules. 
Therefore, the binding of L-ornithine in these enzymes is obtained by direct or solvent aided 
salt bridge interactions and hydrogen bonding, as it is the case of the SpeFL-70S complex. 
Mechanism of ribosomal stalling by SpeFL 
Ribosomal stalling on speFL prevents translation termination by preventing the binding of RF-
1. Toeprinting assays where the wild-type amber (UAG) stop codon of speFL is mutated to the 
opal (UGA) or ochre (UAA) stop codons would indicate the importance of the release factor 
identity for the stalling. The opal stop codon is recognized by RF-2 and the ochre one by both 
RF-1 and -2 and therefore, stalling at any of these mutated templates would indicate a general 
ability to block translation termination. It would be interesting as well to assess whether 
translation elongation could be prevented as well. The incorporation of amino acids at 
position 35 of SpeFL in the absence of a stop codon seems unlikely as U2585 from 23S rRNA 
would have to move to allow the accommodation of a new incoming aminoacylated-tRNA. 
Inverse toeprinting would be a suitable technique to test different mechanistic aspects of the 
ribosomal stalling at speFL by using a library of variants of this sequence (Seip et al., 2018). 
Inverse toeprinting is based on the use of an exonuclease RNase R, that recognizes specific 
sequences in the 3’ end and degrades the mRNA until it reaches the part protected by the 
ribosome. These mRNA fragments, that still contain the 5’ end information, are recovered, 
reverse transcribed and analyzed by deep sequencing. A piece of information that could be 
gathered by using inverse toeprinting is which residues are important for stalling. Performing 
inverse toeprinting on speFL would provide more information about which interactions that 
are observed in our structure are really essential for the stalling. When using a library 
containing single amino acid mutations of SpeFL, it would provide information of the role of 
each amino acid. It could, for instance, answer the question whether the side chain of Asn32 
is important for the stalling or just the backbone impacts the location of U2585 from the 23S 
rRNA. 
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Additional experiments that would shed light on which contacts with the ribosome are 
important would be to perform inverse toeprinting or toeprinting assays in the presence of 
modified ribosomes. Indeed, ribosomes lacking or having mutations in certain bases have 
been used for the study of nascent-chain mediated translational arrest. Ribosomes bearing 
mutations in the ribosomal proteins have as well been used for the study of the stalling 
mechanism (Koch et al., 2017; Nakatogawa & Ito, 2002). Indeed, modifications of uL4 and uL22 
that widen the tunnel constriction could be used to test how interactions between SpeFL and 
these proteins affect the folding of the N-terminal hairpin.  
The formation of the N-terminal sensor hairpin is of particular interest. Based on the structure 
I determined, it is unclear whether the hairpin forms upstream of the tunnel constriction and 
passes through it already structured or if interactions between SpeFL and ribosomal proteins 
uL4 and uL22 help the hairpin to fold. It is possible that ribosomal pausing at the conserved 
stretch of rare codons at the 5’ end of the speFL ORF facilitates hairpin formation. Inverse 
toeprinting with a library of speFL variants would cover as well the analysis of templates that 
have synonymous mutations. This might provide insights into role played by the rare codons 
during the stalling process, in addition to their part in the induction of speF. 
Additional insights concerning the sensor domain specificity could be obtained using inverse 
toeprinting. Adding compounds structurally similar to ornithine to the in vitro translation 
reaction before performing inverse toeprinting could provide insights into how the selectivity 
of SpeFL is obtained. For this case, a more focused library of speFL variants could be created. 
This would involve mutating the residues directly involved in the recognition of L-ornithine 
and the residues around it (residues 10-15 “HIRRT”). As they are part of the hairpin, 
compensatory mutations might be needed in the other strand (residues 2-4 “ENN”) to 
maintain the hairpin structure that seems to be important for the arrest (Figure 40). Mutating 
only residues in this area would maintain the integrity of the effector domain, ensuring that 
these variants would be selected exclusively for their selectivity for the inducing ligand.  
My structural work has shed light on how ribosomal stalling happens at speFL. However, how 
cells cope with ribosomes stalled at speFL is still unknown. In general, known arrest peptides 
seem to be resistant to ribosomal rescue by the known machinery of the cell that recognize 
an empty A-site because of rearrangements at the PTC level and/or occupation of the A-site 
(reviewed by Ito & Chiba, 2013). There are, however, some alternative ways to release the 
arrest for arrest peptides such as the pulling force exerted by the translocon for SecM (Butkus, 
Prundeanu, & Oliver, 2003), insertion into the membrane for MifM (Chiba, Lamsa, & Pogliano, 
2009) and peptidyl-tRNA drop-off mediated by RF-3 and ribosome recycling factor for TnaC 
(M. Gong, Cruz-Vera, & Yanofsky, 2007). In the case of SpeFL, diffusion of the L-ornithine 
molecule from the tunnel when ornithine levels drop might lead to the release of the stalling 
and dissociation from the ribosome as there seems to be some room for this molecule to 
leave. It could be as well that ribosomal collisions resulting from the stalling event causes 
abortive termination (Ferrin & Subramaniam, 2017) or that bacterial ribosome quality control 
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or no-go decay pathways are activated by the stalled ribosome as it is the case in eukaryotes 
(Ikeuchi et al., 2019; Juszkiewicz et al., 2018). 
Mechanism of control of speF operon expression 
L-ornithine dependent ribosomal stalling at position 34 of speFL prevents the binding of Rho, 
thus forcing RNAP to dissociate and terminating transcription prematurely. TnaC regulates the 
expression of the tna operon in a similar way. In both SpeFL and TnaC cases, the prevention 
of the binding of Rho is due to a ribosome arrested with the stop codon in the A-site that 
partially covers the rut sequence (Konan & Yanofsky, 2000). Ribosome mediated 
transcriptional control of the downstream gene is the mechanism by which a recently 
discovered leader peptide, ToiL, functions (Baniulyte & Wade, 2019). ToiL, as SpeFL, arrests 
the ribosomes in the presence of a ligand, in the former case, in response to specific ribosome-
targeting antibiotics (tetracycline, erythromycin or tylosin). The stalling induces 
conformational changes in the mRNA that allow the transcription and translation of the 
downstream gene topAI, a topoisomerase A inhibitor. Unlike SpeFL, in the case of ToiL, the rut 
sequence does not overlap with the ORF but instead is located upstream of it. The termination 
of transcription occurs inside the ORF of topAI. Stalling of a ribosome in the presence of the 
inducing antibiotics has two functions, to liberate the RBS of topAI and to prevent Rho from 
stopping the polymerase. 
An important characteristic about SpeFL that we found is that the basal expression of speF is 
prevented by the existence of a stretch of rare codons at positions 12 and 13. According to 
our model, polysome accumulation on speFL would lead to the partial masking of the rut 
sequence when the speed of translation not reduced by rare codons at positions 12 and 13 
even in the absence of ornithine. This would prevent premature transcription termination and 
would allow a basal level of expression of the speF operon. It would be interesting to know 
how combinations of synonymous mutations to the six different arginine codons affect the 
expression of speF in vivo. The codon AGG at position 12 is less abundant than the codon CGG 
at position 13 (1.6‰ compared to 4.1‰ (Nakamura, Gojobori, & Ikemura, 2000)) so it would 
be worth to see how the replacement with other rare codons or common codons would affect 
the phenotypes we observed in Figure 27. Combinations of codons with different frequencies 
could allow the tuning of the expression of speF. Currently I am working on obtaining the 
mutated versions of the translational fusion plasmids for all the possible combinations of 
arginine codons at positions 12 and 13 to study their effect on the induction of speF. 
Analysis of the effect of mutations in the rut sequence to the induction of speF in vivo could 
lead to a better understanding of how Rho-mediated transcription termination leads to the 
regulation of the operon. However, as the rut sequence partially overlaps with the C-terminal 
part of SpeFL coding for the conserved and necessary for arrest phenylalanines, this study 
should be combined with an assay that provides information about the residues that are 
important for stalling. For instance, as mentioned before, an in vitro deep mutagenesis of the 
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peptide and analysis of the stalling by inverse toeprinting could provide these data (Seip et al., 
2018). Once it is known which residues are essential for the stalling and which amino acid 
substitutions are permitted, synonymous mutations that impair the rut sequence could be 
tested in vivo to analyze their effects on speF induction.  
In our study, we focused on the effects of L-ornithine for the stalling of SpeFL and the induction 
of speF in E. coli. A recent paper focused on the same ORF in Salmonella (Ben-Zvi et al., 2019). 
In this publication, an involvement of L-arginine in the regulation of the speF operon was 
observed. As L-arginine is as well a precursor of putrescine, it would make sense that when 
cells use this amino acid as a precursor to produce putrescine, they would shut down the 
ornithine pathway (Figure 45). In the case of Salmonella, under high arginine levels, an mRNA 
structure that is degraded by RNase G is formed in the speFL-speF intergenic region (Ben-Zvi 
et al., 2019). However, the effects of arginine on the expression of speF in E. coli are still 
unknown. The abundance of secondary structures in the E. coli mRNA suggests the existence 
of a similar mechanism. The involvement of arginine for the regulation of the operon could be 
due to the formation of an L-arginine dependent riboswitch that might be processed by an 
RNase. In line probing experiments (Strauss et al., 2012) in the presence or the absence of L-
arginine could be used to study the involvement of L-arginine in the expression of the speF 
operon in E. coli. 
 
Figure 45. Metabolic pathways for the production of ornithine and putrescine in E. coli. The enzymes 
responsible for the decarboxylation of ornithine into putrescine and the production of putrescine from 
arginine are shown in grey. 
Remaining questions about the expression of speF are the identification of the promoter, as 
well as the transcription factors associated with it. Transcription is known to start in E. coli 
under anaerobic conditions and acidic pH (Kashiwagi et al., 1991). A search for transcription 
factors and sigma factors that act at these conditions will be necessary to answer these 
questions.  
Finally, the exact mechanism for the positive control of speF expression by RNase III, an 
endonuclease that cleaves double stranded RNA, is still unknown (Kashiwagi, Watanabe, & 
Igarashi, 1994). It has been suggested that this endonuclease processes the 5’ UTR of the speF 
operon to free the RBS of speF to allow its translation. The involvement of this endonuclease 
for the processing of the 5’UTR of speF could be studied by using the in-cell SHAPE-seq 
methodology in wild-type and RNase III knockout E. coli strains. In-cell SHAPE-seq (Watters, 
Abbott, & Lucks, 2016), is a modification for the in vivo application of the SHAPE-seq technique 
(selective 2-hydroxyl acylation analyzed by primer extension sequencing) where a reagent 
that modifies the 2’-OH of non-structured RNA nucleotides is added to impair reverse 
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transcription. Next-generation sequencing of the recovered cDNA fragments shows the 
location and the frequency of the modifications induced by the SHAPE reagent. The higher the 
modifications the less structured the RNA fragment is. In the case of the speF operon, it could 
help to identify secondary structures that regulate speF expression whether RNase III is 
present or not.  
Potential physiological role of the speF operon 
The exact physiological role of the speF operon is underexplored. Its involvement in controlling 
the intracellular pH has been suggested by analogy with similar two-component systems but 
not studied (Kanjee & Houry, 2013). Expression of SpeF/PotE leads to the production and 
export of putrescine, a member of the family of polyamines that have several important roles 
for bacteria. Both SpeF and PotE have been linked to biofilm formation and microbial virulence 
(Igarashi & Kashiwagi, 2018; Michael, 2018; Miller-Fleming et al., 2015; Shah & Swiatlo, 2008). 
In Salmonella, deletion of speF/potE reduces the invasion ability into epithelial cells (H. Lee et 
al., 2018). Additionally, in Shewanella oneidensis a direct link between SpeF and the 
cohesiveness of the biofilms has been found (Ding et al., 2014) and in Shewanella baltica 
spoilage potential and biofilm formation are regulated by speF in response to quorum sensing 
proteins (Wang et al., 2019). In the case of E. coli, deletion of potE reduced the growth in vitro 
of avian pathogenic strains (Guerra, Herrero-Fresno, Ladero, et al., 2018) and in vivo, 
decreased the levels of colonization of birds (Guerra, Herrero-Fresno, Pors, et al., 2018).  
It is interesting to note that the product of the speF gene, putrescine, is involved in biofilm 
formation, cell division and stress response among others, because this is as well the case of 
indole, the product of the tna gene (reviewed in Lee & Lee, 2010). Besides, both TnaC and 
SpeFL are conserved in similar classes of  -proteobacteria (Cruz-Vera & Yanofsky, 2008), 
pointing to a possible role of small molecule-dependent arrest peptides in cell signaling among 
this class of microorganisms.  
All these data point to a role of SpeFL in biofilm-associated infections and virulence (Figure 
46). For instance, uropathogenic E. coli co-existing with Enterococcus faecalis (E. faecalis) is 
able to grow in iron-restricted environments, as it is the case of a human host, by redirecting 
their metabolism towards the production of the enterobactin and yersiniabactin siderophores 
and biofilm formation (Keogh et al., 2016). They do so in acidic conditions and high ornithine 
levels secreted by E. faecalis.   
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Figure 46. Schematic model of the potential physiological role of speFL and speF (Adapted from 
Keogh et al., 2016). E. faecalis (blue) regulates E. coli (beige) by secreting L-ornithine (orange hexagon, 
ORN). L-ornithine triggers ribosomal arrest at speFL which in turn activates the expression of speF via 
transcription antitermination. SpeF decarboxylates ornithine into putrescine. Putrescine (green 
hexagon, PUT) can potentially help initiating the expression of fecI by increasing the affinity of the 30S 
subunit for the RBS (ribosome binding site). FecI drives the expression of the fecABCDE operon, 
responsible for the ferric-citrate (red hexagon) transport, thus incorporating iron. In the initial 
colonization stage, the number of E. coli cells is low. Proliferation and infection lead to higher numbers 
of E. coli cells. 
Our findings and the previously reported involvement of speF/potE in biofilm formation and 
virulence suggest that the sensing of L-ornithine by SpeFL could be instrumental for directing 
E. coli cells towards biofilm formation and siderophore production in the presence of E. 
faecalis. Besides, putrescine has been shown to induce expression of FecI (Igarashi & 
Kashiwagi, 2006, 2018), an   factor (19) that drives the RNAP to transcribe the fecABCDE 
operon, which in turn activates iron-citrate transport (Noinaj et al., 2010). Upregulation of this 
operon increases the ability of E. coli to take up iron-citrate, allowing their survival under iron 
limiting conditions. A potential working model for the survival would be that SpeFL sensing of 
the ornithine secreted by E. faecalis triggers the expression of speF, which in turn 
decarboxylates ornithine into putrescine. Putrescine produced by speF might then activate 
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the expression of fecI, and FecI would drive the expression of the fecABCDE operon, increasing 
the uptake of ferric citrate and allowing E. coli to growth and form biofilms (Figure 46). To 
investigate this hypothesis, a collaboration has been set up with the Kline laboratory in 
Singapore to analyze the growth phenotype of uropathogenic E. coli lacking SpeFL in co-
cultures with E. faecalis.  
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Note: 
Dr. Axel Innis started this project when he was a postdoctoral fellow in the laboratory of Prof. 
Thomas Steitz at Yale University. It was continued by Dr. K. Kishore Inampudi, postdoctoral 
fellow, and Dr. A. Carolin Seefeldt, PhD student at the time, both in our laboratory. Using a 
custom-made pure T. thermophilus translation system, Axel Innis prepared T. thermophilus 
70S ribosomes stalled during translation of a short MRL peptide in the presence of the 
antibiotic erythromycin. Although he was able to obtain crystals of this complex, they 
diffracted anisotropically to 3.8 Å resolution and the density for the nascent peptide was very 
weak.  Suspecting that the presence of the mRNA interfered with the crystallization procedure 
and was thus responsible for the poor crystal quality, he devised a change in purification 
strategy that used flexizymes to directly prepare peptidyl-tRNA. Dr. K. Kishore Inampudi used 
flexizyme to attach a formyl-MKF peptide (fMKF) synthetized by Dr. Caterina Lombardo 
(Guichard team (IECB)) to initiator tRNAiMet. He also performed initial biochemical and 
structural experiments by X-ray crystallography. However, well-diffracting crystals of this 
complex were not obtained.  Taking advantage of recent technical advances in cryo-EM, Dr. 
A. Carolin Seefeldt took over this project, performing additional biochemical experiments and 
solving an initial structure of a stalled fMKF-70S complex by cryo-EM. As the resolution was 
low (3.9 Å) and important molecular details could not be elucidated, I prepared fresh sample 
to obtain a cryo-EM structure at higher resolution. I will present these results in the current 
chapter. 
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3.1. Introduction 
Drug sensing by the ribosome differs from the sensing of other small molecules. In the case of 
the drugs, they bind directly to the ribosome with high affinities (Contreras, Barbacid, & 
Vazquez, 1974; Svetlov, Vázquez-Laslop, & Mankin, 2017; Vianna et al., 2019)  whereas in the 
case of small molecules such as amino acids it is still not known if the peptide being translated 
is needed for the binding. The binding of some drugs like macrolides or chloramphenicol 
causes ribosomal stalling depending on the sequence of the peptide that is being translated 
(Davis, Gohara, & Yap, 2014; Kannan et al., 2014; Kannan, Vázquez-Laslop, & Mankin, 2012; 
Marks et al., 2016).  
In this chapter, I will focus on how the presence of a macrolide is sensed by the nascent 
polypeptide chain. Macrolides are broad-spectrum antibiotics that target the ribosome to 
block translation. A representative member of this group is erythromycin (Ery), an antibiotic 
composed of a 14-membered lactone ring, with its C3 connected to a cladinose and C5 to a 
desosamine sugar by glycosylic bonds (Figure 47). It is a natural component that was first 
isolated from Saccharopolyspora erythraea and has been used since the early 1950s for the 
treatment of bacterial infections (reviewed by Dinos, 2017; Kannan & Mankin, 2011). 
 
Figure 47. Chemical structure of erythromycin. The 14-membered macrolactone ring has a C3 
cladinose and a C5 desosamine sugar connected by glycosylic bonds. 
Macrolides are classified according to the size of their lactone ring, the vast majority of which 
are 12-, 14-, 15- or 16-membered rings. There have been three generations of macrolides, 
with natural macrolides making up the first generation, semi-synthetic macrolides the second 
generation and the ketolides in which the cladinose sugar has been replaced by a keto group 
making up the third generation (reviewed by Dinos, 2017; Kannan & Mankin, 2011). 
All these drugs are able to block translation by binding to the ribosomal exit tunnel. They bind 
in the upper part of the tunnel in a similar way. The lactone ring of erythromycin forms 
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hydrophobic interactions with bases U2611, A2057, A2058 and A2059 of the 23S rRNA. The 
C3 cladinose and C5 desosamine sugars of erythromycin extend towards the PTC but do not 
reach the active site. The dimethylamine of C5 desosamine interacts with the bases of residues 
A2058 and A2059 whereas the C3 cladinose contacts the base of 23S rRNA residue C2610 
(Figure 48) (Bulkley et al., 2010; Dunkle et al., 2010; Svetlov et al., 2019). 
 
Figure 48. Binding pocket of erythromycin in the ribosomal exit tunnel of an E. coli 70S ribosome. 
The lactone ring forms hydrophobic stacking with bases U2611, A2057, A2058 and A2059 of the 23S 
rRNA. The desosamine interacts with A2058 and A2059 whereas the cladinose contacts C2610 of the 
23S rRNA. PDB code: 4v7u (Dunkle et al., 2010). 
Historically, macrolides were thought to block the ribosomal exit tunnel like a plug, blocking 
the early steps of translation leading to peptidyl-tRNA drop-off after 3-10 amino acids have 
been incorporated into the nascent chain (Mankin, 2008; Menninger & Otto, 1982; Otaka & 
Kaji, 1975; Tanel Tenson, Lovmar, & Ehrenberg, 2003). According to this mechanism, blocking 
of the tunnel by the drug would prevent the addition of amino acids to the growing chain once 
it reaches the binding site of the drug, the number of amino acids being different depending 
on the drug (Tanel Tenson, Lovmar, & Ehrenberg, 2003). This, in turn, would lead to the 
dissociation of the peptidylated tRNA and to the premature termination of protein synthesis. 
However, this model did not explain why protein synthesis was maintained to some extent 
when cells were treated with high doses of macrolides (Kannan, Vázquez-Laslop, & Mankin, 
2012). It does not explain either how certain amino acid sequences undergo macrolide-
dependent translational arrest to regulate the expression of downstream resistance genes 
(Gryczan et al., 1980; Horinouchi & Weisblum, 1980; Horinouchi, Byeon, & Weisblum, 1983; 
Hue & Bechhofer, 1992; Murphy, 1985). 
Recent works have shown that the mode of action of macrolide antibiotics is more complex 
than simply plugging the ribosomal exit tunnel. Apart from causing peptidyl tRNA drop-off, 
depending on the sequence the ribosome is translating, macrolides can either lead to 
ribosomal arrest or allow translation to continue, thus producing the full-length protein with 
the nascent chain by-passing the drug (Figure 49) (Davis, Gohara, & Yap, 2014; Kannan et al., 
3.1. INTRODUCTION 
87 
2014; Kannan, Vázquez-Laslop, & Mankin, 2012; Starosta et al., 2010). Besides, in the case of 
ketolides, the drug has been shown in at least one instance to cause ribosomal frameshifting 
(Gupta et al., 2013). 
 
Figure 49. Effects of the macrolide antibiotic erythromycin on translation. When translation of a 
ribosome with bound erythromycin starts, the drug may (a) cause peptidyl-tRNA drop-off, (b) nascent-
chain mediated translational arrest or (c) be bypassed by the nascent chain. 
A combination of both structural and biochemical studies has increased our understanding of 
the effects that macrolides can have on bacterial translation. Cryo-EM studies have shown 
how erythromycin blocks the ribosome in the case of arrest peptides (Arenz et al., 2016; Arenz, 
Meydan, et al., 2014; Arenz, Ramu, et al., 2014). They show that the tunnel can indeed 
accommodate a long nascent peptide in the presence of macrolides and how translation is 
blocked by shutting down the PTC. In the case of ErmCL, in the presence of erythromycin, 
incorporation of the first nine amino acids into the nascent chain causes translational arrest. 
The stalling motif (IVI) spans residues 6 to 9 and, regardless the nature of the incoming amino 
acid, it cannot be incorporated into the chain (Vázquez-Laslop, Thum, & Mankin, 2008). The 
inactivation of the PTC is caused by rearrangements of 23S rRNA bases U2585, U2506, A2062 
and A2602 that globally prevent binding and accommodation of an incoming A-site tRNA. 
U2506 makes contacts with the peptide and A2602 shifts towards the PTC when compared to 
a ribosome in an unaccommodated state. U2585 shifts and thus would not be able to contact 
the incoming A-site tRNA and A2062 lies flat against the tunnel to leave space to ErmCL (Arenz, 
Meydan, et al., 2014). In the case of ErmBL, the stalling motif is VDK spanning from residues 9 
to 11. The residue Asp10 of the nascent peptide adopts an altered conformation that 
combined with a shift on the A76 residue of the P-site tRNA would position the carbonyl of 
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Asp10 too far away for peptide bond formation. Besides, binding of erythromycin prevents 
the correct positioning of the Lys11 side chain further increasing the distance for peptide bond 
formation (Arenz et al., 2016). 
Key experiments for understanding macrolide effects on the ribosome were in vivo ribosome 
profiling studies performed both in E. coli and Staphylococcus aureus (Davis, Gohara, & Yap, 
2014; Kannan et al., 2014). Ribosome profiling (Ingolia et al., 2009) is a high-throughput 
technique that maps the position of ribosomes in vivo on the mRNA with codon resolution. 
Total mRNA bound to ribosomes is purified and digested by nucleases leaving the footprint 
protected by the ribosome. These mRNA fragments are then purified, reverse transcribed and 
mapped to the genome after next-generation sequencing (NGS). Ribosome profiling has been 
widely used for studying translational pausing and arrest (Davis, Gohara, & Yap, 2014; Kannan 
et al., 2014; Marks et al., 2016; Mohammad et al., 2016; Mohammad, Green, & Buskirk, 2019; 
Woolstenhulme et al., 2015). In the ribosome profiling studies performed in E. coli and 
Staphylococcus aureus, exposing the cells to macrolide antibiotics showed the existence of 
certain enriched motifs that cause arrest in the presence of erythromycin or telithromycin 
(Kannan et al., 2014), or azithromycin (Davis, Gohara, & Yap, 2014), respectively. In the case 
of erythromycin and telithromycin the motifs are +X(+), XD(K) and XP(X) whereas for 
azithromycin they are +X(+), XP(X), XR(X), XK(X) and XD(X) (the amino acid located in the A site 
is shown in brackets). Besides, previous work in the laboratory has analyzed in vitro by inverse 
toeprinting the sequence dependency of erythromycin for ribosomal stalling and found an 
enrichment of the +X(+), XP(X), +X(W) and XP(W) motifs (Seip et al., 2018). Therefore, 
macrolides act at the level of the PTC in a sequence dependent manner rather than fully 
blocking the ribosomal exit tunnel.  
The +X(+) motif, with + indicating a positively charged amino acid and X any amino acid, is the 
most abundant for the three antibiotics, accounting for 80% (telithromycin), 50% 
(erythromycin) and 37% of the stalling motifs (azithromycin) (Davis, Gohara, & Yap, 2014; 
Kannan et al., 2014). In this motif the first positively charged amino acid represents the 
penultimate residue added to the side chain and the second one corresponds to the acceptor 
amino acid located in the A-site (Davis, Gohara, & Yap, 2014; Kannan et al., 2014; Seip et al., 
2018; Sothiselvam et al., 2014). This motif is present in the ribosome arresting peptide ErmDL 
and toeprinting experiments have shown that this sequence can be reduced to MRL(R) and 
generalized to a M+X(+) motif (Sothiselvam et al., 2014, 2016).  
The common model for the mechanism of the drug-driven ribosomal stalling is that 
interactions between the peptide and the drug trigger rearrangements at the PTC that shut it 
down (Ramu et al., 2011; Vázquez-Laslop, Thum, & Mankin, 2008). However, the fact that 
short tripeptides block the ribosome in a context specific manner when they were assumed 
to barely reach the drug binding site suggests the existence of a complementary mechanism 
where binding of the drug allosterically predisposes the PTC towards inhibition (Sothiselvam 
et al., 2014, 2016). In these short peptides, the positive charge and the size of the side chain 
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of the amino acids in the penultimate and acceptor positions affect the efficiency of peptide 
bond formation in macrolide-bound ribosomes (Sothiselvam et al., 2016). It has been 
suggested that direct steric hindrance and charge repulsion of the side chain of the 
penultimate amino acid and the acceptor amino acid would prevent proper accommodation 
of the A-site tRNA. Another possibility would be that binding of the A-site tRNA displaces the 
P-site tRNA or that both tRNAs might be incorrectly positioned in the PTC thus preventing 
peptide bond formation (Sothiselvam et al., 2016).  
Therefore, to gain a better understanding on how short-macrolide dependent arrest peptides 
sense the drug and render the PTC inactive, we sought to structurally characterize a 
representative peptide of the M+X(+) motif. The original idea was to characterize by X-ray 
crystallography T. thermophilus ribosomes translating the MRL peptide in the presence of 
erythromycin and Arg-tRNAArg using an in vitro translation system. However, the density for 
the peptide was very weak as the sample was not homogeneous. In a normal translation 
system for the synthesis of a tripeptide, several factors and components are needed (EF-G, 
EF-Tu, IF-s, tRNAs, mRNA, GTP…). To simplify the system and the formation of the complex, it 
was decided to attach the first three residues of the peptide directly to the initiator tRNA. This 
strategy not only reduces the cycles of translation the ribosome has to undergo to form the 
stalled complex but also requires a shorter mRNA, which was suspected to cause limitations 
in the diffraction of the crystals. The method chosen for the transfer of the tripeptide was the 
flexizyme technology (Goto, Katoh, & Suga, 2011).  
Flexizyme is a ribozyme, a catalytic RNA that was developed with the aim of genetic 
reprograming (Murakami, Saito, & Suga, 2003). It can transfer activated amino acids and 
derivatives specifically to the 3’ CCA end of a tRNA when the amino acid is attached to a leaving 
group. Sequence optimization led to different flexizyme sequences that recognize substrates 
with different leaving groups and chemical properties. The substrates include natural amino 
acids or peptides but also unnatural amino acids or peptide-like structures (Goto, Katoh, & 
Suga, 2011). 
To increase the reactivity of the flexizyme for peptidylation of the tRNA, Leu2 was replaced by 
a phenylalanine, that shows high reactivity when activated with CME (cyanomethyl ester) with 
the eFx (enhanced) flexizyme (Goto, Katoh, & Suga, 2011). Besides, if a medium resolution 
structure is obtained, the assignment of the phenylalanine side chain should be easy. As it was 
not possible to synthetize the formyl-MRF-CME peptide, it was chosen to change the Arg2 by 
a lysine. Lysine is known to cause ribosomal arrest in the presence of erythromycin when 
located in the penultimate position and a positively charged amino acid is the acceptor of the 
peptide bond (Kannan et al., 2014; Sothiselvam et al., 2014, 2016). Despite the changes in the 
sequence, the peptide formyl-MKF (fMKF) peptide is able to undergo erythromycin-
dependent translational arrest with a strength that is representative of other +X(+) motifs, 
albeit lower than the original formyl-MRL peptide (Figure 50). Besides, inverse toeprinting has 
shown that fMKF keeps the selectivity for a positively charged incoming amino acid in the A-
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site (Seip et al., 2018). Previous work in the laboratory was successful in charging the tRNAiMet 
with the fMKF-CME peptide. However, attempts to structurally characterize an arrested T. 
thermophilus 70S ribosomal complex formed using this peptide in the presence of 
erythromycin and Arg-tRNAArg were unsuccessful. Toeprinting assays were performed to test 
whether the complex with the tRNA charged with flexizyme was formed and it was capable of 
inducing erythromycin dependent translational arrest (Figure 51). They showed that fMKF-
tRNAiMet does indeed cause translational arrest of E. coli 70S ribosomes in vitro in the presence 
of erythromycin and Arg-tRNAArg. 
 
Figure 50. Inverse toeprinting analysis of the enrichment of the M+X(+) motif. (a) Formula used to 
calculate pause strength for an M+X(+) motif, with the amino acid in the ribosomal A-site in brackets. 
(b) RDI (raw data, description and inference) plot showing pause strengths for individual N-terminal 
M+X(+) motifs translated in the absence (-) or presence (+) of Erythromycin. The original peptide 
MRL(R) and the final peptide MKF(R) are shown. 
 
Figure 51. Toeprinting assay showing arrest by fMKF-tRNAiMet of E. coli 70S ribosomes in vitro in the 
presence of erythromycin and Arg-tRNAArg. The custom-made PURExpress system had separated 
amino acids, tRNAs and ribosomes. The start codon (blue arrow) control reaction (lane 1, first lane 
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after sequencing reaction) contained initiator tRNAiMet and L-methionine. As a translocation control, 
the two reactions were performed in presence of tRNAiMet, tRNAArg and their corresponding amino 
acids in the absence (lane 2) or presence (lane 3) of erythromycin (red arrow). fMKF-tRNAiMet can 
translocate in the presence of Arg-tRNAArg (lane 4). By the addition of erythromycin most ribosomes 
arrest at the start codon (lane 5). Toeprinting assay and gel performed by Dr. Carolin Seefeldt (Seefeldt, 
2017). 
Taking advantage of recent technical advances in cryo-EM, the complex was then formed and 
data were collected using the 200 keV Talos Arctica microscope at the IECB in Bordeaux (fMKF-
IECB). The resulting density map at 3.9 Å resolution was thought to be of sufficient quality to 
model the formyl-MKF peptide attached to tRNAiMet and to propose a mechanism for the 
arrest (Figure 52). According to this mechanism, steric hindrance and electrostatic repulsion 
between the side chain of Lysine2 that points into the A-site crevice and an incoming arginine 
side chain would be responsible for the arrest observed, in agreement with previous 
biochemical observations (Davis, Gohara, & Yap, 2014; Kannan et al., 2014; Seip et al., 2018; 
Sothiselvam et al., 2014, 2016). 
 
Figure 52. Examples of density display around different parts of the fMKF-IECB model. (a) 5S rRNA 
shows no base separation. (b and c) α-helix from ribosomal protein uL22 (b) and β-sheet (c) structure 
of the ribosomal protein bL32 show clear density for some side chains. (d) Density for the P-site tRNA. 
(e) The density corresponding to the arrest peptide includes density for the side chains of 
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phenylalanine and lysine while the methionine side chain appears to be disordered. (f) Density 
corresponding to erythromycin. 
However, the lack of high resolution led to a few unknowns such as an ambiguity concerning 
the position of the methionine and the lysine residues as no density was visible for the residue 
pointing towards the exit of the ribosomal tunnel (Figure 52e). Besides, detailed interactions 
between the peptide and the ribosomal bases of the PTC that lead to stalling could not be 
elucidated. With the aim of gaining more insight into the molecular mechanism by which short 
arrest peptides sense macrolides in the ribosomal exit tunnel, I sought to obtain a cryo-EM 
reconstruction of the MKF complex in the presence of erythromycin at higher resolution. 
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3.2. Methods 
3.2.1. Preparation of the complex for cryo-EM 
The complex I formed to study fMKF-70S in the presence of Arg-tRNAArg is composed of an 
initiator tRNA charged with the fMKF peptide using the flexizyme technology (fMKF-tRNAiMet), 
reassociated 70S ribosomes  (Blaha et al., 2000) from E. coli KC6 strain (Calhoun & Swartz, 
2006), Arg-tRNAArg (anticodon CCU) in vitro transcribed and charged with the corresponding 
amino acid, erythromycin and an mRNA containing an RBS and the coding sequence for 
MRFR* so that fMKF-tRNAiMet recognizes an AUG codon in the P-site and Arg-tRNAArg an AGG 
codon in the A-site (Figure 53). The results of the synthesis of fMFK-CME and the results of its 
charging onto tRNAiMet with the flexizyme are shown in Figure 54. The synthetic mRNA MRFR 
(5’-GGC-AAG-GAG-GUA-AAA-AUG-AGG-UUU-AGG-UAA-3’) was purchased (Eurogentec), the 
RBS sequence is shown in bold and the start codon is underlined. 
 
Figure 53. Schematic overview of the fMKF-70S complex formation for structural characterization. 
Ribosomes were purified from E. coli KC6 cells, the fMKF-tRNAiMet was charged using the flexizyme 
technology, Arg-tRNAArg was in vitro transcribed and charged and the mRNA encodes the sequence 
MRFR*.   
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Figure 54. Synthesis of fMKF and peptidylation of tRNAiMet. a) Chemical structure of the fMKF-CME 
peptide. The formylated methionine is shown in orange, the lysine in blue, the phenylalanine in green 
and the CME group in black. b) Absorbance profile of fMKF-CME after purification by RP-HPLC (Reverse 
Phase High Performance Liquid Chromatography). c) ESI (Electrospray ionization) mass spectrogram of 
purified fMKF-CME peptide. Both figures in b) and c) were kindly provided by Dr. Caterina Lombardo. 
d) Chemical structure of flexizyme eFx showing the base pairing with the tRNA to charge (Adapted 
from Murakami et al., 2006). e) Flexizyme reaction showing the charging of fMKF onto tRNAiMet after 
two hours of incubation on ice. Flexizyme charging and gel performed by Dr. K. Kishore Inampudi.  
The complex for cryo-EM was formed by mixing 2.5 µM of re-associated ribosomes with 5 µM 
of mRNA MRFR, 10 µM of fMKF-tRNAiMet and 20 µM of Arg-tRNAArg in a final volume of 20 µL 
of buffer A (50 mM HEPES-KOH pH 7.5, 100 mM K-acetate, 20 mM Mg-acetate, 20 µM Arg-
tRNAArg and 25 µM erythromycin). 0.5 nmol of erythromycin were dried into the tube where 
the complex was formed to obtain a final concentration of 25 µM. The sample was incubated 
for 15 minutes at 37˚C before diluting with buffer A to a final concentration of 120 nM (0.3 
mg/mL) of ribosomes for immediate grid preparation. 
Quantifoil carbon grids (QF-R2/2-Cu) were coated with a thin carbon layer prepared using an 
Edwards Vacuum Carbon Coater E306 with the help of Dr. Yaser Hashem and Dr. Marion 
Decossas. Grids were glow discharged for 20 seconds at 2 mA before application of 4 µL of the 
fMKF-70S complex. After blotting for 2.5 seconds and waiting for 30 seconds, grids were 
plunge-frozen in liquid ethane using a Vitrobot (FEI) set to 4˚C and 100% humidity. 
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3.2.2. Cryo-EM data acquisition and single particle reconstruction 
Grids were first screened on the 200 kV Talos Arctica microscope (FEI) at the IECB to assess 
the quality of the sample. The grids were then imaged using a 300 kV Titan Krios equipped 
with a K2 Summit direct electron detector (Gatan) at EMBL-Heidelberg producing the fMKF-
EMBL dataset. Images were recorded in counting mode with serial-EM at 130,000x with a 
magnified pixel size of 1.05 Å. 30 frames were collected to have a total accumulated dose of 
31,76 electrons per Å2. Defocus values ranged from -0.5 to -1.5 µm with a 0.25 µm increment. 
The data were processed in RELION-2.1 (Scheres, 2012), RELION-3.0 (Zivanov, Nakane, & 
Scheres, 2019) and Cryosparc 0.6 (Punjani et al., 2017). MotionCor2 (Zheng et al., 2017) was 
used for movie alignment and Gctf (K. Zhang, 2016) for CTF estimation. Particles were auto-
picked in RELION from 100 randomly selected micrographs. After 2D classification of these 
particles, 5 representative views of the ribosome were selected to do a template-based auto-
picking in RELION of the micrographs selected by resolution and FOM. The particles were then 
transferred to Cryosparc for 2D classification.  The csparc2star.py and star.py scripts (Asarnow, 
2016) were used for exporting the particles selected in Cryosparc back into RELION. 
Unsupervised 3D classification was then performed using finer angles for the sampling (Table 
4). Classes containing a single P-site tRNA or both P- and E-site tRNAs were combined and 
selected according to an astigmatism cut-off of 1.5%, to reduce the number of particles and 
computational cost. Movie refinement and particle polishing were first performed with 
RELION-2.1. Refined particle coordinates were then used to re-extract particles in RELION-3.0 
in order to perform per particle CTF correction and beam tilt refinement, followed by Bayesian 
polishing.  
Table 4. Values used for the 3D classification. 
 Angular 
sampling (º) 
Offset search range 
(pix) 
Offset search steps 
(pix) 
Local angular 
search range (º) 
Step 1 15 10 2 0 
Step 2 7.5 10 2 45 
Step 3 3.7 5 1 22 
Step 4 1.8 4 1 11 
 
3.2.3. Model building 
An initial model of the fMKF-70S complex was obtained by placing the coordinates of SpeFL-
70S complex into the cryo-EM density map with the volume tool “Fit in Map” of Chimera 
(Pettersen et al., 2004). The tRNAiMet model was taken from a Thermus thermophilus 70S 
ribosome (PDB code: 1vy4) (Polikanov, Steitz, & Innis, 2014). The fMKF peptide was manually 
built with Coot (Emsley & Cowtan, 2004) and refined through multiple rounds of real-space-
refinement in PHENIX (Afonine et al., 2018) and manual rebuilding in Coot. The pixel size was 
optimized by generating post-processed maps with different pixel sizes in RELION-2.1 and 
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assessing the map-to-model correlation in Chimera. The model was validated with MolProbity 
(Williams et al., 2018). The map was sharpened with the auto sharpen function of PHENIX 
using a model that lacked the fMKF peptide, erythromycin and the ions.
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3.3. Results 
3.3.1. Single particle reconstruction of an fMKF-70S complex and 
model building 
In order to understand if and how the binding of erythromycin allosterically predisposes the 
PTC for ribosomal stalling when M+X(+) tripeptides are translated, I prepared the fMKF-70S 
complex shown in Figure 55 as explained in the Methods section of this chapter.  
 
Figure 55. Complex to study drug sensing by short arrest peptides. The arrest sequence studied is 
fMKFR, a representative of the motif M+X(+) that causes arrest in the presence of erythromycin. 
Screening of the ribosomes deposited on carbon-coated grids in our in-house 200 kV Talos 
Arctica transmission electron microscope showed good sample dispersion and ice quality. A 
dataset of 10,004 micrographs was subsequently collected using a 300 kV Titan Krios equipped 
with a K2 camera (EMBL – Heidelberg). A representative example of the micrographs collected 
and its corresponding power spectra is shown in Figure 56. 
 
Figure 56. Example of the micrographs obtained in the fMKF-EMBL dataset. a) Representative 
micrograph showing good dispersion of the particles at 120 nM, obtained with a Titan Krios equipped 
with a K2 Summit direct electron detector at a magnification of 130,000x and a defocus of 0.5 µm. b) 
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Power spectra corresponding to the micrograph in a) obtained with Gctf. The maximum resolution 
estimated for this micrograph was 2.3 Å. 
A detailed view of the protocol I followed to obtain a reconstruction of the fMKF-70S complex 
is shown in Figure 57. After motion correction and CTF estimation, I selected the micrographs, 
according to their Figure of Merit (FOM) and resolution estimation. Due to the large number 
of micrographs collected, the cutoff value in the fMKF-EMBL dataset was stricter than the one 
used for SpeFL, 2.3 Å which is the value of the best images  (Figure 58). This value is a good 
estimation of the limiting resolution for a given dataset. 
 
Figure 57. Flowchart of cryo-EM data processing for the fMKF-EMBL dataset. Steps where RELION-
2.1 and RELION-3.0 were used are shown in purple and green, respectively. 2D classifications were 
performed in Cryosparc. The resolution was obtained using a Fourier Shell correlation (FSC) cutoff of 
0.143.  
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Figure 58. Histogram showing the resolution estimation for the collected micrographs for fMKF-
EMBL. 
The unsupervised 3D classification step was performed using increasingly finer angles for 
sampling and local search as referred in Table 4. By performing the classification at 
increasingly finer angles, the particles were first classified according to large differences, e.g. 
50S subunits differenced from 70S subunits; and then at even finer angles smaller differences 
like the presence of tRNAs or the peptide, could be detected. Particles corresponding to 
ribosomes containing P-site and P- and E-site tRNAs were selected as both showed density for 
the peptide. At this step the refined and postprocessed maps showed clear density of the 
fMKF peptide at the same level as the rest of the ribosome. Movie refinement, polishing and 
another round of 3D refinement and postprocessing were performed to improve the quality 
of the map. The final map from RELION-2.1 was obtained with 315,071 particles and reached 
an overall resolution of 2.9 Å.  
Following the release of RELION-3.0, I performed per particle CTF correction, beam tilt 
refinement and Bayesian polishing. This improved the nominal resolution to 2.4 Å and, more 
importantly, yielded a map of considerably higher quality (Figure 59 and Figure 60). Local 
resolution estimation shows that the core of the ribosome reaches 2.2 Å resolution, almost 
the maximum resolution attainable with the pixel size used (1.05 Å) as stated by the Nyquist 
theorem (Figure 60) (Cheng et al., 2015).  
The improvement in the resolution of the map was needed to correctly model the peptide in 
the density. In the map obtained in RELION-2.1, even though a previous error in the modelling 
of the peptide was hinted, the ambiguity for the assignment of the density for Met1 and Lys2 
of fMKF was not yet resolved (Figure 61a). Thanks to the improved cryo-EM density map from 
RELION-3.0, I could clearly distinguish the formyl group of the initial methionine and the 
carbonyl groups started to be visible in fMKF and concluded that the peptide had been 
modeled incorrectly into the previously obtained 3.9 Å reconstruction (Figure 61b). Map 
sharpening in PHENIX confirmed the assignment as the carbonyl groups of the backbone were 
now clearly delineated (Figure 61c). The values for the data collection, model refinement and 
statistics are in Table 5. 
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Figure 59. Cryo-EM density map of the fMKF-70S complex. Transverse section of the fMKF-70S density 
map, showing the small (30S, gray) and large (50S, white) subunits, the P-site tRNA (beige), the fMKF 
peptide (light orange) and erythromycin (dark orange). 
 
Figure 60. Refined cryo-EM density map and its cross-section obtained in RELION-3.0 filtered and 
colored by local resolution estimation values in Chimera.  
 
Figure 61. Density of fMKF and erythromycin displayed as mesh with the fitted model of fMKF (light 
orange) and erythromycin (dark orange) at different stages of the processing. (a) Density map after 
3.3. RESULTS 
101 
postprocessing in RELION-2.1. (b) Density map after postprocessing in RELION-3.0. (c) Density map 
after postprocessing in RELION-3.0 and sharpening with PHENIX auto sharpen. 
Table 5. Cryo-EM statistics and model refinement. 
 fMKF-EMBL 
(EMDB-XXXX) 
(PDB-XXXX) 
Data collection and processing  
Magnification 130,000x 
Voltage (kV) 300 
Electron exposure (e–/Å2) 31.76 
Defocus range (μm) -0.5 to -1.5 
Pixel size (Å) 1.05 
Symmetry imposed C1 
Initial particle images (no.) 1,324,977 
Final particle images (no.) 315,071 particles 
Map resolution (Å) 2.4 
FSC threshold 0.143 
Map resolution range (Å) 2.2-4.1 
  
Refinement  
Initial model used (PDB code) SpeFL-DLS 
Model resolution (Å) 2.7 
    FSC threshold 0.143 
Model resolution range (Å) 2.5-8.7 
Map sharpening B factor (Å2) -10 
Model composition  
    Non-hydrogen atoms 145,492 
    Protein residues 5519 
    Ligands 1 
B factors (Å2)  
    Protein 42.85 
    Ligand 25.61 
R.m.s. deviations 
    Bond lengths (Å) 
    Bond angles (°) 
 
0.0154 
1.89 
 Validation 
    MolProbity score 
    Clashscore 
    Poor rotamers (%)   
 
1.23 
2.58 
0.19 
 Ramachandran plot 
    Favored (%) 
    Allowed (%) 
    Disallowed (%) 
 
96.91 
3.07 
0.02 
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3.3.2. Structure interpretation 
The fMKF-EMBL cryo-EM density map shows base separation, density for side chains and the 
bumps for the carbonyl groups of the backbone of proteins, and solvent molecules (Figure 
62). It shows clear density for a P-site tRNA with the fMKF peptide attached to it and for 
erythromycin (Figure 59). In contrast to previously reported cryo-EM structures containing 
erythromycin (Arenz et al., 2016; Arenz, Meydan, et al., 2014; Arenz, Ramu, et al., 2014; Halfon 
et al., 2019), the lactone ring of erythromycin is completely visible (Figure 62). 
Erythromycin binds to the ribosome in the same way as for crystallography structures of E. 
coli ribosomes soaked with erythromycin (Dunkle et al., 2010) and cryo-EM structures of 
ribosomes stalled during translation of erythromycin-dependent arrest peptides (Figure 
59)(Arenz et al., 2016; Arenz, Meydan, et al., 2014; Arenz, Ramu, et al., 2014). 
Figure 62. Quality of the cryo-EM density of fMKF-EMBL. Cryo-EM densities for (a) the tunnel 
extension of ribosomal protein uL22, (b) a hydrated magnesium ion bound to the 23S rRNA, (c) 
erythromycin and (d) helix H64 of the 23S rRNA. 
The complex was prepared with an 8-fold excess of Arg-tRNAArg to ribosomes. The excess was 
further increased to over 150-fold when the sample was diluted for cryo-EM as the dilution 
buffer contained 20  M of Arg-tRNAArg. However, no density for the A-site tRNA was visible 
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in the cryo-EM density map, consistent with the previous observation from the structure that 
was previously solved in the laboratory (Seefeldt, 2017).  
In this lower resolution structure (3.9 Å), well-defined density was visible for the 
phenylalanine side chain. However, the density for the other two residues of fMKF was subject 
to interpretation, with two alternative conformations possible. Based on the available 
biochemical knowledge, however, the fMKF peptide was modeled with the side chain of Lys2 
pointing towards the A-site crevice formed by residues U2504, U2506 and C2452 of 23S rRNA. 
In contrast, the initial methionine was modeled as an alanine due to a lack of density 
corresponding to the side chain (Figure 52e). Superimposing the fMKF-IECB structure with the 
structure of a complex of a ribosome in the pre-attack state suggested that side chain of 
methionine is not relevant and that steric and electrostatic hindrance provoked by the side 
chain of Lys2 would prevent the binding of an A-site tRNA (Figure 63a) (Seefeldt, 2017).  
In the higher resolution fMKF-EMBL structure that I obtained (2.4 Å), the density for Met1 was 
clear, with a bump visible for the formyl group and bumps for the carbonyl groups. The density 
for the phenylalanine at position 3 was well defined. The side chain of lysine 2 is partially 
disordered and points away from the PTC towards erythromycin (Figure 61). Therefore, it 
shows inverted positions for methionine and lysine when compared to the previous model. In 
the case of the fMKF-EMBL structure, it is the side chain of the formylated methionine that 
occupies the A-site tRNA crevice and would prevent the accommodation of an incoming amino 
acid (Figure 63a). 
 
Figure 63. Comparison between the model interpreted from the 3.9 Å resolution map (fMKF-IECB) 
(a) with the 2.4 Å one (fMKF-EMBL) (b).  Both structures were overlaid to a structure containing A-site 
tRNA in the pre-attack position (PDB code: 1vy4, (Polikanov, Steitz, & Innis, 2014)), shown in gray in 
the figure. In the lower resolution structure (a) lysine was thought to point towards the A-site crevice. 
The increase in resolution (b) shows that it is the methionine side chain that occupies the position of 
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the incoming A-site tRNA. Erythromycin is shown in dark orange, the MKF peptide in light orange and 
the P-site tRNA in beige. 
The conformation of the peptide that I observe is stabilized through interactions with the 
ribosome. The side chain of the formylated methionine stacks against the base of 23S rRNA 
residue C2452 and contacts the bases of residues A2451 and U2506, all of which contribute 
to stabilizing the Met1 side chain in the A-site crevice. The amine N3 of the 23S rRNA base 
U2506 appears to form a hydrogen bond with the backbone amine of Lys2. However, the 
sidechain of Lys2 that points towards erythromycin is partially disordered and does not appear 
to form specific contacts with the drug. Phe3 forms T-shaped π-stacking interactions with 23S 
ribosomal base A2062 (Figure 64). Therefore, the conformation of fMKF observed in the 
structure is stabilized by several contacts with the ribosome. 
 
Figure 64. Interactions between MKF and the ribosome. The peptide MKF is represented as spheres, 
as well as the ribosomal bases A2062, A2451, C2452 and U2506 of 23S rRNA that interact with the 
initial methionine and phenylalanine.  
The location of the Met1 side chain in the A-site crevice is surprising. Toeprinting, ribosome 
profiling and inverse toeprinting experiments showed that the +X(+) motif is important for the 
stalling and, therefore, it was suggested that the side chain of the first positively charged 
amino acid would prevent by steric and static hindrance the accommodation of the incoming 
positively charged amino acid (Kannan et al., 2014; Seip et al., 2018; Sothiselvam et al., 2014, 
2016). This is indeed the case for ribosomal stalling of the +X(+) containing arrest peptide 
ErmDL (data and structure kindly provided by Prof. Daniel Wilson). In this E. coli 70S structure 
of a ribosome arrested during translation of ermDL in the presence of erythromycin, the side 
chain of Arg6 is located in the A-site crevice, preventing the binding of the incoming A-site 
tRNA charged with arginine (Figure 65).  
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Figure 65. Comparison between ermDL-70S (a) and fMKF-70S (b). Both structures were overlaid onto 
a structure containing A-site tRNA in the pre-attack position (PDB code: 1vy4, (Polikanov, Steitz, & 
Innis, 2014)), shown in gray in the figure. In the ErmDL-70S structure the side chain of Arg6 points into 
the A-site crevice, preventing the binding of the incoming A-site Arg-tRNAArg. In the case of fMKF-70S 
the side chain of Met1 occupies this position. Erythromycin is shown in dark orange, the MKF peptide 
in light orange and the P-site tRNA in beige. 
The positioning of the Met1 side chain in the A-site crevice seen in the fMKF-70S structure 
coincides with rearrangements of the mobile bases of the PTC. Indeed, the base of 23S rRNA 
residue U2506 moves towards the fMKF peptide to contact Met1 at this position when 
compared to a ribosome in the pre-accommodation state (PDB code: 1vq6 (Schmeing, Huang, 
Strobel, et al., 2005)) or with the tRNA accommodated before peptide bond formation (Figure 
66a) (PDB code 1vy4 (Polikanov, Steitz, & Innis, 2014)). It is also shifted when overlaid with a 
structure of the E. coli 70S ribosome bound to erythromycin (PDB code: 4v7u (Dunkle et al., 
2010)) or when compared to complexes featuring other erythromycin-dependent arrest 
peptides  (Figure 66b) (PDB codes: 5jte (Arenz et al., 2016), 3j7z (Arenz, Meydan, et al., 2014) 
and ermDL-70S from the Wilson laboratory). The movement of U2506 towards Met1 seems 
to be stabilized by contacts with the side chain of Met1 and by hydrogen bonding with the 
backbone amine of Lys2. The conformation of U2506 observed in the fMKF-70S structure 
prevents, together with the side chain of Met1, any incoming aminoacyl-tRNA from binding 
to the A-site. 
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Figure 66. Comparison of the conformation of 23S rRNA residue U2506. Ribosomal base U2506 from 
the fMKF-EMBL structure is shown in beige and the fMKF peptide in light orange. The A-site tRNA from 
the pre-attack structure (PDB code 1vy4 (Polikanov, Steitz, & Innis, 2014)) is shown in grey. a) Overlaid 
structures of a Haloarcula marismortui ribosome in the pre-accommodation state (magenta, PDB code: 
1vq6 (Schmeing et al., 2005)), T. thermophilus ribosome in the pre-attack state (marine, PDB code 1vy4 
(Polikanov, Steitz, & Innis, 2014)) and erythromycin containing E. coli ribosome (lime green, PDB code: 
4v7u (Dunkle et al., 2010)) showing base U2506. b) Overlaid structures of E. coli ribosomes arrested at 
ermBL (magenta, PDB code: 5jte (Arenz et al., 2016)), ermCL (marine, PDB code: 3j7z (Arenz, Meydan, 
et al., 2014)) and ermDL (lime green, ErmDL-70S structure from Wilson´s laboratory)) showing base 
U2506. 
Ribosomal base A2062 has been shown to be important for erythromycin-dependent arrest 
during the translation of ermCL (Vázquez-Laslop, Thum, & Mankin, 2008). This base adopts a 
different conformation in the fMKF-70S structure when compared to the pre-accommodation, 
pre-attack and Ery-containing structures, pointing up towards the PTC to interact with fMKF 
(Figure 67a). It does adopt a similar but slightly rotated conformation when compared to 
ErmCL-70S. However, in the structures of ErmBL and ErmDL base A2062 points down towards 
the exit of ribosomal tunnel (Figure 67b). This positioning of A2062 seems to prevent the 
rearrangement of the fMKF by reducing the available space in the tunnel. 
Taken together, the conformational changes in the mobile bases of the PTC and the contacts 
of the peptide with the ribosome observed in the fMKF-70S structure prevent the 
accommodation of any incoming tRNA, regardless its nature. Based on this structure, removal 
of the Met1 side chain of fMKF from the A-site crevice seems to be hindered by a reduced 
space in the tunnel. The reduction of space is caused by the binding of the drug and the 
movement of base A2062 towards the PTC due to interactions with the peptide. Importantly, 
the structure that I obtained does not explain why the nature of the incoming amino acylated 
tRNA would be important in the M+X(+) motif, as it has been shown by in vivo ribosome 
profiling, in vitro toeprinting and inverse toeprinting assays (Davis, Gohara, & Yap, 2014; 
Kannan et al., 2014; Seip et al., 2018; Sothiselvam et al., 2014, 2016). 
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Figure 67. Comparison of the conformation of 23S rRNA residue A2062. Ribosomal base A2062 from 
the fMKF-EMBL structure is shown in beige and the fMKF peptide in light orange. The A-site tRNA from 
the pre-attack structure (PDB code 1vy4 (Polikanov, Steitz, & Innis, 2014)) is shown in grey. a) Overlaid 
structures of a Haloarcula marismortui ribosome in the pre-accommodation state (magenta, PDB code: 
1vq6 (Schmeing et al., 2005)), T. thermophilus ribosome in the pre-attack state (marine, PDB code 1vy4 
(Polikanov, Steitz, & Innis, 2014)) and erythromycin containing E. coli ribosome (lime green, PDB code: 
4v7u (Dunkle et al., 2010)) showing base A2062. b) Overlaid structures of E. coli ribosomes arrested at 
ermBL (magenta, PDB code: 5jte (Arenz et al., 2016)), ermCL (marine, PDB code: 3j7z (Arenz, Meydan, 
et al., 2014)) and ermDL (lime green, ErmDL-70S structure from Wilson´s laboratory)) showing base 
A2062. 
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3.4. Discussion and perspectives 
In this chapter, the cryo-EM structure of a fMKF-70S complex has been presented. It has been 
formed in the presence of erythromycin, Arg-tRNAArg and fMKF attached to the initiator tRNA 
with flexizyme. It shows with nearly atomic resolution an MKF peptide with the side chain of 
Met1 located in the A-site preventing the binding of an aminoacylated-tRNA in the presence 
of erythromycin. 
Given that the amino acid occupying the A-site crevice is the initial methionine, it does not 
explain the selectivity of the arrest for the incoming amino acid that was previously observed 
for the +X(+) motif in the presence of macrolide antibiotics (Davis, Gohara, & Yap, 2014; 
Kannan et al., 2014; Seip et al., 2018; Sothiselvam et al., 2014, 2016). Indeed, what was 
postulated was that the side chain of the first positively charged amino acid of the +X(+) motif 
would point towards the A-site crevice. This would prevent the accommodation of the next 
incoming amino acid via steric and electrostatic repulsion.  As this effect was not observed 
with negatively charged amino acids, –X(–), it was postulated that the length of the side chain 
is also important for the arrest (Sothiselvam et al., 2016). This is what has been observed for 
ErmDL-70S ribosomes in the presence of erythromycin, in which Arg6 of ErmDL points into the 
A-site crevice and blocks the incorporation of Arg8 into the nascent chain of ErmDL (data and 
structure provided by Prof. Daniel Wilson).  
This raises the question whether the fMKF-70S structure is an artifact of preparing the 
complex using the flexizyme technique, the result of an extended incubation time prior to 
cryo-EM grid preparation, or both. It is also possible that the conformational state observed 
for fMKF does occur in nature but represents a dead-end conformation after Arg-tRNAArg 
repeatedly fails to enter the A-site (Figure 68). 
Since the tripeptide was already attached to tRNAiMet when I formed the complex with the 
ribosome and erythromycin, it might fold into some low energy conformation that cannot be 
reached if the peptide folds co-translationally. The native conformation might then be similar 
to the one observed for the ErmDL peptide, with the positively charged side chain of the 
penultimate amino acid pointing to the A-site crevice (Figure 68c). As a result, the 
conformation of fMKF that I observe might be a misfolded state, in which the peptide is 
trapped in an off-pathway local energy minimum. If this is the case then the flexizyme might 
cause an artifactual conformation where the peptide is no longer reactive to any amino acid. 
Previous work in the laboratory has shown that the blockage of translation by the tripeptide 
attached with flexizyme seems to be erythromycin dependent or relieved when erythromycin 
is not present, as the arrest was not observed when erythromycin was absent in the 
toeprinting experiments (Figure 51). However, a control was missing in this assay in which the 
acceptor amino acid arginine is replaced by any other amino acid. If the stalling happens as 
well in the presence of other acceptor amino acid, it would mean that using the flexizyme 
technology renders the peptide in a non-native conformation that loses the selectivity for a 
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positively charged amino acid in the A-site. If this is indeed the case then the structural 
characterization by cryo-EM could be as well repeated by forming the complex in vitro using 
naturally amino acylated tRNAs. The problem would be that the sample would be more 
heterogeneous, with ribosomes at different steps of elongation or initiation or even empty 
ribosomes. A large dataset combined with in silico sorting of the particles could lead to the 
resolution of a high-resolution structure of the complex of interest. Adding puromycin to the 
system after in vitro translation might increase the percentage of particles corresponding to 
the complex of interest as it was the case for SpeFL. 
 
Figure 68. Model to account for the effects of erythromycin on the translation of fMKF. (a) Peptide 
bond formation by the nucleophilic attack of the α-amine of Phe3 (blue) to the α-carbonyl group of 
Lys2 (purple) leads to an elongated by one peptidyl-tRNA in the A site (b). Translocation of the tRNA 
to the P-site might lead to different conformations of the peptide that block the accommodation of 
the incoming amino-acylated tRNA. It could have the Lys2 side chain pointing to the A-site crevice and 
thus preventing the binding of a positively charged incoming aminoacylated-tRNA (c). It could be that 
steric and static repulsion between the side chain of the positively charged incoming aminoacylated-
tRNA and the lysine2 side chain triggers a conformational change in the peptide (d) that renders it in 
the dead-end conformation observed by cryo-EM where the Met1 side chains points into the A-site 
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crevice (e). Both conformations might trigger peptidyl-tRNA drop-off a common phenomenon 
observed in macrolide-bound ribosomes.  
Another explanation might be that the conformation observed comes from extended 
incubation prior to the preparation of cryo-EM grids. If this is the case, the conformation with 
the lysine2 side chain pointing towards the A-site crevice (Figure 68c) might be the first 
conformation adopted by the peptide before it transitions into a more stable dead-end 
conformation with the Met1 side chain pointing into the A-site crevice (Figure 68e). This might 
happen spontaneously or it could be facilitated by the Arg-tRNAArg attempting to 
accommodate into the A-site (Figure 68d). In this scenario, repeating the characterization by 
cryo-EM forming the complex in vitro using naturally aminoacylated tRNAs would not solve 
the issue unless the grids were prepared immediately after mixing the components of the in 
vitro translation system or by using a microfluidics device that mixes the reactions and rapidly 
deposits them on the grid (Frank, 2017). Nevertheless, this hypothesis could be tested in vitro 
by toeprinting. Using two different templates, one coding for MKFR and the other for MKFA, 
for example, it should be possible to tell if the problem is due to the incubation time by 
comparing the stalling pattern when fMKF-tRNAiMet and Arg-tRNAArg / Ala-tRNAAla are added 
together or sequentially. If all tRNAs are added at the same time, stalling is expected for MKFR 
but not for MKFA. If the tRNAs are added sequentially and stalling is observed for MKFA, this 
would mean that letting the complex equilibrate before adding the incoming aminoacyl-tRNA 
helps the peptide reach a dead-end conformation that stalls the ribosome irrespective of 
which tRNA is in the A-site. Similar experiments could be carried out with different amino acids 
in the A-site. 
An interesting possibility is that the conformation I observe for fMKF is not a dead end, but 
rather an intermediate leading to peptidyl-tRNA drop-off. Indeed, it is known that treating E. 
coli cells with macrolide antibiotics leads to peptidyl-tRNA drop-off after 3-10 amino acids 
have been incorporated into the nascent chain both in vitro and in vivo (Mankin, 2008; 
Menninger & Otto, 1982; Otaka & Kaji, 1975; Tanel Tenson, Lovmar, & Ehrenberg, 2003). It 
could be that either the conformation with Lys2 pointing to the A-site or the one with Met1 
pointing to the A-site lead to peptidyl-tRNA drop-off. The exact mechanism by which this 
happens is still unknown. By preventing the binding of any amino acid, the Met1 side chain 
conformation seen in the fMKF-70S structure might cause the premature dissociation of the 
peptidyl-tRNA in the P-site. However, this might be as well caused in the case of Lys2 pointing 
to the A-site. Peptidyl-tRNA drop-off can be observed by precipitating the translating 
ribosomes with formic acid (Tanel Tenson, Lovmar, & Ehrenberg, 2003). While free and bound 
peptidyl-tRNAs are precipitated, free peptides are not. The latter can thus be quantified in the 
precipitate and in the supernatant by reverse-phase high-performance liquid chromatography 
(HPLC) with mass spectrometry to calculate the drop-off rate (Tanel Tenson, Lovmar, & 
Ehrenberg, 2003). By comparing the peptidyl-tRNA drop-off rate in samples formed using the 
flexizyme technology versus in vitro translation systems it could be detected if the dead-end 
conformation leads to drop-off more frequently. 
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Once it is known whether this conformation happens in nature, it would be interesting to test 
the arrest in ribosomes lacking the base of 23S rRNA residue A2062, as was previously done 
to study erythromycin-dependent arrest during translation of ermCL (Koch et al., 2017). This 
would answer whether removing A2062 leaves more space in the tunnel for the peptide to 
rearrange and allow continuation of translation of the M+X(+) motif in erythromycin bound 
ribosomes. 
In summary, the cryo-EM structure I solved is in contradiction with the hypothesis raised from 
previously reported biochemical and structural data about how the +X(+) motif blocks the 
ribosome in the presence of erythromycin. Therefore, further investigations on the matter are 
needed to test whether this conformation indeed happens in vivo or it is an artifact due to the 
method for complex formation. 
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4.1. General discussion and perspectives 
The work during my thesis focused on understanding how arrest peptides can sense small 
molecules, such as amino acids or antibiotics. In the first part of my thesis, my structural 
studies of the L-ornithine sensing arrest peptide SpeFL show for the first time how a small 
molecule other than a drug is sensed by a ribosome nascent chain complex. In the second 
part, the structure that I obtained of a ribosome stalled during translation of a short 
erythromycin-dependent arrest motif is at odds with the prevailing model in the field. Further 
biochemical investigations will be needed to assess the biological implications of this 
structure. 
Pursuing the structural characterization of ligand-sensing arrest peptides in complex with the 
ribosome is necessary to understand the differences in the sensing of drugs and other small 
molecules by the ribosome. In the SpeFL-70S complex, it seems that the ligand might already 
be loosely bound to the ribosome and that the translation of the peptide and the positioning 
of the sensor domain are responsible for fixing ornithine in its binding pocket. However, it is 
still unknown whether other small molecules trigger ribosomal arrest in the same way as 
SpeFL or if they bind tightly to the ribosome in the absence of a nascent peptide the same way 
that drugs do. Another possibility could be that neither of the above happens and instead the 
binding site of the ligand is entirely created by the peptide.  
In relation to the sensing of the molecule, how small metabolite sensing relates to the folding 
of the peptide is still not characterized. In the case of the effector domain of SpeFL, recognition 
of L-ornithine by the sensor domain eases its folding. However, for the sensor domain, it is 
still unclear whether the recognition of L-ornithine facilitates the folding or if prior hairpin 
formation is needed for SpeFL to specifically recognize the molecule once it reaches its binding 
pocket. In the case of drug dependent arrest peptides, reduction of the space available in the 
ribosomal exit tunnel facilitates the folding of the peptide in a conformation that causes the 
stalling (Arenz et al., 2016; Arenz, Meydan, et al., 2014; Arenz, Ramu, et al., 2014). To address 
this issue, further structural studies may be needed at different stages of translation. In the 
case of SpeFL, time resolved cryo-EM (Frank, 2017) might shed light into whether the N-
terminal hairpin forms in the upper part of the tunnel before reaching the molecule binding 
site or the folding is produced at this stage. Another way for investigating the folding of SpeFL 
could be to attach the sensor domain to the critical residues of stalling of the ligand 
independent arrest peptide SecM. By solving the structure in the presence and absence of 
ornithine, the differences in folding of the peptide might be observed.   
A better understanding of how ligand sensing arrest peptides work could lead to a directed 
evolution of arrest peptides with new functionalities. Among these functionalities, the 
development of genetic circuits and platforms for gene expression is of interest. Nowadays, 
well-known ligand-induced transcription factors like AraC or LacI are widely used for 
controlling gene expression. However, for certain applications an immediate response on 
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gene expression is needed and this is not obtained with transcription factors, as these proteins 
have to be expressed first (Bervoets & Charlier, 2019). Besides, evolving a transcription factor 
to sense a particular molecule is complicated as it would have to recognize not only the 
molecule but also the operator sequence that allows it to control gene expression. 
Riboswitches have gained importance in the synthetic biology field. In the case of 
riboswitches, the binding of the ligand to the aptamer region is recognized by the switching 
sequence that triggers the conformational change in the expression platform responsible for 
expression of the downstream gene. Therefore, the control of the expression is almost 
immediate. However, the limitation for developing artificial riboswitches is the need to link 
the aptamer and the expression platform through a switching sequence. This means that even 
if a new ligand-sensing aptamer can be identified by SELEX (Ellington & Szostak, 1990; Tuerk 
& Gold, 1990), the expression platform and switching sequence have to be adapted for each 
aptamer (Boussebayle et al., 2019; Nutiu & Li, 2005). 
The use of arrest peptides might overcome the limitations of protein factors and riboswitches 
as a means to control gene expression. In order to use arrest peptides as genetic switches only 
the sequence that undergoes arrest needs to be developed, as it is independent form the 
expression platform. The equivalent of the expression platform could be the hairpin system 
of ermCL that controls the exposure of the RBS of ermC in response to erythromycin. This 
system has already been used for the study of potential arrest sequences (Bailey, Chettiath, 
& Mankin, 2008). In this case, the potential arrest sequence replaces the N-terminus of ErmCL 
leaving only the regulatory part. In this study, the first codons of ermC are fused to LacZ as 
a reporter gene (Bailey, Chettiath, & Mankin, 2008). By replacing the reporter gene with a 
heterologous biosynthetic gene, for example, synthesis of a protein can be produced only 
when the ligand is added, with the arrest peptide thus functioning as a biological switch. Novel 
arrest peptides could be developed using high-throughput techniques such as inverse 
toeprinting (Seip et al., 2018), for the sensing of small molecules such as pollutants, drugs or 
other. By using a library of random sequences as templates, sequences that recognize a 
specific ligand could be identified. These sequences could be then developed to specifically 
recognize a ligand and not structurally similar compounds. Therefore, the use of arrest 
peptides as genetic switches over riboswitches or transcription factors is advantageous 
because when developing and evolving arrest peptides only the ligand sensing peptide has to 
be identified.  
In summary, pursuing the structural and biochemical characterization of ligand dependent 
arrest peptides would not only enlighten fundamental aspects of the mechanisms and control 
of translation but could also lead to the directed evolution of arrest peptides for applications 
such as synthetic biology.
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4.2. Conclusion 
The structure of SpeFL that I solved revealed at near-atomic resolution how a small molecule 
is sensed by a ribosome nascent chain complex in a highly specific manner. My work showed 
as well that ribosomal stalling at SpeFL leads to the induction of the expression of the speF 
operon by preventing premature Rho-dependent transcriptional termination. The 
involvement of the enzymes encoded by this operon in the synthesis of polyamines and the 
role that these molecules and L-ornithine play in biofilm formation and infection point to a 
role of SpeFL in promoting bacterial virulence. 
In addition, my structural study of the fMKF-70S complex stalled in the presence of 
erythromycin and Arg-tRNAArg shows how the rearrangements of the PTC and the peptide 
prevent the binding of an incoming aminoacyl-tRNA. It fails to explain, however, why an 
incoming positively charged amino acid is important in the +X(+) motif, as was shown by 
previous studies. It therefore opens up further biochemical investigations on the matter to 
study the A-site specificity of the complex obtained by flexizyme. 
In summary, the structure of SpeFL that I obtained resulted in a better understanding of how 
small molecules are able to block the ribosome in a sequence dependent manner by causing 
rearrangements at the PTC. In the case of fMKF-70S structure, further biochemical 
experiments should be pursued to stablish its biological relevance. In any case, both structures 
set the basis for further studies on how the ribosome senses small molecules to regulate gene 
expression. 
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ABSTRACT 
Polyamines are essential metabolites that play an important role in cell growth, stress 
adaptation, and microbial virulence1-3. In order to survive and multiply within a human host, 
pathogenic bacteria adjust the expression and activity of polyamine biosynthetic enzymes in 
response to different environmental stresses and metabolic cues2. Here, we show that ornithine 
capture by the ribosome and the nascent peptide SpeFL controls polyamine synthesis in g-
proteobacteria by inducing the expression of the ornithine decarboxylase SpeF4, via a 
mechanism involving ribosome stalling and transcription antitermination. In addition, we 
present the cryo-EM structure of an Escherichia coli (E. coli) ribosome stalled during translation 
of speFL in the presence of ornithine. The structure shows how the ribosome and the SpeFL 
sensor domain form a highly selective binding pocket that accommodates a single ornithine 
molecule but excludes near-cognate ligands. Ornithine pre-associates with the ribosome and is 
then held in place by the sensor domain, leading to the compaction of the SpeFL effector 
domain and blocking the action of release factor RF1. Thus, our study not only reveals basic 
strategies by which nascent peptides assist the ribosome in detecting a specific metabolite, but 
also provides a framework for assessing how ornithine promotes virulence in several human 
pathogens. 
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INTRODUCTION 
Putrescine is a naturally abundant polyamine that is produced from ornithine by the enzyme 
ornithine decarboxylase, whose expression and activity are tightly regulated2. Two ornithine 
decarboxylase genes exist in E. coli, the constitutive speC and the inducible speF, which along 
with its operon partner potE, an ornithine-putrescine antiporter, is expressed under mild acidic 
stress and high ornithine levels4-6. Searching for regulatory elements upstream of speF, we found 
a short open reading frame (ORF) encoding a putative 34-amino acid peptide, which we named 
speFL (leader of speF) (see Methods, Fig. 1a). This ORF is conserved in many pathogenic γ-
proteobacteria (Supplementary Fig. 1), including Salmonella Typhimurium (S. Typhimurium), 
where it was recently reported as orf347. Translation of orf34 in the presence of ornithine activates 
speF expression by preventing premature Rho-dependent transcription termination7. However, 
the mechanism by which ornithine triggers speF expression is unknown. 
RESULTS 
To investigate how speF is activated, we performed toeprinting assays8,9 to monitor the position 
of ribosomes on a transcript encoding SpeFL (Fig. 1b and Supplementary Data 1, Supplementary 
Tables 1 and 2). A faint toeprint corresponding to ribosomes that reached the UAG stop codon 
was visible in the absence of exogenous ligand. Addition of ornithine resulted in two strong 
toeprint signals for ribosomes stalled with codons 33 or 34 of speFL in the ribosomal P-site. 
Ribosome stalling occurred in a dose-dependent manner with respect to ornithine concentration 
(Supplementary Fig. 2), but no toeprints were observed in the presence of putrescine, highlighting 
the strict dependence of the stalling process on ornithine availability. Translating a double-
frameshifted speFLfs template that encodes a different amino acid sequence did not yield 
ornithine-dependent toeprints (Supplementary Fig. 3), indicating that ribosome stalling depends 
on the nascent peptide rather than on the mRNA structure. In the absence of release factors, the 
toeprint at position 34 intensified, reflecting impaired translation termination. Treatment with 
puromycin led to the disappearance of this toeprint, while ornithine-dependent toeprints 
remained visible. Puromycin causes premature peptide release and insensitivity to this antibiotic 
is characteristic of arrest peptides, a class of nascent regulatory peptides that stall the ribosomes 
that are translating them, often in a ligand-dependent manner10,11. Finally, we showed that an 
RNA element including speFL and the 257-nucleotide speFL-speF intergenic region induces the 
expression of a speF1–3-lacZa translational fusion in vivo in response to ornithine (Fig. 1c). 
Treatment with bicyclomycin, which specifically blocks the ATPase activity of Rho12, resulted in 
constitutive speF1–3-lacZa expression, confirming the previously reported7 involvement of Rho in 
	 3 
the regulation of speF. Thus, ribosomes translating speFL stall in an ornithine-dependent manner, 
inducing speF through a Rho-dependent mechanism. 
 
Figure 1 | Mechanism of speF activation by SpeFL and ornithine. a, Schematic layout of the 
speF operon showing the sequence of the SpeFL peptide and the reaction catalyzed by SpeF. 
b, Toeprinting assay8,9 to monitor the translation of speFL in the absence (–) or presence (+) of 
10 mM ornithine, 10 mM putrescine, release factors (RF1,2,3) or 90 µM puromycin. Arrows 
indicate ribosomes stalled with the codon for the indicated amino acid in the P-site (Ala33 – 
open triangle; Arg34 – filled triangle). c, E. coli TB1 cells56 transformed with a plasmid carrying 
a speF1–3-lacZa translational fusion whose expression is placed under the control of speFL and 
the speFL-speF intergenic region. Cells were grown on rich medium supplemented with 50 
µg/ml streptomycin, 100 µg/ml ampicillin, 1 mM IPTG and 0.5 mM X-Gal in the absence (–) or 
presence (+) of 3 µmol ornithine or 20 µg bicyclomycin. Blue cells express the speF1–3-lacZa 
translational fusion. d, Model of speF induction following the ornithine-dependent stalling of 
ribosomes translating speFL. The speFL open reading frame is boxed and shown partly in 
turquoise, with the overlapping rut site in yellow. Consecutive rare arginine codons R12 and 
R13 are shown in red letters. The leading ribosome on speFL is outlined in black while the 
second and third ribosomes are outlined in gray. The SpeFL peptide is in turquoise. e, Codon 
frequency at each position of speFL in E. coli (red line) and in the Enterobacteriales order 
(nspecies=10 (see Supplementary Fig. 1); mean – blue lines; ± standard deviation (SD) – light blue 
boxes). Codon usage values were obtained from the Codon Usage Database (NCBI-Genbank 
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Flat File Release 160.0 [June 15 2007])57. f, The same assay as in c, showing the induction of a 
speF1–3-lacZa translational fusion by wild-type (WT – R12rR13r) or synonymous speFL variants 
with different combinations of rare (r) or common (c) arginine codons at positions 12 and 13, 
in the absence (–) or presence (+) of different amounts of ornithine. Mutated codons are shown 
in red. 
In S. Typhimurium, Rho-dependent transcription termination occurs immediately downstream of 
an mRNA hairpin that includes the 3’ end of speFL7. This hairpin is conserved in E. coli and would 
cause an RNA polymerase that has just finished transcribing speFL to pause (Fig. 1d, 
Supplementary Fig. 4). A ribosome translating speFL can unwind the pause hairpin upon reaching 
the stop codon, freeing the RNA polymerase and allowing transcription to resume. When 
ornithine levels are low, the leading ribosome on speFL terminates and dissociates from the 
mRNA, exposing part of a predicted Rho utilization (rut) site13. Rho-mediated transcriptional 
attenuation is commonly used for metabolic control and can be coupled with translational arrest 
at a leader ORF, for example during the regulation of E. coli tryptophanase operon by the 
tryptophan-dependent arrest peptide TnaC14. For Rho to bind to the nascent transcript and cause 
premature transcription termination, a full rut site must be available. Since polysome 
accumulation on speFL would interfere with rut availability, we hypothesized that consecutive 
rare arginine codons at positions 12 and 13 of speFL may slow translation enough to fully expose 
the rut site and give Rho a chance to bind. As reported previously7, this region of speFL contains 
rare codons in many γ-proteobacteria, especially at position 12 (Fig. 1e). While replacing codon 
13 with a common synonymous codon caused a mild decrease in speF1–3-lacZa induction, the 
same mutation at position 12 or mutation of both codons gave rise to a basal level of speF 
expression that was not observed with wild-type speFL (Fig. 1f), consistent with a model whereby 
efficient Rho binding is dependent on polysomes not accumulating on rut. When ornithine levels 
are high, the leading ribosome on speFL undergoes nascent peptide-mediated translational arrest. 
Ribosome stalling masks the rut site and polysomes accumulate (Supplementary Fig. 5). This 
prevents Rho from binding, allowing transcription to proceed and speF to be expressed. 
To determine how nascent SpeFL functions as an ornithine sensor, we used cryo-EM to obtain 
two structures of a SpeFL–70S ribosome complex stalled in the presence of ornithine at an overall 
resolution of 2.7 Å (Fig. 2a, Supplementary Fig. 5, 6 and 7, and Supplementary Table 3). We 
observed a major subpopulation corresponding to a stalled termination complex with well-
resolved density for a 34-residue peptidyl-tRNAArg bound to the P-site, but the elongation 
complex stalled on codon 33 that was seen by toeprinting was not observed (Fig. 2b). This 
discrepancy may result from differences in the kinetics of the purified translation system used for 
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toeprinting and the S30 extract-based translation system used for cryo-EM sample preparation. 
Alternatively, the elongation complex may be less stable than the termination complex, resulting 
in complex dissociation during sucrose gradient centrifugation. 
 
Figure 2 | Structural basis for the specific recognition of L-ornithine by the SpeFL-70S 
complex. a, Transverse section of a cryo-EM density map of the SpeFL–70S complex, showing 
the small (30S, light gray) and large (50S, white) ribosomal subunits, the P-site tRNA (pale blue) 
and the SpeFL peptide (turquoise). b, Cryo-EM density displayed as a mesh, fitted with a 
molecular model of SpeFL, with the N– and C–terminal domains highlighted. The N-terminal 
hairpin is also indicated. c, Binding pocket formed by the 23S rRNA (white) and SpeFL 
(turquoise), with a single L-ornithine molecule (orange) surrounded by 4 solvent molecules (red) 
fitted into the cryo-EM density of the SpeFL-ESRF complex. The existence of these solvent 
molecules was validated using two independently determined structures of the SpeFL-70S 
complex (see Supplementary Fig. 9). d, Chemical diagram showing interactions between the 
23S rRNA (dark gray), SpeFL (turquoise), L-ornithine (orange) and solvent molecules (red) inside 
the ligand binding pocket. Possible hydrogen bonds are shown as dotted lines. e, Toeprinting 
assay8,9 to monitor the translation of speFL in the absence (–) or presence of 10 mM (+) of various 
small molecules in the presence of release factors (RF1,2,3). Arrows indicate ribosomes stalled 
with the indicated amino acid in the P-site (Ala33 – open triangle; Arg34 – filled triangle). 
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In the stalled SpeFL-70S termination complex, SpeFL adopts a compact fold that completely 
obstructs the upper two-thirds of the exit tunnel and can be subdivided into N- and C-terminal 
domains, corresponding to residues 1–13 and 14–34 of SpeFL, respectively. The N-terminal 
domain forms a hairpin, while secondary structure elements stabilize the C-terminal domain, 
most notably two type I b-turns between residues 19–22 and 23–26, and one 310–helix between 
residues 27–32. In addition, SpeFL interacts extensively with the 23S ribosomal RNA (23S rRNA) 
and with ribosomal proteins uL4 and uL22 through a combination of p–stacking, salt bridges and 
hydrogen bonding (Supplementary Fig. 8). All of these structural elements contribute to 
stabilizing the complex fold adopted by SpeFL inside the exit tunnel. 
A clear peak of density that could be unambiguously attributed to a single L-ornithine molecule 
was visible inside a cavity formed by 23S rRNA residues C462, G463, U464, A751, A788 and 
A789 and by Pro9, Arg12 and Arg13 of the N-terminal domain of SpeFL, referred to here as the 
sensor domain (Fig. 2c, d and Supplementary Fig. 9). To our knowledge, this cavity represents a 
novel binding site for small molecules on the ribosome, which could be targeted for future 
antibiotic development (Supplementary Fig. 10). The ornithine recognition loop of SpeFL consists 
of a HIRRXXH motif spanning residues 10–16, among which His10, Arg13 and His16 help form 
the ligand-binding pocket by interacting with 23S rRNA and ribosomal protein uL22 residues (Fig 
2c, d and Supplementary Fig. 8). Deletion of residues 1–7 of SpeFL, which disrupts the hairpin 
but retains the HIRRXXH motif (Supplementary Fig. 11), mutation of the strictly conserved Arg12 
and Arg13 to alanine or lysine (Supplementary Fig. 12) or mutation of His10, Ile11 or His16 to 
alanine (Supplementary Fig. 13) abolished ornithine-dependent translational arrest in vitro, 
highlighting the importance of the hairpin and of the conserved residues of the HIRRXXH motif 
for the stalling process. The side chain and a-amino groups of ornithine interact with the 
backbone phosphates of 23S rRNA residues A789 and G463, respectively (Fig. 2d). Ornithine is 
further stabilized via hydrogen bonding between its a-carboxyl group and both the guanidino 
group of SpeFL residue Arg13 and the N6-amino group of 23S rRNA residue A751. The 
availability of two independently obtained cryo-EM maps of the SpeFL-70S complex enabled us 
to accurately model and cross-validate the positions of ordered metal ions and solvent molecules 
within the complex. Four of these solvent molecules fill the cavity and make additional bridging 
interactions between ornithine and the 23S rRNA or SpeFL (Fig. 2c, d and Supplementary Fig. 9). 
Thus, small molecules differing from ornithine by only a single methylene group are either too 
short (L-2,4–diaminobutyric acid) or too long (L-lysine) for the binding pocket, while the deletion 
of ligand functional groups (putrescine, L-norvaline, L-norleucine, 5-aminovaleric acid) or the 
use of a D-enantiomer (D-ornithine) abolish stalling by preventing the formation of certain 
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hydrogen bonds (Fig. 2e and Supplementary Data 2). The tight coordination of L-ornithine via 
each of its potential hydrogen bond donors and acceptors therefore explains the high selectivity 
of SpeFL and the ribosome for their cognate ligand. 
To understand how ornithine capture by the sensor domain stalls the ribosome, we must focus 
on the C-terminal effector domain of SpeFL, which consists of a hydrophobic core composed of 
four phenylalanine residues (Phe20, Phe28, Phe30 and Phe31) nucleated around the strictly 
conserved Phe26 (Fig. 3a and Supplementary Fig. 8). Residues Phe28, Phe30 and Phe31 establish 
p–stacking interactions with the bases of 23S rRNA residues U2586, G2505 and A2062, 
respectively, which help to position the effector domain in the upper part of the ribosomal exit 
tunnel (Fig. 3a, Supplementary Fig. 8). Mutation of Phe26 or any of these three aromatic residues 
to alanine abolishes or severely impairs ribosome stalling in vitro (Fig. 3b and Supplementary 
Data 3), highlighting their importance for translational arrest. Since the SpeFL-70S structure 
corresponds to stalled ribosomes with a UAG stop codon in the A-site, it is clear that SpeFL must 
inhibit the action of RF1, the release factor responsible for recognizing this stop codon. 
Comparing our structure with that of a Thermus thermophilus 70S ribosome in complex with RF1 
and a P-site tRNA15 reveals that the binding of RF1 to the SpeFL-70S complex is prevented by 
23S rRNA residue U2585, which adopts a conformation that would sterically clash with the GGQ 
loop of RF1. The movement of U2585 is caused by residue Asn32 of SpeFL, which takes the 
place of its base in the 70S–RF1–P-tRNA complex (Fig. 3c, d). The nature of residue 32 is likely 
not to be critical for stalling as even an N32A mutant undergoes ornithine-dependent 
translational arrest (Fig. 3b and Supplementary Data 3). Moreover, the identity of the release 
factor is not important as all possible stop codons are observed for speFL across different species 
(Supplementary Fig. 1). Thus, the continued synthesis of SpeFL after the recognition of ornithine 
by the sensor domain leads to the compaction of the effector domain and forces U2585 into a 
conformation that prevents release factor action, causing the ribosome to stall. 
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Figure 3 | Inhibition of peptide release by SpeFL. a, Close-up of the ribosomal exit tunnel 
showing the sensor and effector domains of SpeFL (turquoise) interacting with residues of the 
23S rRNA (white). Ornithine (orange) is trapped between the tunnel wall and the sensor 
domain, while synthesis of all 34 amino acids of SpeFL leads to compaction of the effector 
domain and blockage of the peptidyl transferase center (PTC). b, Toeprinting assay8,9 to monitor 
the translation of wild-type (WT) and mutant speFL in the absence (–) or presence (+) of 10 mM 
ornithine or 90 µM puromycin. Arrows indicate ribosomes stalled with the indicated amino 
acid in the P-site (Ala33 – open triangle; Arg34 – filled triangle). c, Structure of an E. coli 70S–
RF1–P-tRNA complex (PDB 5J3C)15, showing the GGQ loop of RF1 (peach, with residue Gln-
235 labeled) and 23S rRNA residue U2585 (white). d, Close-up of the SpeFL–70S structure 
showing the same view as in c. Residue Asn32 of SpeFL (turquoise) forces U2585 to adopt a 
conformation that prevents RF1 binding. 
Metabolite sensing by a translating ribosome is a complex and dynamic process whose 
understanding has been hampered by the lack of high-resolution structural data11,16-18. With the 
exception of antibiotic-dependent translational arrest19-21, in which the drug binds directly to the 
empty ribosome, it is not known if the metabolite helps to create a binding surface for the nascent 
peptide or vice versa11, even though the latter has been suggested for the binding of tryptophan 
to the nascent TnaC peptide17. In the SpeFL–70S structure, ornithine interacts primarily with the 
ribosome, either directly or via bridging solvent molecules, whereas SpeFL provides only a few 
stabilizing interactions that help capture the cognate ligand (Fig. 2d). This implies that ornithine 
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is already loosely associated with the 23S rRNA prior to the arrival of the SpeFL sensor domain 
(Fig. 4), as suggested by molecular dynamics simulations pointing to the existence of binding 
crevices for different amino acid side chains within the ribosomal exit tunnel22. Additionally, the 
close proximity of the sensor domain to the tunnel constriction formed by ribosomal proteins uL4 
and uL22 raises the possibility that the sensor domain begins to fold in the upper part of the exit 
tunnel, consistent with the decreased speF expression seen for the R12rR13c mutant (Fig. 1f). 
Indeed, a partially folded sensor hairpin emerging from the tunnel constriction could rapidly 
contact and fix an ornithine molecule present within its adjacent binding crevice on the 23S 
rRNA. Once the interaction between the sensor domain and the tunnel wall has been stabilized 
through the binding of ornithine, the effector domain can be synthesized and compacted, 
resulting in the inhibition of peptide release from the ribosome. Since metabolite recognition 
must occur before SpeFL is fully synthesized, this process has to operate under a kinetic regime. 
In other words, the concentration of free ornithine must be significantly above the KD of the 
interaction, resulting in a rate of metabolite binding that is greater than the rate of SpeFL synthesis. 
This increases the likelihood that ligand recognition takes place by ensuring that ornithine is 
present within its binding pocket when the sensor domain of SpeFL reaches the corresponding 
region of the exit tunnel. Such a scenario is reminiscent of kinetically controlled riboswitches, 
which require high ligand concentrations to ensure that metabolite binding occurs faster than 
RNA transcription23. These basic strategies for ligand recognition could be used by other 
metabolite-sensing nascent peptides. 
 
Figure 4 | Mechanism of ornithine sensing and capture by the SpeFL–70S complex. Model for 
the binding of ornithine (orange) by the ribosome and SpeFL (turquoise), leading to inactivation 
of the peptide release activity of the ribosome (red cross). The tunnel constriction is shown as 
a blue dotted line. 
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In conclusion, our data reveal how the ribosome aided by SpeFL functions as a highly selective 
ornithine sensor to regulate polyamine biosynthesis in pathogenic bacteria like E. coli or S. 
Typhimurium. Both speF and potE, whose expression is regulated by SpeFL in response to 
fluctuating ornithine levels, have been linked to biofilm formation and microbial virulence24-26. 
However, the exact physiological roles of the speF operon remain unclear. A recent study on 
interspecies niche modulation during mixed Enterococcus faecalis (E. faecalis) and uropathogenic 
E. coli infections27 may provide us with a clue in this regard. In this work, ornithine secreted by 
E. faecalis helps uropathogenic E. coli grow in the iron-restricted environment of a human host 
by redirecting its metabolism towards siderophore production. Since we know that E. faecalis 
lowers the pH of the polymicrobial culture by producing lactic acid and that low pH and 
ornithine are required for speF induction, it is reasonable to assume that SpeFL could play a role 
in this E. faecalis-driven promotion of E. coli growth. Indeed, ornithine produced by E. faecalis 
might be sensed by SpeFL to trigger the expression of SpeF, which in turn decarboxylates 
ornithine into putrescine. Putrescine turns on the expression of a number of genes28, including 
the sigma factor FecI, a protein that activates the ferric citrate uptake operon fecABCDE. Ferric 
citrate is a naturally abundant compound inside the host, which allows uropathogenic E. coli to 
grow under iron limiting conditions29. Although a direct link between ornithine secreted by E. 
faecalis and ferric citrate uptake has yet to be demonstrated, it is known that the production of 
the siderophores enterobactin and yersiniabactin is stimulated in this manner27. Thus, a possible 
involvement of SpeFL in sensing ornithine cues within polymicrobial communities of this kind 
must now be examined. 
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METHODS 
No statistical methods were used to predetermine sample size. The experiments were not 
randomized and investigators were not blinded to allocation during experiments and outcome 
assessment. 
Bioinformatic identification of speFL. Homologs of E. coli speF were identified using tblastn31 (E-
value lower than 10-4, >70% coverage), redundancy was minimized using CD-Hit32 (95% 
sequence identity cutoff) and regions between speF and the nearest upstream annotated genes 
were compiled (unknown, hypothetical, uncharacterized or leader genes were considered not to 
be annotated). All possible forward ORFs within the last 500 nucleotides of these upstream 
regions were extracted, considering ATG and alternative start codons defined for bacterial, 
archaeal and plant plastid genetic codes (NCBI Genetic codes Table 11). Possible Shine-Dalgarno 
sequences were not taken into account. In cases where more than one ORF was possible, the 
longest ORF was kept. Redundancy within the ORFs thus obtained was minimized with CD-Hit 
(95% sequence identity cutoff). A pairwise comparison of the resulting ORFs was then carried 
out as follows. First, nucleotide sequences were translated into amino acid sequences. A sliding 
window of 10 amino acids was applied to each sequence and an alignment score based on a 
BLOSUM6233 substitution matrix was computed for all possible combinations of 10-amino acid 
fragments from each pair of ORFs (no gaps allowed). A graph in which each node represents a 
10-amino acid fragment and each edge represents an alignment score greater than 10 between 
two fragments (with the alignment score as a weight) was constructed. Finally, we used MCL34,35 
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to identify clusters within this graph and found a major cluster of conserved upstream ORFs 
corresponding to speFL. 
Phylogeny of speFL. Homologs of E. coli speFL were identified using tblastn31 and a phylogenetic 
analysis of speFL from 15 representative species of g–proteobacteria was carried out using the 
EMBL-EBI Simple Phylogeny server36. The resulting tree was displayed with Dendroscope37 
(Supplementary Fig. 1). 
Toeprinting assays. Toeprinting was performed as described previously9. Briefly, DNA templates 
containing a T7 promoter, a ribosome binding site, wild-type or mutant speFL, the first 75 
nucleotides of the speFL-speF intergenic region and the NV1 sequence38 were generated or 
amplified by polymerase chain reaction (PCR). The wild-type template was amplified by PCR 
from E. coli DH5a genomic DNA using oligonucleotides 1, 2 and 3 followed by PCR 
amplification of the product with oligonucleotides 4 and 5 (see Supplementary Table 1 for the 
sequences of all oligonucleotides used). The speFL-D1–7 template was obtained using the same 
protocol as for the wild type, but substituting oligonucleotide 2 with 6. Templates with point 
mutations and the double frame-shifted template speFLfs were purchased as gBlocks from IDT 
and amplified with oligonucleotides 4 and 5 (see Supplementary Table 2 for the sequences of all 
DNA templates).  DNA templates were transcribed and translated in vitro using the PURExpress 
D RF123 system (New England Biolabs). Ligands were dissolved in water and added as needed 
at the beginning of the reaction. A Yakima Yellow-labeled probe (2 µM) complementary to the 
NV1 sequence38 was added to the 5 µL reaction after incubating for 60 minutes at 30°C, and the 
sample was incubated for another 5 minutes at the same temperature. When needed, samples 
were treated with 90 µM puromycin at 30°C for 3 minutes, immediately followed by reverse 
transcription with 50 U of AMV reverse transcriptase (Promega) for 20 minutes at 30°C. RNA was 
degraded by adding 0.5 µL of a 10 M NaOH stock at 30°C for 15 minutes. Samples were 
neutralized with 0.7 µL of a 7.5 M HCl stock and the remaining cDNA was purified using a 
nucleotide removal kit (Qiagen). Sequencing reactions were performed according to the method 
of Sanger. Briefly, 1 pmol of DNA template was mixed with 10 pmol of oligonucleotide 9 labeled 
with Yakima Yellow and 1µL of HemoKlen Taq DNA Polymerase (New England Biolabs) in a 
6µL reaction mixture containing 50 mM Tris-HCl pH 9.0, 2 mM MgCl2, 6.6 µM dNTPs, 10 µM 
ddGTP, 117 µM ddATP, 200 µM ddTTP or 66 µM ddCTP. Primers were extended with 30 cycles 
of 30 seconds of annealing at 42 °C and 1 minute of elongation at 70 °C. The purified cDNA and 
sequencing reactions were dried using a SpeedVac and resuspended in 6 µl or 3.5 µl gel-loading 
buffer (95 % formamide, 0.25 % (w/v) xylene cyanol, 0.25 % (w/v) SDS), respectively. Samples 
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were denatured at 95°C for 5 minutes, and 2µL of the sequencing reactions and 3 µL of the 
toeprinting were separated by 7.5 % sequencing PAGE (2000 V, 40 W for 2-2.5h) followed by 
detection on a Typhoon imager (GE). 
β-galactosidase assay. To test for in vivo activity, a translational reporter plasmid was obtained 
by fusing a region containing speFL, the speFL–speF intergenic region and the first three codons 
of speF to lacZα. The insert was prepared by PCR amplification from the E. coli K12 genome 
using oligonucleotides 7 and 8. Oligonucleotides 9 and 10 were used to linearize the pErmZa 
plasmid39 . The insert and linearized plasmid were mixed and transformed following the AQUA 
cloning protocol40. Plasmids containing point mutations in the R12–R13 region were generated 
by site-directed mutagenesis as follows. The wild-type plasmid was linearized by PCR 
amplification with oligonucleotides 11 and 12, 13 or 14 (the latter included the mutations). The 
PCR product was purified from a 2% TAE-agarose gel with a Gel Extraction Kit (Qiagen) and 
phosphorylated for 30 minutes at 37 °C with 4U of T4 Polynucleotide Kinase (New England 
Biolabs) in a total volume of 20 µl according to the manufacturer’s instructions. The plasmid was 
circularized again by incubating the phosphorylated product with 400 U of T4 DNA ligase (New 
England Biolabs) for 2 hours at 16°C. The plasmids were transformed into E. coli TB139 and the 
cells were grown in lysogeny broth (LB) at 37ºC (200 rpm) with streptomycin (50 µg/ml) and 
ampicillin (100 µg/ml) until they reached an optical density of 0.6 at 600 nm. 5 µL of the cell 
culture were plated onto LB-agar plates supplemented with streptomycin, ampicillin, 1 mM 
Isopropyl-β-D-1-thiogalactopyranoside (IPTG) and 0.5 mM 5-bromo-4-chloro-3-indolyl-beta-D-
galactopyranoside (X-gal). 20 µg of bicyclomycin (Santa Cruz Biotechnology) or 0–3 µmol of L-
ornithine (Sigma) were added after a 6 hour incubation at 37°C. The plates were then incubated 
at 37°C overnight and pictures were taken the next day.  
Preparation of an E. coli SpeFL–70S complex for cryo-EM. The SpeFL–70S complex was 
prepared using a modified disome purification strategy20. Briefly, SpeFL was expressed in an RTS 
100 E. coli HY Kit (Biotechrabbit) for 1 hour at 30°C in the presence of 10 mM L-ornithine if 
indicated, using a pEX-K4-SpeFL_2x plasmid (Eurofins) that carries two copies of speFL arranged 
as a bicistronic mRNA (Supplementary Fig. 5; insert sequence: 5’-CGA-TCG-AAT-TCT-AAT-
ACG-ACT-CAC-TAT-AGG-GCT-TAA-GTA-TAA-GGA-GGA-AAA-AAT-ATG-GAA-AAT-AAC-
AGC-CGC-ACT-ATG-CCC-CAT-ATA-AGG-CGG-ACA-ACT-CAT-ATT-ATG-AAG-TTT-GCT-
CAT-CGC-AAT-AGC-TTC-GAC-TTT-CAC-TTC-TTC-AAT-GCC-CGT-TAG-TCT-ACC-GAC-TAA-
GGG-CAC-TTC-AGC-TAA-AGT-TTT-ATA-AGG-AGG-AAA-AAA-TAT-GGA-AAA-TAA-CAG-
CCG-CAC-TAT-GCC-CCA-TAT-AAG-GCG-GAC-AAC-TCA-TAT-TAT-GAA-GTT-TGC-TCA-
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TCG-CAA-TAG-CTT-CGA-CTT-TCA-CTT-CTT-CAA-TGC-CCG-TTA-GTC-TAC-CGA-CTA-AGG-
GCA-CTT-CAG-CTA-GAT-ATC-TAG-CAT-AAC-CCC-TTG-GGG-CCT-CTA-AAC-GGG-TCT-
TGA-GGG-GTT-TTT-TG-3’). Reaction volumes of 50 µL and 750 µL were used for analytical and 
preparative purposes, respectively. When indicated, the reaction was treated with 100 µM 
puromycin for 3 minutes at 30°C before being layered over 10-40% (w/v) sucrose gradients 
containing Buffer A (50 mM HEPES-KOH pH 7.5, 100 mM K-acetate, 25 mM Mg-acetate and 10 
mM L-ornithine), prepared using a Gradient Master 108 (Biocomp). Sucrose gradient 
ultracentrifugation was performed for 2 hours and 45 minutes at 35,000 rpm in a SW 41 Ti rotor 
(Beckman-Coulter) at 4°C. Polysome fractions were detected and collected using a UV detection 
system (UA-6, Teledyne ISCO) coupled to a gradient fractionator (Foxy R1, Teledyne ISCO). 
Polysomes were washed in 100 kDa molecular weight cutoff (MWCO) spin concentrators to 
remove sucrose, concentrate ribosomes and replace the solution with Buffer A. The concentration 
of ribosomes was inferred by measuring the absorbance of the sample at 260 nm (1 A260 = 60 
µg/ml or 24 nM) with a NanoDrop One (ThermoFisher). For analytical purposes, 13.2 pmol of 
ribosomes with an excess of 10 nmol of rnaseH oligonucleotide were incubated for 1 hour at 
25°C with 7.5 U of RNase H or without it (RNase H– control). The sample for cryo-EM grid 
preparation was treated with 75 U of RNase H (New England Biolabs) per 250 pmol of ribosomes 
for one hour at 25°C in the presence of 5 nmol of oligonucleotide 15. The monosomes obtained 
after RNAse H treatment were isolated by sucrose gradient ultracentrifugation as described 
above. The sample was flash frozen in liquid nitrogen and stored at -80 ºC. 
Cryo-EM grid preparation. Frozen SpeFL–70S complex was thawed and diluted in Storage Buffer 
to yield a final concentration of 120 nM. Quantifoil carbon grids (QF-R2/2-Cu) were coated with 
a thin carbon layer prepared using an Edwards Vacuum Carbon Coater E306. Grids were glow 
discharged for 30 seconds at 2 mA before application of 4 µL of the SpeFL–70S complex. After 
blotting for 2 seconds and waiting for 30 seconds, grids were plunge-frozen in liquid ethane using 
a Vitrobot (FEI) set to 4°C and 100% humidity. 
Cryo-EM data acquisition and processing. Grids were imaged using two 300-keV Titan Krios 
(FEI) equipped with a K2 Summit direct electron detector (Gatan) at ESRF (France) and at the 
Diamond Light Source (eBIC, UK) producing the SpeFL-ESRF and SpeFL-DLS datasets, 
respectively. Images were recorded with EPU in counting mode with a magnified pixel size of 
1.067 Å (Supplementary Table 3). 30 frames were collected to have a total accumulated dose of 
30 electrons per Å2. Data were processed in Relion 2.141, Relion 3.042 and Cryosparc 0.643 
according to the scheme presented in Supplementary Figure 6. Briefly, MotionCor244 was used 
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for movie alignment, Gctf45 for Contrast Transfer Function (CTF) estimation and either Relion 2.1 
or Cryosparc for 2D classification of the particles obtained by automated picking in Relion 2.1. 
The csparc2star.py and star.py scripts46 were used for exporting particles selected in Cryosparc 
back into Relion. 3D classification was performed in Relion 2.1 in three steps: (i) unsupervised 
classification with 4 times downsized particles, (ii) focused classification on all 3 tRNA sites with 
background subtraction and 3 times downsized particles, and (iii) focused classification on the 
P-site tRNA with background subtraction and 2 times downsized particles. Classes containing a 
single P-tRNA or both P- and E-site tRNAs were combined after ensuring that each class contained 
a peptide with the same conformation in the ribosomal exit tunnel when refined individually. 
Movie refinement and particle polishing were first performed with Relion 2.1. Refined particle 
coordinates were then used to re-extract particles in Relion 3.0 in order to perform per particle 
CTF and beam tilt refinement, followed by Bayesian polishing. 
Model building and refinement. An initial model of the SpeFL–70S complex was obtained by 
placing the coordinates for an E. coli 70S ribosome (PDB 4U27)47 into the cryo-EM density map 
with Situs48, using the colores routine for the initial fit at 15 Å and the collage routine for fitting 
subdomains of the ribosome (30S body, 30S head, 30S spur, 50S body and L1 stalk) as 
independent rigid bodies at progressively higher resolutions until reaching the map resolution. 
The pixel size was optimized by generating post-processed maps with different pixel sizes in 
Relion 2.1 and assessing the map-to-model correlation after real space refinement in Phenix49 
with the initial model. A model for the SpeFL peptide was built manually with Coot50 and refined 
through multiple rounds of real-space refinement in Phenix and manual rebuilding in Coot. The 
model was validated with MolProbity51. Automatic map sharpening was performed in Phenix 
using a refined model from which L-ornithine had been removed (Supplementary Fig. 7 and 9). 
The quality of the sharpened maps was such that ordered ions and solvent molecules could be 
modeled into the density and validated using the two structural replicates. Hydrated magnesium 
ion clusters were identified on the basis of their distinctive cryo-EM density. The identity of 
individual magnesium and potassium ions could be inferred by analogy with a recent X-ray 
structure of the Thermus thermophilus ribosome52. All other solvent molecules were modeled as 
unknown atom and residue types. The resulting map was used to prepare all figures except Fig. 
2a, for which a post-processed map from Relion was used (sharpening B-factor of –10). 
Figure preparation. Figures showing cryo-EM density or atomic models were prepared using 
Chimera53, Chimera X54 or Pymol Molecular Graphics Systems (version 1.7.4 Schrödinger)55. 
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Data availability. The SpeFL-ESRF and SpeFL-DLS structures were deposited in the RCSB PDB 
with accession codes 6TC3 and 6TBV, and cryo-EM maps were deposited in the EMDB with 
accession codes EMD-10458 and EMD-10453. 
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Supplementary	Figure	1	
 
Supplementary Figure 1 | Conservation of SpeFL across g-proteobacteria. a, Phylogenetic tree 
showing the distribution of representative speFL sequences from several orders of  g-
proteobacteria. b, Multiple sequence alignment of SpeFL homologs from different species. The 
sequence shown for Salmonella typhimurium corresponds to the previously reported orf341. 
SpeFL and its homologs belong to the group of proteins of unknown function DUF26182. The 
stop codon found after each sequence is indicated on the right of the alignment. 
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Supplementary	Figure	2	
 
Supplementary Figure 2 | Dose-dependence of ornithine-mediated ribosome stalling on speFL. 
Toeprinting assay3,4 to monitor the translation of wild type speFL in the presence of increasing 
concentrations of ornithine. All samples were treated with 90 µM puromycin. Arrows indicate 
	 23 
ribosomes stalled with the codon for the indicated amino acid in the P-site (Ala33 – open triangle; 
Arg34 – filled triangle). A schematic representation of the DNA template used for toeprinting is 
provided (RBS – ribosome binding site; NV15 – sequence used to anneal the Yakima Yellow-
labeled probe for reverse transcription). 
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Supplementary	Figure	3	
Supplementary Figure 3 | The amino acid sequence of SpeFL is important for ornithine-
dependent translational arrest. Toeprinting assay3,4 to monitor the translation of wild type (WT) 
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and double frameshifted (fs) speFL in the presence (+) or absence (–) of 10 mM ornithine, release 
factors (RF1,2,3) or 90 µM puromycin. Arrows indicate ribosomes stalled with the codon for the 
indicated amino acid in the P-site (Ala33 – open triangle; Arg34 – filled triangle). Schematic 
representations of the DNA templates used for toeprinting are provided (RBS – ribosome binding 
site; NV15 – sequence used to anneal the Yakima Yellow-labeled probe for reverse transcription). 
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Supplementary	Figure	4	
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Supplementary Figure 4 | Mechanism of the SpeFL- and Rho-dependent regulation of the speF 
operon. The mRNA sequence of speFL and part of the adjacent intergenic region is shown at 
various stages of the induction process, namely (a) when the RNA polymerase pauses on a hairpin 
encompassing the 3’ end of speFL, (b) when the leading ribosome translating speFL unwinds the 
pause hairpin, (c) when the leading ribosome terminates translation in the absence of ornithine 
to allow Rho to bind to the rut site and (d) when the leading ribosome stalls in the presence of 
ornithine and blocks Rho binding, allowing the operon to be transcribed. The footprints of the 
ribosomes are in gray, speFL is in turquoise, the rut site is in yellow, rare codons R12 and R13 
are in red and the UAG stop codon is indicated with an asterisk. The predicted 3’ end of the 
premature transcript is at position –1 of the consensus pause-inducing sequence element G–11G–
10(C/T)–1G+16. 
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Supplementary	Figure	5	
Supplementary Figure 5 | Purification of a SpeFL-70S complex stalled in the presence of 
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ornithine. a, Overlaid absorbance profiles of sucrose gradients containing a translation mixture 
incubated without ornithine (black), in the presence of 10 mM L-ornithine (red) or in the presence 
of 10 mM L-ornithine followed by treatment with 100 µM puromycin (blue). A schematic diagram 
depicting the expected ribosomal species in each fraction is shown on the right. b, Overlaid 
absorbance profiles of sucrose gradients loaded with polysomal fractions from a, with (blue) or 
without (black) RNase H treatment. Expected ribosomal species for each fraction are shown on 
the right. c, Schematic representation of the purification strategy for SpeFL-70S. The collected 
fractions are indicated with gray boxes.   
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Supplementary	Figure	6	
 
Supplementary Figure 6 | Flowchart of cryo-EM data processing for the SpeFL-ESRF and SpeFL-
DLS datasets. Steps where Relion 2.17 and Relion 3.08 were used are shown in purple and green, 
respectively. The step where Cryosparc 0.69 was used is indicated with an asterisk. Note the 
increase in resolution when using Relion 3.0 compared to Relion 2.1. This increase was also 
matched by the quality of the resulting cryo-EM density. Both structures could be refined to an 
overall resolution of 2.7 Å using a Fourier shell correlation (FSC) cutoff of 0.143. 
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Supplementary	Figure	7	
 
Supplementary Figure 7 | Quality of the cryo-EM reconstructions. a, Refined cryo-EM density 
map obtained in Relion 3.08 filtered and colored by local resolution estimation values in 
Chimera10. A cross-section of the same map is also shown. b,c,d, Representative cryo-EM 
densities for (b) a hydrated magnesium ion bound to the 23S rRNA, (c) the tunnel extension of 
ribosomal protein uL22 and (d) helix H64 of the 23S rRNA. 
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Supplementary	Figure	8	
 
Supplementary Figure 8| Interactions between SpeFL and the ribosome. A cartoon 
representation of SpeFL (turquoise) is shown in the middle panel. a, Potential hydrogen bond 
between Ala33 of SpeFL and the base of 23S rRNA residue G2061. b, Potential hydrogen bonds 
between Asn32 of SpeFL and the base of 23S rRNA residue U2584. c, Hydrophobic core of the 
SpeFL effector domain formed by residues Phe20, Phe26, Phe28, Phe30 and Phe31. Phe28, 
Phe30 and Phe31 of SpeFL form p-stacking interactions with the bases of 23S rRNA residues 
U2586, G2505 and A2062, respectively. d, Potential hydrogen bonds between Asn24 of SpeFL 
and Lys90 of ribosomal protein uL22, and electrostatic interaction between Arg23 of SpeFL and 
the phosphate backbone of 23S rRNA residue m5U747. e, The HIRRXXH ornithine-binding motif 
of SpeFL, showing potential hydrogen bonds between His10 and His16 of SpeFL, and Gly91 and 
Lys90 of ribosomal protein uL22, respectively. p-stacking interaction between 23S rRNA residue 
A1614 and His10 of SpeFL.  f, Electrostatic interactions between residue Glu2 of SpeFL and 
residues Arg67 of ribosomal protein uL4. Possible hydrogen bond between residue Asn3 of SpeFL 
and the phosphate backbone of 23S rRNA residue C796.  
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Supplementary	Figure	9	
 
Supplementary Figure 9 | Sharpened cryo-EM density for L-ornithine and neighboring solvent 
molecules. A single L-ornithine molecule (orange) surrounded by 4 solvent molecules (red) is 
fitted into the cryo-EM density of the ligand binding pocket obtained for the (a) SpeFL-ESRF and 
(b) SpeFL-DLS datasets. Note that peaks for the solvent molecules are visible in the two 
independently determined cryo-EM maps, indicating that these densities cannot be attributed to 
random noise. 
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Supplementary	Figure	10	
 
Supplementary Figure 10 | Small ligand binding pockets of the ribosomal exit tunnel. Overview 
and close-up view of a cross-section of the E. coli 70S ribosomal exit tunnel showing the L-
ornithine molecule observed in this work (orange) together with small molecules that are known 
to bind to the ribosomal exit tunnel: blasticin S (PDB: 4v9q, dark blue)11, chloramphenicol (PDB: 
4v7w, light green)12, clindamycin (PDB: 4v7v, magenta)13, dalfopristin (PDB: 4u24, light blue)14, 
erythromycin (PDB: 4v7u, purple)13, hygromycin (PDB: 5dox, red)15, linezolid (PDB: 3dll, pink)16, 
puromycin (PDB: 1q82, cyan)17, sparsomycin (PDB: 1njn, dark green)18 and tryptophan (PDB: 
4uy8, yellow)19. The different regions of the tunnel are highlighted: the tRNA binding pocket 
(red), the peptidyl transferase center (PTC) (orange), the upper tunnel (yellow), the constriction 
formed by uL22 and uL4 (green) and the lower tunnel (blue). 
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Supplementary	Figure	11	
Supplementary Figure 11 | Importance of residues 1–7of SpeFL. Toeprinting assay3,4 to monitor 
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the translation of wild-type speFL and speFLD1–7 in the absence (–) or presence (+) of 10 mM 
ornithine, release factors (RF1,2,3) or 90 µM puromycin. Arrows indicate ribosomes stalled with 
the indicated amino acid in the P-site (Ala33 – open triangle; Arg34 – filled triangle). A schematic 
representation of the DNA template used for toeprinting is provided (RBS – ribosome binding 
site; NV15 – sequence used to anneal the Yakima Yellow-labeled probe for reverse transcription). 
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Supplementary	Figure	12	
 
Supplementary Figure 12 | Importance of residues 12 and 13 of SpeFL. Toeprinting assay3,4 to 
monitor the translation of wild-type speFL, speFL-R12A-R13A (A12A13) and speFL-R12K-R13K 
(K12K13) in the absence (–) or presence (+) of 10 mM ornithine, release factors (RF1,2,3) or 90 µM 
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puromycin. Arrows indicate ribosomes stalled with the indicated amino acid in the P-site (Ala33 
– open triangle; Arg34 – filled triangle). A schematic representation of the DNA template used 
for toeprinting is provided (RBS – ribosome binding site; NV15 – sequence used to anneal the 
Yakima Yellow-labeled probe for reverse transcription). 
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Supplementary	Figure	13	
 
Supplementary Figure 13 | Importance of residues 10, 11 and 16 of SpeFL. Toeprinting assay3,4 
to monitor the translation of wild-type speFL, speFL-H10A, speFL-I11A and speFL-H16A in the 
	 40 
absence (–) or presence (+) of 10 mM ornithine, release factors (RF1,2,3) or 90 µM puromycin. 
Arrows indicate ribosomes stalled with the indicated amino acid in the P-site (Ala33 – open 
triangle; Arg34 – filled triangle). A schematic representation of the DNA template used for 
toeprinting is provided (RBS – ribosome binding site; NV15 – sequence used to anneal the Yakima 
Yellow-labeled probe for reverse transcription). 
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Supplementary Table 1 | Oligonucleotides  
Number Name Sequence 
1 T7_RBS_ATG_f 
CGA-TCG-AAT-TCT-AAT-ACG-ACT-CAC-
TAT-AGG-GCT-TAA-GTA-TAA-GGA-GGA-
AAA-AAT-ATG 
2 TP_SpeFL_WT_f 
GGA-GGA-AAA-AAT-ATG-GAA-AAT-AAC-
AGC-CGC-ACT-ATG-CCC-CAT-ATA-AGG-
CGG-ACA-ACT 
3 TP_speFL_NV_r 
GGT-TAT-AAT-GAA-TTT-TGC-TTA-TTA-
ACT-GCG-GAA-TAC-AGG-CAT-ATG-CCT-
GTA-ATA-CA 
4 
T7_f CGA-TCG-AAT-TCT-AAT-ACG-ACT-CAC-
TAT-AG 
5 TP_NV1_r 
GGT-TAT-AAT-GAA-TTT-TGC-TTA-TT 
6 TP_speFL_M1-7_f 
GGA-GGA-AAA-AAT-ATG-CCC-CAT-ATA-
AGG-CGG-ACA-ACT 
7 pZa_speFL_WT_f 
CTA-GTC-TTA-ATT-AAG-TCT-TAT-AAG-
GAG-GAA-AAC-ATA-TGG-AAA-ATA-ACA-
GCC-G 
8 pZa_speFL_WT_r 
CGA-CGT-TGT-AAA-ACG-ACG-GCC-AGT-
GAA-TCC-TTT-TTT-GAC-ATT-TTT-CAT-
CTC-TTT-A 
9 pZa_f 
GTG-GTT-ATA-ATG-AAT-CGT-TAA-TAA-
G 
10 pZa_r 
ATG-TTT-TCC-TCC-TTA-TAA-GAC-TTA-
ATT-AAG 
11 pZa_SpeFL R12cR13r_f CGT-CGG-ACA-ACT-CAT-ATT-ATG-AAG-
TTT-GCT-CAT-CGC-AAT-AGC 
12 pZa_SpeFL R12rR13c_f AGG-CGT-ACA-ACT-CAT-ATT-ATG-AAG-
TTT-GCT-CAT-CGC-AAT-AGC 
13 pZa_SpeFL R12cR13c_f CGT-CGT-ACA-ACT-CAT-ATT-ATG-AAG-
TTT-GCT-CAT-CGC-AAT-AGC 
14 pZa_SpeFL_R12R13_mut_r 
TAT-ATG-GGG-CAT-AGT-GCG-GCT-GTT-
ATT 
15 rnaseH 
CCT-CCT-TAT-AAA-ACT 
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Supplementary Table 2 | DNA templates  
Name Sequence 
TP_SpeFL_WT 
CGA-TCG-AAT-TCT-AAT-ACG-ACT-CAC-TAT-AGG-GCT-TAA-
GTA-TAA-GGA-GGA-AAA-AAT-ATG-GAA-AAT-AAC-AGC-CGC-
ACT-ATG-CCC-CAT-ATA-AGG-CGG-ACA-ACT-CAT-ATT-ATG-
AAG-TTT-GCT-CAT-CGC-AAT-AGC-TTC-GAC-TTT-CAC-TTC-
TTC-AAT-GCC-CGT-TAG-TCT-ACC-GAC-TAA-GGG-CAC-TTC-
AGC-GTA-CAG-GTC-TTC-CTG-ACT-CTC-TGT-ATT-ACA-GGC-
ATA-TGC-CTG-TAT-TCC-GCA-GTT-AAT-AAG-CAA-AAT-TCA-
TTA-TAA-CC 
TP_SpeFL_M1-7 
CGA-TCG-AAT-TCT-AAT-ACG-ACT-CAC-TAT-AGG-GCT-TAA-
GTA-TAA-GGA-GGA-AAA-AAT-ATG-CCC-CAT-ATA-AGG-CGG-
ACA-ACT-CAT-ATT-ATG-AAG-TTT-GCT-CAT-CGC-AAT-AGC-
TTC-GAC-TTT-CAC-TTC-TTC-AAT-GCC-CGT-TAG-TCT-ACC-
GAC-TAA-GGG-CAC-TTC-AGC-GTA-CAG-GTC-TTC-CTG-ACT-
CTC-TGT-ATT-ACA-GGC-ATA-TGC-CTG-TAT-TCC-GCA-GTT-
AAT-AAG-CAA-AAT-TCA-TTA-TAA-CC 
TP_SpeFL_fs 
CGA-TCG-AAT-TCT-AAT-ACG-ACT-CAC-TAT-AGG-GCT-TAA-
GTA-TAA-GGA-GGA-AAA-AAT-ATG-AAA-ATA-ACA-GCC-GCA-
CTA-TGC-CCC-ATA-TcA-GGC-GGA-CAA-CTC-ATA-TTA-TcA-
AGT-TTG-CTC-ATC-GCA-ATA-GCT-TCG-ACT-TTC-ACT-TCT-
TCA-ATG-CCC-GTT-tAG-TCT-ACC-GAC-TAA-GGG-CAC-TTC-
AGC-GTA-CAG-GTC-TTC-CTG-ACT-CTC-TGT-ATT-ACA-GGC-
ATA-TGC-CTG-TAT-TCC-GCA-GTT-AAT-AAG-CAA-AAT-TCA-
TTA-TAA-CC 
 
TP_speFL_R12AR13A 
CGA-TCG-AAT-TCT-AAT-ACG-ACT-CAC-TAT-AGG-GCT-TAA-
GTA-TAA-GGA-GGA-AAA-AAT-ATG-GAA-AAT-AAC-AGC-CGC-
ACT-ATG-CCC-CAT-ATA-gcg-gcg-ACA-ACT-CAT-ATT-ATG-
AAG-TTT-GCT-CAT-CGC-AAT-AGC-TTC-GAC-TTT-CAC-TTC-
TTC-AAT-GCC-CGT-TAG-TCT-ACC-GAC-TAA-GGG-CAC-TTC-
AGC-GTA-CAG-GTC-TTC-CTG-ACT-CTC-TGT-ATT-ACA-GGC-
ATA-TGC-CTG-TAT-TCC-GCA-GTT-AAT-AAG-CAA-AAT-TCA-
TTA-TAA-CC 
TP_speFL_R12KR13K 
CGA-TCG-AAT-TCT-AAT-ACG-ACT-CAC-TAT-AGG-GCT-TAA-
GTA-TAA-GGA-GGA-AAA-AAT-ATG-GAA-AAT-AAC-AGC-CGC-
ACT-ATG-CCC-CAT-ATA-Aaa-aaa-ACA-ACT-CAT-ATT-ATG-
AAG-TTT-GCT-CAT-CGC-AAT-AGC-TTC-GAC-TTT-CAC-TTC-
TTC-AAT-GCC-CGT-TAG-TCT-ACC-GAC-TAA-GGG-CAC-TTC-
AGC-GTA-CAG-GTC-TTC-CTG-ACT-CTC-TGT-ATT-ACA-GGC-
ATA-TGC-CTG-TAT-TCC-GCA-GTT-AAT-AAG-CAA-AAT-TCA-
TTA-TAA-CC 
TP_speFL_H10A 
CGA-TCG-AAT-TCT-AAT-ACG-ACT-CAC-TAT-AGG-GCT-TAA-
GTA-TAA-GGA-GGA-AAA-AAT-ATG-GAA-AAT-AAC-AGC-CGC-
ACT-ATG-CCC-gcg-ATA-AGG-CGG-ACA-ACT-CAT-ATT-ATG-
AAG-TTT-GCT-CAT-CGC-AAT-AGC-TTC-GAC-TTT-CAC-TTC-
TTC-AAT-GCC-CGT-TAG-TCT-ACC-GAC-TAA-GGG-CAC-TTC-
AGC-GTA-CAG-GTC-TTC-CTG-ACT-CTC-TGT-ATT-ACA-GGC-
ATA-TGC-CTG-TAT-TCC-GCA-GTT-AAT-AAG-CAA-AAT-TCA-
TTA-TAA-CC 
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Name Sequence 
TP_speFL_I11A 
CGA-TCG-AAT-TCT-AAT-ACG-ACT-CAC-TAT-AGG-GCT-TAA-
GTA-TAA-GGA-GGA-AAA-AAT-ATG-GAA-AAT-AAC-AGC-CGC-
ACT-ATG-CCC-CAT-gcg-AGG-CGG-ACA-ACT-CAT-ATT-ATG-
AAG-TTT-GCT-CAT-CGC-AAT-AGC-TTC-GAC-TTT-CAC-TTC-
TTC-AAT-GCC-CGT-TAG-TCT-ACC-GAC-TAA-GGG-CAC-TTC-
AGC-GTA-CAG-GTC-TTC-CTG-ACT-CTC-TGT-ATT-ACA-GGC-
ATA-TGC-CTG-TAT-TCC-GCA-GTT-AAT-AAG-CAA-AAT-TCA-
TTA-TAA-CC 
TP_speFL_H16A 
CGA-TCG-AAT-TCT-AAT-ACG-ACT-CAC-TAT-AGG-GCT-TAA-
GTA-TAA-GGA-GGA-AAA-AAT-ATG-GAA-AAT-AAC-AGC-CGC-
ACT-ATG-CCC-CAT-ATA-AGG-CGG-ACA-ACT-gcg-ATT-ATG-
AAG-TTT-GCT-CAT-CGC-AAT-AGC-TTC-GAC-TTT-CAC-TTC-
TTC-AAT-GCC-CGT-TAG-TCT-ACC-GAC-TAA-GGG-CAC-TTC-
AGC-GTA-CAG-GTC-TTC-CTG-ACT-CTC-TGT-ATT-ACA-GGC-
ATA-TGC-CTG-TAT-TCC-GCA-GTT-AAT-AAG-CAA-AAT-TCA-
TTA-TAA-CC 
TP_speFL_F26A 
CGA-TCG-AAT-TCT-AAT-ACG-ACT-CAC-TAT-AGG-GCT-TAA-
GTA-TAA-GGA-GGA-AAA-AAT-ATG-GAA-AAT-AAC-AGC-CGC-
ACT-ATG-CCC-CAT-ATA-AGG-CGG-ACA-ACT-CAT-ATT-ATG-
AAG-TTT-GCT-CAT-CGC-AAT-AGC-gcg-GAC-TTT-CAC-TTC-
TTC-AAT-GCC-CGT-TAG-TCT-ACC-GAC-TAA-GGG-CAC-TTC-
AGC-GTA-CAG-GTC-TTC-CTG-ACT-CTC-TGT-ATT-ACA-GGC-
ATA-TGC-CTG-TAT-TCC-GCA-GTT-AAT-AAG-CAA-AAT-TCA-
TTA-TAA-CC 
TP_speFL_F28A 
CGA-TCG-AAT-TCT-AAT-ACG-ACT-CAC-TAT-AGG-GCT-TAA-
GTA-TAA-GGA-GGA-AAA-AAT-ATG-GAA-AAT-AAC-AGC-CGC-
ACT-ATG-CCC-CAT-ATA-AGG-CGG-ACA-ACT-CAT-ATT-ATG-
AAG-TTT-GCT-CAT-CGC-AAT-AGC-TTC-GAC-gcg-CAC-TTC-
TTC-AAT-GCC-CGT-TAG-TCT-ACC-GAC-TAA-GGG-CAC-TTC-
AGC-GTA-CAG-GTC-TTC-CTG-ACT-CTC-TGT-ATT-ACA-GGC-
ATA-TGC-CTG-TAT-TCC-GCA-GTT-AAT-AAG-CAA-AAT-TCA-
TTA-TAA-CC 
TP_speFL_F30A 
CGA-TCG-AAT-TCT-AAT-ACG-ACT-CAC-TAT-AGG-GCT-TAA-
GTA-TAA-GGA-GGA-AAA-AAT-ATG-GAA-AAT-AAC-AGC-CGC-
ACT-ATG-CCC-CAT-ATA-AGG-CGG-ACA-ACT-CAT-ATT-ATG-
AAG-TTT-GCT-CAT-CGC-AAT-AGC-TTC-GAC-TTT-CAC-gcg-
TTC-AAT-GCC-CGT-TAG-TCT-ACC-GAC-TAA-GGG-CAC-TTC-
AGC-GTA-CAG-GTC-TTC-CTG-ACT-CTC-TGT-ATT-ACA-GGC-
ATA-TGC-CTG-TAT-TCC-GCA-GTT-AAT-AAG-CAA-AAT-TCA-
TTA-TAA-CC 
TP_speFL_F31A 
CGA-TCG-AAT-TCT-AAT-ACG-ACT-CAC-TAT-AGG-GCT-TAA-
GTA-TAA-GGA-GGA-AAA-AAT-ATG-GAA-AAT-AAC-AGC-CGC-
ACT-ATG-CCC-CAT-ATA-AGG-CGG-ACA-ACT-CAT-ATT-ATG-
AAG-TTT-GCT-CAT-CGC-AAT-AGC-TTC-GAC-TTT-CAC-TTC-
gcg-AAT-GCC-CGT-TAG-TCT-ACC-GAC-TAA-GGG-CAC-TTC-
AGC-GTA-CAG-GTC-TTC-CTG-ACT-CTC-TGT-ATT-ACA-GGC-
ATA-TGC-CTG-TAT-TCC-GCA-GTT-AAT-AAG-CAA-AAT-TCA-
TTA-TAA-CC 
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Name Sequence 
TP_speFL_N32A 
CGA-TCG-AAT-TCT-AAT-ACG-ACT-CAC-TAT-AGG-GCT-TAA-
GTA-TAA-GGA-GGA-AAA-AAT-ATG-GAA-AAT-AAC-AGC-CGC-
ACT-ATG-CCC-CAT-ATA-AGG-CGG-ACA-ACT-CAT-ATT-ATG-
AAG-TTT-GCT-CAT-CGC-AAT-AGC-TTC-GAC-TTT-CAC-TTC-
TTC-gcg-GCC-CGT-TAG-TCT-ACC-GAC-TAA-GGG-CAC-TTC-
AGC-GTA-CAG-GTC-TTC-CTG-ACT-CTC-TGT-ATT-ACA-GGC-
ATA-TGC-CTG-TAT-TCC-GCA-GTT-AAT-AAG-CAA-AAT-TCA-
TTA-TAA-CC 
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Supplementary Table 3 | Cryo-EM statistics and model refinement 
 #1 SpeFL-ESRF 
(EMDB-10458) 
(PDB 6TC3) 
#2 SpeFL-DLS 
(EMDB-10453) 
(PDB 6TBV) 
Data collection and 
processing 
  
Magnification    130,000x 130,000x 
Voltage (kV) 300 300 
Electron exposure (e–/Å2) 30 29.6 
Defocus range (µm) -0.5 to -1.6 -0.6 to -1.5 
Pixel size (Å) 1.067 1.067 
Symmetry imposed C1 C1 
Initial particle images (no.) 226,054 305,663 
Final particle images (no.) 68,195 137,494  
Map resolution (Å) 2.7 2.7 
FSC threshold 0.143 0.143 
Map resolution range (Å) 2.5-10 2.5-8.7 
   
Refinement   
Initial model used (PDB 
code) 
4ybb 4ybb 
Model resolution (Å) 2.1 2.1 
    FSC threshold 0.143 0.143 
Model resolution range (Å) 2.1-69.39 2.1-69.39 
Map sharpening B factor (Å2) -10 -10 
Model composition   
    Non-hydrogen atoms 245,116 245,116 
    Protein residues 10,310 10,310 
    Ligands   
B factors (Å2)   
    Protein 48.22 53.05 
    Ligand 34.32 38.14 
R.m.s. deviations 
    Bond lengths (Å) 
    Bond angles (°) 
 
0.01 
0.97 
 
0.01 
0.93 
 Validation 
    MolProbity score 
    Clashscore 
    Poor rotamers (%)    
 
1.21 
1.82 
0.41 
 
1.17 
1.66 
0.6 
 Ramachandran plot 
    Favored (%) 
    Allowed (%) 
    Disallowed (%) 
 
96.12 
3.74 
0.14 
 
96.27 
3.66 
0.07 
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Supplementary	Data	1 
 
Supplementary Data 1 | Ornithine-dependent ribosomal stalling on speFL. Toeprinting assay3,4 
to monitor the translation of speFL in the absence (–) or presence (+) of 10 mM ornithine, 10 mM 
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putrescine, release factors (RF1,2,3) or 90 µM puromycin. Arrows indicate ribosomes stalled with 
the codon for the indicated amino acid in the P-site (Ala33 – open triangle; Arg34 – filled 
triangle). A schematic representation of the DNA template used for toeprinting is provided (RBS 
– ribosome binding site; NV15 – sequence used to anneal the Yakima Yellow-labeled probe for 
reverse transcription). 
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Supplementary	Data	2 
 
Supplementary Data 2 | Selectivity of SpeFL for L-ornithine.  Toeprinting assay3,4 to monitor the 
translation of wild-type (WT) speFL in the absence (–) or presence of 10 mM (+) of various small 
molecules (see Fig. 2e for details). All samples were treated with 90 µM puromycin. Arrows 
indicate ribosomes stalled with the indicated amino acid in the P-site (Ala33 – open triangle; 
Arg34 – filled triangle). A schematic representation of the DNA template used for toeprinting is 
provided (RBS – ribosome binding site; NV15 – sequence used to anneal the Yakima Yellow-
labeled probe for reverse transcription).  
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Supplementary	Data	3 
 
Supplementary Data 3 | Aromatic residues in the SpeFL effector domain are important for 
translational arrest.  Toeprinting assay3,4 to monitor the translation of wild-type (WT) and mutant 
speFL in the absence (–) or presence (+) of 10 mM ornithine, release factors (RF1,2,3) or 90 µM 
puromycin.  Arrows indicate ribosomes stalled with the indicated amino acid in the P-site (Ala33 
– open triangle; Arg34 – filled triangle). A schematic representation of the DNA template used 
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for toeprinting is provided (RBS – ribosome binding site; NV15 – sequence used to anneal the 
Yakima Yellow-labeled probe for reverse transcription). 
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